Account Options

  1. Sign in
    Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

    Patents

    1. Advanced Patent Search
    Publication numberUS20100130743 A1
    Publication typeApplication
    Application numberUS 12/694,441
    Publication date27 May 2010
    Filing date27 Jan 2010
    Priority date12 Mar 2004
    Also published asDE602005017474D1, EP1727804A1, EP1727804B1, US7674807, US20070299085, WO2005095351A1
    Publication number12694441, 694441, US 2010/0130743 A1, US 2010/130743 A1, US 20100130743 A1, US 20100130743A1, US 2010130743 A1, US 2010130743A1, US-A1-20100130743, US-A1-2010130743, US2010/0130743A1, US2010/130743A1, US20100130743 A1, US20100130743A1, US2010130743 A1, US2010130743A1
    InventorsKatsuaki Wada, Takuya Gombuchi, Yasushi Yoneta, Yuichi Otsu, Katsuhiko Shibuya, Norihiko Nakakura, Rüdiger Fischer, Tetsuya Murata, Eiichi Shimojo
    Original AssigneeBayer Cropscience Ag
    Export CitationBiBTeX, EndNote, RefMan
    External Links: USPTO, USPTO Assignment, Espacenet
    Heterocycle-substituted, n-phenyl-phthalamide derivatives, related compounds and their use as insecticides
    US 20100130743 A1
    Abstract
    Novel benzenedicarboxamides of the formula (I) wherein X represents hydrogen, halogen atom, nitro, C1-6alkylsulfonyloxy, C1-6alkylsulfinyl, C1-6alkylsulfenyl or C1-6alkylsulfonyl, R1 represents C1-6alkyl, C1-6alkylthio-C1-6alkyl, C1-6alkylsulfinyl-C1-6alkyl or C1-6 alkylsulfonyl-C1-6alkyl, Y represents halogen or C1-6alkyl, m represents 0 or 1, A represents O, S, SO, SO2, CH2 or CH(CH3), and Q represents a 5- or 6-membered heterocyclic group that contains at least one hetero atom selected from the group consisting of N, O and S and can be optionally substituted; processes for their preparation, their intermediates and their use as insecticides.
    Images(57)
    Previous page
    Next page
    Claims(6)
    1-3. (canceled)
    4. A process for the preparation of a compound of formula (I),
    wherein
    X represents hydrogen, halogen, nitro, C1-6alkylsulfonyloxy, C1-6alkylsulfinyl, C1-6alkylsulfenyl or C1-6alkylsulfonyl,
    R1 represents C1-6alkyl, C1-6alkylthio-C1-6alkyl, C1-6alkylsulfinyl-C1-6alkyl or C1-6alkylsulfonyl-C1-6alkyl,
    Y represents halogen or C1-6alkyl,
    m represents 0 or 1,
    A represents O, S, SO, SO2, CH2 or CH(CH3), and
    Q represents a 5-membered or 6-membered heterocyclic group that contains at least one hetero atom selected from the group consisting of N, O and S and can be optionally substituted;
    comprising
    (a) reacting a compound of formula (II)
    wherein R1 and X have the same definition as above, with a compound of formula (III)
    wherein Y, A, m and Q have the same definition as above, in the presence of an inert solvent, and optionally in the presence of an acid catalyst, or
    (b) reacting a compound of formula (IV)
    wherein X, Y, A, m and Q have the same definitions as above with a compound of formula (V)

    H2N—R1  (V)
    wherein R1 has the same definition as above, in the presence of an inert solvent, and optionally in the presence of an acid catalyst, or
    (c) reacting a compound of formula (VI)
    wherein X and R1 have the same definitions as above, with a compound of formula (III),
    wherein Y, A, m and Q have the same definition as above, in the presence of an inert solvent, and optionally in the presence of an acid catalyst, or
    (d) reacting a compound of formula (VII)
    wherein X, Y, A, m and Q have the same definitions as above, with a compound of formula (V),

    H2N—R1  (V)
    wherein R1 has the same definitions as above, in the presence of an inert solvent, and optionally in the presence of an acid catalyst, or
    (e) reacting a compound of formula (VIII)
    wherein X, Y, A, m and Q have the same definitions as above, with a compound of formula (V),

    H2N—R1  (V)
    wherein R1 has the same definitions as above, in the presence of an inert solvent, and optionally in the presence of an acid catalyst, or
    (f) in case where R1 represents C1-6alkylsulfinyl-C1-6alkyl or C1-6alkylsulfonyl-C1-6alkyl in formula (I): reacting a compound of formula (If)
    wherein
    RIf represents C1-6alkylthio-C1-6alkyl, and
    X, Y, A, m and Q have the same definitions as above, with an oxidizing agent in the presence of an inert solvent.
    5-9. (canceled)
    10. A compound of formula (VII)
    wherein
    X represents hydrogen, halogen, nitro, C1-6alkylsulfonyloxy, C1-6alkylsulfinyl, C1-6alkylsulfenyl or C1-6alkylsulfonyl,
    Y represents halogen or C1-6alkyl,
    A represents O, S, SO, SO2, CH2 or CH(CH3),
    m represents 0 or 1, and
    Q represents a 5-membered or 6-membered heterocyclic group that contains at least one hetero atom selected from the group consisting of N, O and S and can be optionally substituted.
    11. (canceled)
    12. A compound of formula (IX)
    wherein
    X represents hydrogen, halogen, nitro, C1-6alkylsulfonyloxy, C1-6alkylsulfinyl, C1-6alkylsulfenyl or C1-6alkylsulfonyl,
    Y represents halogen or C1-6alkyl,
    A represents O, S, SO, SO2, CH2 or CH(CH3),
    m represents 0 or 1, and
    Q represents a 5-membered or 6-membered heterocyclic group that contains at least one hetero atom selected from the group consisting of N, O and S and can be optionally substituted.
    Description
    • [0001]
      The present invention relates to novel benzenedicarboxamides, processes for the preparation thereof, their intermediates and their use as insecticides.
    • [0002]
      It was already known that phthalamide derivatives are useful as insecticides [see JP-A 11-240857 (1999), JP-A 2001-64258, JP-A 2001-64268, JP-A 2001-131141, JP-A 2003-40864, WO 01/21576 and WO 03/11028], and also that they show medicinal function [see JP-A 59-163353 (1984)].
    • [0003]
      There have now been found novel benzenedicarboxamides of the formula (I)
    • [0000]
    • [0000]
      wherein
      • X represents hydrogen, halogen atom, nitro, C1-6alkylsulfonyloxy, C1-6alkylsulfinyl, sulfenyl or C1-6alkylsulfonyl,
        • R1 represents C1-6alkyl, C1-6alkylsulfinyl-C1-6alkyl or C1-4 alkylsulfonyl-C1-6alkyl,
      • Y represents halogen or C1-6alkyl,
      • m represents 0 or 1,
      • A represents O, S, SO, SO2, CH2 or CH(CH3), and
      • Q represents a 5- or 6-membered heterocyclic group that contains at least one hetero atom selected from the group consisting of N, O and S and can be optionally substituted.
    • [0010]
      The compounds of the formula (I), according to the invention, can be obtained by
      • (a) reacting compounds of the formula (II)
    • [0000]
        • wherein R1 and X have the same definitions as aforementioned,
        • with compounds of the formula (III)
    • [0000]
        • wherein Y, A, m and Q have the same definitions as aforementioned,
        • in the presence of inert solvents, and if appropriate in the presence of an acid catalyst,
          or
      • (b) reacting compounds of the formula (IV)
    • [0000]
        • wherein X, Y, A, m and Q have the same definitions as aforementioned,
        • with compounds of the formula (V)
    • [0000]

      H2N—R1  (V)
        • wherein R1 has the same definitions as aforementioned,
        • in the presence of inert solvents, and if appropriate in the presence of an acid catalyst,
          or
      • (c) reacting compounds of the formula (VI)
    • [0000]
        • wherein X and R1 have the same definitions as aforementioned,
        • with the compounds of the formula (III),
    • [0000]
        • wherein Y, A, m and Q have the same definitions as aforementioned,
        • in the presence of inert solvents, and if appropriate in the presence of an acid catalyst,
          or
      • (d) reacting compounds of the formula (VII)
    • [0000]
        • wherein X, Y, A, m and Q have the same definitions as aforementioned,
        • with the compounds of the formula (V),
    • [0000]

      H2N—R1  (V)
        • wherein R1 has the same definitions as aforementioned,
        • in the presence of inert solvents, and if appropriate in the presence of an acid catalyst,
          or
      • (e) compounds of the formula (VIII)
    • [0000]
        • wherein X, Y, A, in and Q have the same definitions as aforementioned,
        • are reacted with the compounds of the formula (V),
    • [0000]

      H2N—R1  (V)
        • wherein R1 has the same definitions as aforementioned,
        • in the presence of inert solvents, and if appropriate in the presence of an acid catalyst,
          or
      • (f) in the case that R1 represents C1-6alkylsulfinyl-C1-6alkyl or C1-6alkylsulfonyl-C1-6alkyl in the formula (I), reacting compounds of the formula (If)
    • [0000]
        • wherein
        • R1f represents C1-6alkylthio-C1-6alkyl, and
        • X, Y, A, in and Q have the same definitions as aforementioned,
        • with an oxidizing agent in the presence of inert solvents.
    • [0041]
      According to the present invention, the benzenedicarboxamides of the formula (I) show a strong insecticidal action.
    • [0042]
      The compounds of the formula (I) are conceptually embraced in the general formula described in the aforementioned JP-A 11-240857 (1999). But they are not specifically disclosed at all in it and new compounds. Surprisingly, they show particularly remarkable insecticidal action compared with similar compounds described in the known prior art.
    • [0043]
      In the present specification:
    • [0044]
      “Halogen” represents fluorine, chlorine, bromine and iodine, and preferably represents fluorine, chlorine and bromine.
    • [0045]
      “Alkyl” represents straight chain or branched chain C1-12alkyl, for example, methyl, ethyl, n- or iso-propyl, n-, iso-, sec- or tert-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, etc. and preferably represents C1-6alkyl.
    • [0046]
      As each alkyl part in “alkylsulfonyloxy”, “alkylsulfenyl”, “alkylthioalkyl”, “alkylsulfinylalkyl”, “alkylsulfonylalkyl”, “alkoxy”, “alkylthio”, “alkylsulfinyl”, “alkylsulfonyl”, “haloalkyl”, “haloalkoxy”, “haloalkylthio”, “haloalkylsulfinyl”, “haloalkylsulfonyl” and “haloalkylcarbonyl”, there can be mentioned the same as described in the above-mentioned “alkyl” as examples.
    • [0047]
      As each halogen part in “haloalkyl”, “haloalkoxy”, “haloalkylthio”, “haloalkylsulfinyl”, “haloalkylsulfonyl” and “haloalkylcarbonyl”, there can be mentioned the same as described in the above-mentioned “halogen” as examples.
    • [0048]
      “5- or 6-membered heterocyclic group” contains at least one hetero atom selected from the group consisting of N, O and S, and preferably represents a heterocyclic group containing “one to three N atoms”, or “one O atom”, or “one S atom”, or “both one S atom and one to two N atoms”, or “both one O atom and one to two N atoms”, and as specific examples thereof, pyrazolyl, triazolyl, pyrazolinyl, imidazolyl, thiazolyl, pyrrolyl, furyl, thienyl, oxadiazolyl and pyrimidinyl, and moreover as most preferable examples thereof, pyrazolyl, triazolyl, pyrazolinyl, imidazolyl, thiazolyl, pyrrolyl, oxadiazolyl and pyrimidinyl are exemplified.
    • [0049]
      In the compounds of the formula (I), according to the invention, the compounds in case that
      • X represents hydrogen, fluorine, chlorine, bromine, iodine, nitro, C1-4 alkylsulfonyloxy, C1-4alkylsulfinyl, C1-4 alkylsulfenyl or C1-4 alkylsulfonyl,
      • R1 represents C1-4alkyl, C1-4alkylthio-C1-4alkyl, C1-4alkylsulfinyl-C1-4alkyl or C1-4alkylsulfonyl-C1-4alkyl,
      • Y represents fluorine, chlorine, bromine or C1-4alkyl,
      • m represents 0 or 1,
      • A represents O, S, SO, SO2, CH2 or CH(CH3), and
      • Q represents 5-membered or 6-membered heterocyclic group that contains at least one hetero atom selected from a group consisting of N, O and S and can be optionally substituted by at least one selected from a group consisting of C1-6alkyl, C1-6alkoxy, C1-6alkylthio, C1-6alkylsulfinyl, C1-6alkylsulfonyl, C1-10haloalkoxy, C1-6haloalkoxy, C1-6haloalkylthio, C1-6haloalkylsulfinyl, C1-6haloalkylsulfonyl, C1-6haloalkylcarbonyl, halogen, oxo and hydroxy group, can be mentioned as preferable.
    • [0056]
      Above all, in the compounds of the formula (I), the compounds in case that
      • X represents hydrogen, fluorine, chlorine, bromine, iodine, nitro, methanesulfonyloxy, C1-2 alkylsulfenyl or C1-2 alkylsulfonyl,
      • R1 represents isopropyl, C1-2alkylthio-C3-4alkyl, C1-2alkylsulfinyl-C3-4alkyl or C1-2alkylsulfonyl-C3-4alkyl,
      • Y represents fluorine, chlorine or methyl,
      • m represents 0 or 1,
      • A represents O, S, SO, SO2, CH2 or CH(CH3), and
      • Q represents heterocyclic group, selected from a group consisting of pyrazolyl, triazolyl, pyrazolinyl, imidazolyl, thiazolyl, pyrrolyl, oxadiazolyl and pyrimidinyl, that can be optionally substituted by at least one selected from the group consisting of C1-4alkyl, C1-4alkoxyl, C1-4alkylthio, C1-4alkylsulfinyl, C1-4alkylsulfonyl, C1-8haloalkyl, C1-4haloalkoxy, C1-4haloalkylthio, C1-4haloalkylsulfinyl, C1-4haloalkylsulfonyl, C1-4haloalkylcarbonyl, fluorine, chlorine, bromine, iodine, oxo and hydroxy group,
        are particularly preferable.
    • [0063]
      The compounds of the formula (I), according to the present invention, include stereo isomers (R/S configuration) in case that the group R1 has an asymmetric carbon.
    • [0064]
      The aforementioned process (a) can be illustrated by the following reaction scheme in case that, for example, 3-(1,1-dimethyl-2-methylthioethylimino)-4-iodo-3H-isobenzofuran-1-one and 1-(4-amino-3-methylbenzyl)-3,5-bis(trifluoromethyl)-1H-pyrazole are used as starting materials.
    • [0000]
    • [0065]
      The aforementioned preparation process (b) can be illustrated by the following reaction scheme in case that, for example, 2-{4-[3,5-bis(trifluoromethyl)pyrazole-1-ylmethyl]-2-methylphenyl}-4-fluoroisoindole-1,3-dione and (S)-1-methyl-2-methylthioethylamine are used as starting materials.
    • [0000]
    • [0066]
      The aforementioned preparation process (c) can be illustrated by the following reaction scheme in case that, for example, 3-iodo-N-(1,1-dimethyl-2-methylthioethyl)-phthalamic acid and 2-methyl-4-[1-(3-trifluoromethylpyrazole-1-yl)-ethyl]aniline are used as starting materials.
    • [0000]
    • [0067]
      The aforementioned preparation process (d) can be illustrated by the following reaction scheme in case that, for example, 1-[4-(4-iodo-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methyl-benzyl]-3,5-bis(trifluoromethyl)-(1,2,4)-triazol and 1-methyl-2-methylthioethylamine are used as starting materials.
    • [0000]
    • [0068]
      The aforementioned preparation process (e) can be illustrated by the following reaction scheme in case that, for example, N-{4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-ylmethyl]-2-methyl-phenyl}-6-iodo-phthalamic acid and 1-methyl-2-methylthioethylamine are used as starting materials.
    • [0000]
    • [0069]
      The aforementioned process (f) can be illustrated by the following reaction scheme in case that, for example, N2-(1-methyl-2-methylthioethyl)-3-iodo-N1-{2-methyl-4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-ylmethyl]phenyl}phthalamide and m-chloroperbenzoic acid are used as starting materials.
    • [0000]
    • [0070]
      The compounds of the formula (II), used as starting materials in the above-mentioned preparation process (a), are per se known compounds and can be easily prepared according to the process described in, for example, JP-A 11-240857 (1999), JP-A 2001-131141.
    • [0071]
      As specific examples of the compounds of the formula (Ia), used as starting materials in the preparation process (a), there can be mentioned the following:
      • 3-isopropylimino-3H-isobenzofuran-1-one,
      • 4-fluoro-3-isopropylimino-3H-isobenzofuran-1-one,
      • 4-chloro-3-isopropylimino-3H-isobenzofuran-1-one,
      • 4-bromo-3-isopropylimino-3H-isobenzofuran-1-one,
      • 4-iodo-3-isopropylimino-3H-isobenzofuran-1-one,
      • 3-(1-methyl-2-methylsulfanyl-ethylimino)-3H-isobenzofuran-1-one,
      • 4-fluoro-3-(1-methyl-2-methylsulfanyl-ethylimino)-3H-isobenzofuran-1-one,
      • 4-chloro-3-(1-methyl-2-methylsulfanyl-ethylimino)-3H-isobenzofuran-1-one,
      • 4-bromo-3-(1-methyl-2-methylsulfanyl-ethylimino)-3H-isobenzofuran-1-one,
      • 4-iodo-3-(1-methyl-2-methylsulfanyl-ethylimino)-3H-isobenzofuran-1-one,
      • 3-(1,1-dimethyl-2-methylsulfanyl-ethylimino)-3H-isobenzofuran-1-one,
      • 3-(1,1-dimethyl-2-methylsulfanyl-ethylimino)-4-fluoro-3H-isobenzofuran-1-one,
      • 4-chloro-3-(1,1-dimethyl-2-methylsulfanyl-ethylimino)-3H-isobenzofuran-1-one,
      • 4-bromo-3-(1,1-dimethyl-2-methylsulfanyl-ethylimino)-3H-isobenzofuran-1-one,
      • 3-(1,1-dimethyl-2-methylsulfanyl-ethylimino)-4-iodo-3H-isobenzofuran-1-one,
      • 3-isopropylimino-1-oxo-1,3-dihydro-isobenzofuran-4-yl methanesulfonate
      • 3-(1-methyl-2-methylsulfanyl-ethylimino)-1-oxo-1,3-dihydro-isobenzofuran-4-yl methanesulfonate
      • 3-(1,1-dimethyl-2-methylsulfanyl-ethylimino)-1-oxo-1,3-dihydro-isobenzofuran-4-yl
        methanesulfonate and so on.
    • [0090]
      The compounds of the formula (III), used as starting materials in the above-mentioned preparation process (a), which are partly novel compounds that are not described in the existing literature yet, can be obtained, for example, by reducing compounds of the formula (IX)
    • [0000]
    • [0000]
      wherein Y, A, m and Q have the same definitions as aforementioned,
      according to the catalytic hydrogen reduction process, a well-known process in the field of organic chemistry, with hydrogen in the presence of a catalytic reduction catalyst, for example, palladium carbon, Raney nickel, platinum oxide, etc.
    • [0091]
      The above-mentioned catalytic hydrogen reduction process can be conducted in an adequate diluent.
    • [0092]
      As examples of the diluent used in that case there can be mentioned ethers, for example, ethyl ether, methyl ethyl ether, isopropyl ether, butyl ether, dioxane, tetrahydrofuran (THF), etc.; alcohols, for example, methanol, ethanol, isopropanol, butanol, ethylene glycol, etc. and as catalytic reduction catalyst there can be mentioned, palladium carbon, Raney nickel, platinum oxide, etc.
    • [0093]
      The reaction can be conducted at the temperatures generally from about 0 to about 100° C., preferably from room temperature (20° C.) to about 80° C.
    • [0094]
      Said reaction can be conducted usually under normal pressure but can be operated optionally also under elevated pressure.
    • [0095]
      For example, a compound of the formula (III) can be obtained by hydrogenating the compounds of the formula (IX) in a diluent, for example, ethanol, in the presence of 0.1-10% (w/w) palladium carbon.
    • [0096]
      Also by a reduction reaction using metals etc. instead of catalytic hydrogen reduction, the compounds of the formula (III) can be obtained from the compounds of the formula (IX).
    • [0097]
      As a reduction process using metals etc., there can be mentioned, for example, a process of reacting iron powder in acetic acid, a process of reacting zinc dust under neutral condition (Organic Syntheses Collective Vol. II, p. 447), a process of reacting stannic chloride under acidic condition (Organic Syntheses Collective Vol. II, p. 254), a process of reacting titanium trichloride under neutral condition, etc.
    • [0098]
      The compounds of the formula (IX) are novel compounds and can be obtained by reacting the compounds of the formula (IX) wherein A represents other than oxygen atom, for example, compounds of the formula (X)
    • [0000]
    • [0000]
      wherein
      • Y and m have the same definitions as aforementioned,
      • A1 represents S, SO, SO2, CH2 or CH(CH3), and
      • M represents chlorine, bromine or methanesulfonyloxy,
        with compounds of the formula (XI)
    • [0000]

      H-Q  (XI)
    • [0000]
      wherein Q has the same definition as aforementioned.
    • [0102]
      The compounds of the formula (X), are well known in the field of organic chemistry and described in publications, for example, Chem. Abstr., Vol. 58, 3444e (1963); Bull. Soc. Claim. Fr. (1934), p. 539-545; J. Chem. Res. Miniprint, Vol. 8 (1987), p. 2133-2139; J. Chem. Soc. B (1967), p. 1154-1158; J. Chem. Soc. (1961), p. 221-222; J. Amer. Chem. Soc., Vol. 111 (1989), p. 5880-5886; J. Amer. Chem. Soc., Vol. 96 (1974), p. 7770-7781; Can. J. Chem., Vol. 68 (1990), p. 1450-1455, Tetrahedron Letter, vol. 35 (1994), p. 7391-7394.
    • [0103]
      As specific examples of the compounds of the formula (X), there can be mentioned specifically
      • 2-methyl-4-nitrobenzyl chloride,
      • 3-methyl-4-nitrobenzyl chloride
      • 4-nitrobenzyl methanesulfonate
      • 2-methyl-4-nitrobenzyl methanesulfonate
      • 3-methyl-4-nitrobenzyl methanesulfonate,
      • 4-nitrobenzenesulfenyl chloride,
      • 4-nitrobenzenesulfinyl chloride,
      • 4-nitrobenzenesulfonyl chloride,
      • 4-nitro-3-methylbenzenesulfonyl chloride,
      • 3-fluoro-4-nitrobenzyl bromide,
      • 3-chloro-4-nitrobenzyl chloride and so on.
    • [0115]
      The nitro-substituted benzoic acids and their esters, starting materials of the compounds of the formula (X), are known compounds described in, for example, Chem. Ber., Vol. 52 (1919), p. 1083; Bull. Soc. Chim. Fr. (1962), p. 2255-2261; Tetrahedron (1985), p. 115-118; Chem. Pharm. Bull., Vol. 41 (1993), p. 894-906; WO 2001/042227.
    • [0116]
      The compounds of the formula (XI) include known compounds and as their specific examples, there can be mentioned:
      • 3,5-bis(trifluoromethyl)-1H-pyrazole,
      • 5-difluoromethoxy-3-trifluoromethyl-1H-pyrazole,
      • 4-pentafluoroethyl-1H-pyrazole,
      • 5-hexafluoro-n-propyl-1H-pyrazole,
      • 3,5-bis(trifluoromethyl)-1H-(1,2,4)-triazole,
      • 5-pentafluoroethyl-3-trifluoromethyl-1H-(1,2,4)-triazole,
      • 5-difluoromethyl-3-trifluoromethyl-1H-(1,2,4) triazole,
      • 5-hydroxy-3,5-bis(trifluoromethyl)-1H-4,5-dihydropyrazole,
      • 2,4-bis(trifluoromethyl)-1H-imidazole,
      • 3-(2,2,2-trifluoroethyl)-5-trifluoromethyl-1,2-dihydro-(1,3,4)-triazol-2-one,
      • 2,5-bis(trifluoromethyl)-(1,3,4)-triazole,
      • 5-pentafluoroethyl-1H-pyrazole,
      • 3-pentafluoroethyl-1H-pyrazole,
      • 4-bromo-3-trifluoromethyl-1H-pyrazole,
      • 3-trifluoromethyl-1H-pyrazole,
      • 5-(difluoromethyl)-1,2-dihydro-2-methyl-3H-(1,2,4)-triazol-3-one,
      • 4-(trifluoromethyl)-2H-1,2,3-triazole,
      • 4-iodo-3-pentafluoroethyl-1H-pyrazole,
      • 3-pentafluoroethyl-4-(1,1,2,2-tetrafluoroethyl)-1H-pyrazole,
      • 3,4-bis-pentafluoroethyl-1H-pyrazole,
      • 3,5-diiodo-4-methyl-1H-pyrazole,
      • 3-Heptafluoropropylsulfanyl-5-trifluoromethyl-1H-(1,2,4)-triazole,
      • 3,5-bis(pentafluoroethyl)-1H-(1,2,4)-triazole and so on.
    • [0140]
      The above-mentioned reaction of the compounds of the formula (X) with the compounds of the formula (XI) can be conducted in an adequate diluent.
    • [0141]
      As examples of the diluent used in that case there can be mentioned, for example, aliphatic, alicyclic and aromatic hydrocarbons (may be optionally chlorinated), for example, pentane, hexane, cyclohexane, petroleum ether, ligroine, benzene, toluene, xylene, dichloromethane, etc.; ethers, for example, ethyl ether, methyl ethyl ether, isopropyl ether, butyl ether, dioxane, dimethoxyethane (DME), tetrahydrofuran (THF), diethylene glycol dimethyl ether (DGM), etc.; ketones, for example, acetone, methyl ethyl ketone (MEK), methyl isopropyl ketone, methyl isobutyl ketone (MIBK), etc.; nitriles, for example, acetonitrile, propionitrile, acrylonitrile, etc.; esters, for example, ethyl acetate, amyl acetate, etc.; acid amides, for example, dimethylformamide (DMF), dimethylacetamide (DMA), N-methylpyrrolidone, 1,3-dimethyl-2-imidazolidinone, hexamethyl phosphoric triamide (HMPA), etc.
    • [0142]
      The reaction can be conducted in the presence of an acid binder and as said acid binder there can be mentioned, for example, as inorganic base, hydrides, hydroxides, carbonates, bicarbonates, etc. of alkali metals or alkaline earth metals, for example, sodium hydride, lithium hydride, sodium hydrogen carbonate, potassium hydrogen carbonate, sodium carbonate, potassium carbonate, lithium hydroxide, sodium hydroxide, potassium hydroxide, calcium hydroxide, etc.; inorganic alkali metal amides, for example, lithium amide, sodium amide, potassium amide, etc.; as organic base, alcoholates, tertiary amines, dialkylaminoanilines and pyridines, for example, triethylamine, 1,1,4,4-tetramethylethylenediamine (TMEDA), N,N-dimethylaniline, N,N-diethylaniline, pyridine, 4-dimethylaminopyridine (DMAP), 1,4-diazabicyclo[2,2,2]octane (DABCO), 1,8-diazabicyclo[5,4,0]undec-7-ene (DBU), etc.
    • [0143]
      The above-mentioned reaction can also be conducted by a process using a phase transfer catalyst in the presence of a diluent. As examples of the diluent used in that case there can be mentioned water; aliphatic, alicyclic and aromatic hydrocarbons (may be optionally chlorinated), for example, pentane, hexane, cyclohexane, petroleum ether, ligroine, benzene, toluene, xylene, etc.; ethers, for example, ethyl ether, methyl ethyl ether, isopropyl ether, butyl ether, dioxane, dimethoxyethane (DME), tetrahydrofuran diethylene glycol dimethyl ether (DGM), etc. As examples of the phase transfer catalyst, quaternary ions, for example, tetramethylammonium bromide, tetrapropylammonium bromide, tetrabutylammonium bromide, tetrabutylammonium bissulfate, tetrabutylammonium iodide, trioctylmethylammonium chloride, benzyltriethylammonium bromide, butylpyridinium bromide, heptylpyridinium bromide, benzyltriethylammonium chloride, etc.; crown ethers, for example, dibenzo-18-crown-6, dicyclohexyl-18-crown-6, 18-crown-6, etc.; cryptands, for example, [2.2.2]-cryptate, [2.1.1]-cryptate, [2.2.1]-cryptate, [2.2.B]-cryptate, [3.2.2]-cryptate, etc.
    • [0144]
      The above-mentioned reaction can be conducted in a substantially wide range of temperature. It is adequate to conduct it at the temperatures in a range of generally from about 0 to about 200° C., preferably from room temperature (20° C.) to about 150° C.
    • [0145]
      Although said reaction is conducted desirably under normal pressure, it can be operated also under elevated pressure or under reduced pressure.
    • [0146]
      In conducting the above-mentioned reaction, the aimed compounds of the formula (IX) can be obtained, for example, by reacting 1 mole to a little excess mole amount of the compounds of the formula (XI) to 1 mole of the compounds of the formula (X) in a diluent, for example, DMF, in the presence of potassium carbonate.
    • [0147]
      As the compounds of the formula (IX) obtained according to the above-mentioned process, there can be mentioned, for example, the corresponding 4-nitrobenzyl derivatives to the 4-aminobenzyl derivatives of the formula (III) mentioned hereinafter. And, as one typical example, 1-(3-methyl-4-nitrobenzyl)-3,5-bis-(trifluoromethyl)-1H-pyrazole can be mentioned.
    • [0148]
      Furthermore, in a case where Q represents 2-thiazolyl in the formula (IX), as a specific example, 2-(3-methyl-4-nitrobenzyl)-4-pentafluoroethyl-thiazole can be prepared by the following way in which a known compound, 3-methyl-4-niirobenzylcyanide (see J. Chem. Soc., vol. 97 (1910), p. 2260) is reacted with hydrogen sulfide, and then the product, 3-methyl-4-nitro-benzylthioamide is reacted with a commercial product, 1-bromo-3,3,4,4,4-pentafluoro-2-butanone and then cyclized, according to a method described in J. Heterocycl. Chem., vol. 28 (1991) p. 907 to 911.
    • [0149]
      In a case where Q represents 1,3,4-oxadiazol-2-yl in the formula (IX), as a specific example, 2-(3-methyl-4-nitrophenyl)-5-trifluoromethyl-1,3,4-oxazole can easily be obtained, according to a method described in Heterocycles, (1994), vol. 38, p. 981 to 990, from the corresponding aldoxime as a starting material which can be prepared by a method described in Justus Liebigs Ann. Chem., (1927) vol. 45, p. 166.
    • [0150]
      And, as another specific example, 2-(3-methyl-4-nitrobenzyl)-5-trifluoromethyl-1,3,4-oxazole can easily be obtained, according to a method described in Heterocycles, (1994) vol. 38, p. 981 to 990, from the corresponding 3-methyl-4-nitrobenzaldehyde oxime. In the above preparation, the oxime can be obtained from a known 3-methyl-4-nitrobenzaldehyde [see J. Chem. Soc. B, (1967) p. 1154 to 1158] as a starting material, according to methods described in J. Chem. Soc. C, (1969) p. 986 to 990 and then Tetrahedron Letter, vol. 35 (1994) p. 9099 to 9100.
    • [0151]
      In a case where Q represents 2H-1,2,3-triazol-2-yl in the formula (IX), as a specific example, 2-(3-methyl-4-nitrobenzyl)-2H-4-trifluoromethyl-1,2,3-triazole can easily be prepared by a reaction of a known 3-methyl-4-nitrobenzyl chloride with a known 2H-4-trifluoromethyl-1,2,3-triazole described in J. Chem. Soc., Perkin Transaction 2, vol. 10 (1989) p. 1355 to 1375.
    • [0152]
      In a case where Q represents 1H-1,2,4-triazol-1-yl in the formula (IX), as a specific example, 5-(3-methyl-4-nitrophenylsulfanyl)-1-methyl-3-trifluoromethyl-1H-1,2,4-triazole can easily be prepared by a reaction of 1-fluoro-3-methyl-4-nitrobenzene with a known 5-mercapto-1-methyl-3-trifluoromethyl-1H-1,2,4-triazole described in J. Med. Chem., vol. 35 (1992) p. 2103 to 2112, according to the same preparation as Synthesis Example 47 hereinafter.
    • [0153]
      In a case where Q represents 1,2,4-oxazol-3-yl in the formula (IX), as a specific example, 3-(3-methyl-4-nitrophenyl)-5-trifluoromethyl-1,2,4-oxazole can easily be obtained from 3-methyl-4-nitrobenzamideoxime, according to a method described in 3. Org. Chem., vol. 68(2), 2003, p. 605-608. And, 3-methyl-4-nitrobenzamideoxime can be prepared by a reaction of a commercial 3-methyl-4-nitrobenzonitrile with hydroxylamine, according to a method described in Chem. Ber., vol. 22 (1889), p. 2428.
    • [0154]
      And, as another specific example, 3-(3-methyl-4-nitrobenzyl)-5-trifluoromethyl-1,2,4-oxazole can easily be obtained from 2-(3-methyl-4-nitrophenyl)-acetamideoxime as well, according to a method described in J. Org. Chem., vol. 68(2), 2003, p. 605-608. And, 2-(3-methyl-4-nitrophenyl)-acetamideoxime can be prepared by a reaction of 3-methyl-4-nitrophenyl-acetonitrile with hydroxylamine, according to a method described in Chem. Ber., vol. 22 (1889), p. 2428.
    • [0155]
      In a case where Q represents 1H-1,2,4-triazol-3-yl in the formula (IX), as specific examples, 1-methyl-3-(3-methyl-4-nitrophenyl)-5-trifluoromethyl-1H-1,2,4-triazole can easily be prepared by a reaction of the above 3-(3-methyl-4-nitrophenyl)-5-trifluoromethyl-1,2,4-oxazole with methylhydrazine, according to a method described in J. Org. Chem., vol. 68(2), 2003, p. 605-608, and also 1-methyl-3-(3-methyl-4-nitrobenzyl)-5-trifluoromethyl-1H-1,2,4-thiazole can be done by a reaction of the above 3-(3-methyl-4-nitrobenzyl)-5-trifluoromethyl-1,2,4-oxazole with methylhydrazine as well.
    • [0156]
      The compounds of the formula (IX) can be prepared, besides the above-mentioned preparation process, also by the process to be mentioned later in Examples as an alternative.
    • [0157]
      As specific examples of the compounds of the formula (III) there can be mentioned, for example, the following:
      • 1-(4-amino-3-methylbenzyl)-3,5-bis(trifluoromethyl)-1H-pyrazole,
      • 1-(4-amino-3-methylbenzyl)-5-difluoromethoxy-3-trifluoromethyl-1H-pyrazole,
      • 1-(4-amino-3-methylbenzyl)-4-pentafluoroethyl-1H-pyrazole,
      • 1-(4-amino-3-methylbenzyl)-5-hexafluoro-n-propyl-1H-pyrazole,
      • 1-(4-amino-3-methylbenzyl)-3,5-bis(trifluoromethyl)-1H-(1,2,4)-triazole,
      • 1-(4-amino-3-methylbenzyl)-5-pentafluoroethyl-3-trifluoromethyl-1H-(1,2,4)-triazole,
      • 1-(4-amino-3-methylbenzyl)-5-difluoromethyl-3-trifluoromethyl-1H-(1,2,4)-triazole,
      • 4-(4-amino-3-methylbenzyl)-5-difluoromethoxy-1-difluoromethyl-3-trifluoromethyl-1H-pyrazole,
      • 4-(4-amino-3-methylbenzyl)-3-difluoromethoxy-1-difluoromethyl-5-trifluoromethyl-1H-pyrazole,
      • 1-(4-amino-3-methylbenzyl)-5-hydroxy-3,5-bis(trifluoromethyl)-1H-4,5-dihydropyrazole,
      • 1-(4-amino-3-methylbenzyl)-2,4-bis(trifluoromethyl)-1H-imidazole,
      • 4-(4-amino-3-methylbenzyl)-2-(2,2,2-trifluoroethyl)-5-trifluoromethyl-2,4-dihydro-3H-(1,2,4)-triazol-3-one,
      • 2-(4-amino-3-methylbenzyl)-4-(2,2,2-trifluoroethyl)-5-trifluoromethyl-2,4-dihydro-3H-(1,2,4)-triazol-3-one,
      • 1-(4-amino-3-methylbenzyl)-2,5-bis(trifluoromethyl)-1,3,4-triazole,
      • 2-(4-amino-3-methylbenzyl)-4,6-bis(trifluoromethyl)-pyrimidine,
      • 2-(4-amino-3-methylphenoxy)-4,6-bis(trifluoromethyl)-pyrimidine,
      • 1-(4-amino-3-methylphenyl)-3,5-bis(trifluoromethyl)-1H-pyrazole,
      • 1-(4-amino-3-methylphenyl)-5-pentafluoroethyl-1H-pyrazole,
      • 1-(4-amino-3,7-methylphenyl)-3-pentafluoroethyl-1H-pyrazole,
      • 1-(4-amino-3-methylphenyl)-4-pentafluoroethyl-1H-pyrazole,
      • 1-(4-amino-3-methylphenyl)-3-methyl-5-trifluoromethyl-1H-pyrazole,
      • 1-(4-amino-3-methylphenyl)-5-methyl-3-trifluoromethyl-1H-pyrazole,
      • 1-(4-amino-3-methylphenyl)-3-pentafluoroethyl-5-trifluoromethyl-1H-pyrazole,
      • 1-(4-amino-3-methylphenyl)-4-bromo-3-trifluoromethyl-1H-pyrazole,
      • 1-(4-amino-3-methylphenyl)-3-trifluoromethyl-1H-pyrazole,
      • 1-(4-amino-3-methylphenyl)-5-hydroxy-3-(2,2,2-trifluoroethyl)-5-trifluoromethyl-1H-4,5-dihydropyrazole,
      • 5-(4-amino-3-methylphenyl)-1-(2,2,2-trifluoroethyl)-3-trifluoromethyl-pyrazole,
      • 5-(4-amino-3-methylphenyl)-1-difluoromethyl-3-trifluoromethyl-pyrazole,
      • 3-(4-amino-3-methylphenyl)-1-difluoromethyl-3-difluoromethoxy-pyrazole,
      • 1-(4-amino-3-methylbenzyl)-3,4-bis(pentafluoroethyl)-1H-pyrazole,
      • 1-(4-amino-3-methylbenzyl)-3,5-bis(pentafluoroethyl)-1H-pyrazole,
      • 1-(4-amino-3-methylbenzyl)-3,4-bis(pentafluoropropyl)-1H-pyrazole,
      • 1-(4-amino-3-methylbenzyl)-3,5-bis(pentafluoropropyl)-1H-pyrazole,
      • 1-(4-amino-3-methylbenzyl)-3,5-bis(pentafluoroethyl)-1H-(1,2,4)-triazole,
      • 1-(4-amino-3-methylbenzyl)-2,5-bis(pentafluoroethyl)-1H-(1,3,4)-triazole,
      • 2-(4-amino-3-methylphenyl)-5-(trifluoromethyl)-1,3,4-oxadiazole,
      • 2-(4-amino-3-methylphenyl)-5-(pentafluoroethyl)-1,3,4-oxadiazole,
      • 2-(4-amino-3-methylphenyl)-5-(heptafluoropropyl)-1,3,4-oxadiazole,
      • 2-(4-amino-3-methylbenzyl)-5-(trifluoromethyl)-1,3,4-oxadiazole,
      • 2-(4-amino-3-methylbenzyl)-4-(trifluoromethyl)-2H-1,2,3-triazole,
      • 2-(4-amino-3-methylbenzyl)-4-(pentafluoroethyl)-thiazole,
      • 5-(4-amino-3-methylphenyl)sulfanyl-1-methyl-3-(trifluoromethyl)-1H-1,2,4-triazole,
      • 3-(4-amino-3-methylphenyl)-5-(trifluoromethyl)-1,2,4-oxadiazole,
      • 3-(4-amino-3-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-1,2,4-triazole,
      • 1-(4-amino-3-chlorobenzyl)-3,5-bis(trifluoromethyl)-1H-pyrazole,
      • 1-(4-amino-3-fluorobenzyl)-3,5-bis(trifluoromethyl)-1H-pyrazole and so on.
    • [0204]
      The compounds of the formula (IV), used as starting materials in the above-mentioned preparation process (b), are novel compounds and can be easily obtained according to the process described in Japanese Laid-open Patent Publication No. 61-246161 (1986), for example, by reacting compounds of the formula (XD)
    • [0000]
    • [0000]
      wherein X has the same definition as aforementioned,
      with the compounds of the formula (III).
    • [0000]
    • [0000]
      wherein Y, A, m and Q have the same definitions as aforementioned.
    • [0205]
      The reaction can be conducted in an adequate diluent. As the diluent used in that case there can be mentioned, for example, aliphatic, alicyclic and aromatic hydrocarbons (may be optionally chlorinated), for example, pentane, hexane, cyclohexane, petroleum ether, ligroin, benzene, toluene, xylene, dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane, chlorobenzene, dichlorobenzene, etc.; ethers, for example, ethyl ether, methyl ethyl ether, isopropyl ether, butyl ether, dioxane, dimethoxyethane (DME), tetrahydrofuran (THF), diethylene glycol dimethyl ether (DGM), etc.; esters, for example, ethyl acetate, amyl acetate, etc.; acid amides, for example, dimethylformamide (DMF), dimethylacetamide (DMA), N-methylpyrrolidone, 1,3-dimethyl-2-imidazolidinone, hexamethyl phosphoric triamide (HMPA), etc.; acids, for example, acetic acid etc.
    • [0206]
      The reaction can be conducted in a substantially wide range of temperature. It is adequate to conduct it at the temperatures in a range of generally from room temperature (20° C.) to about 200° C., preferably from room temperature to 150° C.
    • [0207]
      Although said reaction is conducted desirably under normal pressure, it can be operated also under elevated pressure or under reduced pressure.
    • [0208]
      In conducting the reaction, the aimed compounds of the formula (IV) can be obtained, for example, by reacting equimolar to a little excess mole amount of the compounds of the formula (II) to 1 mole of the compounds of the formula (XII) in a diluent, for example, acetic acid.
    • [0209]
      Many of the compounds of the above-mentioned formula (XII) are publicly known, and as their specific examples there can be mentioned, phthalic anhydride, 3-fluorophthalic anhydride, 3-chlorophthalic anhydride, 3-bromophthalic anhydride, 3-iodophthalic anhydride, 3-methanesulfonyloxyphthalic anhydride, etc.
    • [0210]
      Among the above-mentioned compounds, 3-methanesulfonyloxyphthalic anhydride can be easily obtained from 3-hydroxyphthalic anhydride and methanesulfonyl chloride according to the process described in Tetrahedron Letters Vol. 29, p. 5595-8 (1988).
    • [0211]
      As specific examples of the compounds of the formula (IV), used as starting materials in the preparation process (b), there can be mentioned the following:
      • 4-chloro-2-{2-methyl-4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-ylmethyl]phenyl}-isoindole-1,3-dione,
      • 2-{2-methyl-4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl-methyl]-phenyl}-isoindole-1,3-dione,
      • 4-chloro-2-[2-methyl-4-(5-difluoromethoxy-3-trifluoromethyl-1H-pyrazol-1-yl-methyl)-phenyl]-isoindole-1,3-dione,
      • 4-chloro-2-[2-methyl-4-(4-pentafluoroethyl-1H-pyrazol-1-yl-methyl)-phenyl]-isoindole-1,3-dione,
      • 4-bromo-2-{2-methyl-4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl-methyl]-phenyl}-isoindole-1,3-dione,
      • 4-bromo-2-[2-methyl-4-(5-difluoromethoxy-3-trifluoromethyl-1H-pyrazol-1-yl-methyl)-phenyl]-isoindole-1,3-dione,
      • 4-bromo-2-[2-methyl-4-(4-pentafluoroethyl-1H-pyrazol-1-yl-methyl)-phenyl]-isoindole-1,3-dione,
      • 4-iodo-2-{2-methyl-4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl-methyl]-phenyl}-isoindole-1,3-dione,
      • 4-iodo-2-[2-methyl-4-(5-difluoromethoxy-3-trifluoromethyl-1H-pyrazol-1-yl-methyl)-phenyl]-isoindole-1,3-dione,
      • 4-iodo-2-[2-methyl-4-(4-pentafluoroethyl-1H-pyrazol-1-yl-methyl)-phenyl]-isoindole-1,3-dione,
      • 4-iodo-2-[2-methyl-4-(5-hexafluoro-n-propyl-1H-pyrazol-1-yl-methyl)-phenyl]-isoindole-1,3-dione,
      • 4-methanesulfonyloxy-2-{2-methyl-4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl-methyl]-phenyl}-isoindole-1,3-dione,
      • 4-chloro-2-{2-methyl-4-[3,5-bis(trifluoromethyl)-1H-(1,2,4)-triazol-1-yl-methyl]-phenyl}-isoindole-1,3-dione,
      • 4-chloro-2-{2-methyl-4-[5-pentafluoroethyl-3-trifluoromethyl-1H-(1,2,4)-triazol-1-yl-methyl]-phenyl}-isoindole-1,3-dione,
      • 4-chloro-2-{2-methyl-4-[5-difluoromethoxy-1-difluoromethyl-1H-(1,2,4)-triazol-1-yl-methyl]-phenyl}-isoindole-1,3-dione,
      • 4-iodo-2-{2-methyl-4-[3,5-bis(trifluoromethyl)-1H-(1,2,4)-triazol-1-yl-methyl]-phenyl}-isoindole-1,3-dione,
      • 4-iodo-2-{2-methyl-4-[5-pentafluoroethyl-3-trifluoromethyl-1H-(1,2,4)-triazol-1-yl-methyl]-phenyl}-isoindole-1,3-dione,
      • 4-iodo-2-{2-methyl-4-[5-difluoromethyl-3-trifluoromethyl-1H-(1,2,4)-triazol-1-yl-methyl]-phenyl}-isoindole-1,3-dione,
      • 4-methanesulfonyloxy-2-{2-methyl-4-[3,5-bis(trifluoromethyl)-1H-(1,2,4)-triazol-1-yl-methyl]-phenyl}-isoindole-1,3-dione,
      • 4-iodo-2-[2-methyl-4-(5-difluoromethoxy-1-difluoromethyl-3-trifluoromethyl-1H-pyrazol-4-yl-methyl)-phenyl]-isoindole-1,3-dione,
      • 4-iodo-2-[2-methyl-4-(5-hydroxy-3,5-bis(trifluoromethyl)-1H-4,5-dihydropyrazol-1-yl-methyl)-phenyl]-isoindole-1,3-dione,
      • 4-iodo-2-{2-methyl-4-[2,4-bis(trifluoromethyl)-1H-imidazol-1-yl-methyl]-phenyl}-isoindole-1,3-dione,
      • 4-iodo-2-{2-methyl-4-[3-(2,2,2-trifluoroethyl)-5-trifluoromethyl-1,2-dihydro-(1,3,4)-triazol-2-on-1-yl-methyl]-phenyl}-isoindole-1,3-dione,
      • 4-iodo-2-{2-methyl-4-[3-(2,2,2-trifluoroethyl)-3-trifluoromethyl-4,5-dihydro-(1,2,4)-triazol-5-on-1-yl-methyl]-phenyl}-isoindole-1,3-dione,
      • 4-iodo-2-{2-methyl-4-[2,5-bis(trifluoromethyl)-(1,3,4)-triazol-1-yl-methyl]-phenyl}-isoindole-1,3-dione,
      • 4-iodo-2-{2-methyl-4-[4,6-bis(trifluoromethyl)pyrimidin-2-yl-methyl]-phenyl}-isoindole-1,3-dione,
      • 4-iodo-2-{2-methyl-4-[4,6-bis(trifluoromethyl)pyrimidin-2-yloxy]-phenyl}-isoindole-1,3-dione,
      • 4-chloro-2-{2-methyl-4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl}-isoindole-1,3-dione,
      • 4-chloro-2-[2-methyl-4-(5-pentafluoroethyl-1H-pyrazol-1-yl)-phenyl]-isoindole-1,3-dione,
      • 4-chloro-2-[2-methyl-4-(3-pentafluoroethyl-1H-pyrazol-1-yl)-phenyl]-isoindole-1,3-dione,
      • 4-chloro-2-[2-methyl-4-(4-pentafluoroethyl-1H-pyrazol-1-yl)-phenyl]-isoindole-1,3-dione,
      • 4-iodo-2-[2-methyl-4-[3-methyl-5-trifluoromethyl-1H-pyrazol-1-yl]-phenyl]-isoindole-1,3-dione,
      • 4-iodo-2-[2-methyl-4-(5-methyl-3-trifluoromethyl-1H-pyrazol-1-yl)-phenyl]-isoindole-1,3-dione,
      • 4-iodo-2-[2-methyl-4-(3-pentafluoroethyl-5-trifluoromethyl-1H-pyrazol-1-yl)-phenyl]-isoindole-1,3-dione,
      • 4-iodo-2-[2-methyl-4-(4-bromo-3-trifluoromethyl-1H-pyrazol-1-yl)phenyl]-isoindole-1,3-dione,
      • 4-iodo-2-[2-methyl-4-(3-trifluoromethyl-1H-pyrazol-1-yl)-phenyl]-isoindole-1,3-dione,
      • 4-iodo-2-{2-methyl-4-[5-hydroxy-3-(2,2,2-trifluoroethyl)-5-trifluoromethyl-1H-4,5-dihydropyrazol-1-yl]-phenyl}-isoindole-1,3-dione,
      • 4-iodo-2-{2-methyl-4-[1-(2,2,2-trifluoroethyl)-3-trifluoromethyl-pyrazol-5-yl]-phenyl}-isoindole-1,3-dione,
      • 4-iodo-2-[2-methyl-4-(1-difluoromethyl-3-trifluoromethyl-pyrazol-5-yl)-phenyl]-isoindole-1,3-dione,
      • 4-iodo-2-[2-methyl-4 (1-difluoromethyl-3-difluoromethoxy-pyrazol-3-yl)-phenyl]-isoindole-1,3-dione,
      • 4-iodo-2-{2-methyl-4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl}-isoindole-1,3-dione,
      • 4-iodo-2-[2-methyl-4-(5-pentafluoroethyl-1H-pyrazol-1-yl)-phenyl]-isoindole-1,3-dione,
      • 4-iodo-2-[2-methyl-4-(3-pentafluoroethyl-1H-pyrazol-1-yl)-phenyl]-isoindole-1,3-dione,
      • 4-iodo-2-[2-methyl-4-(4-pentafluoroethyl-1H-pyrazol-1-yl)-phenyl]-isoindole-1,3-dione,
      • 4-bromo-2-{2-methyl-4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl}-isoindole-1,3-dione,
      • 4-bromo-2-[2-methyl-4-(5-pentafluoroethyl-1H-pyrazol-1-yl)-phenyl]-isoindole-1,3-dione,
      • 4-bromo-2-[2-methyl-4-(3-pentafluoroethyl-1H-pyrazol-1-yl)-phenyl]-isoindole-1,3-dione,
      • 4-bromo-2-[2-methyl-4-(4-pentafluoroethyl-1H-pyrazol-1-yl)-phenyl]-isoindole-1,3-dione,
      • 4-chloro-2-{2-methyl-4-[3,4-bis(pentafluoroethyl)-1H-pyrazol-1-ylmethyl]-phenyl}-isoindole-1,3-dione,
      • 4-chloro-2-{2-methyl-4-[3,5-bis(pentafluoroethyl)-1H-pyrazol-1-ylmethyl]-phenyl}-isoindole-1,3-dione,
      • 4-chloro-2-{2-methyl-4-[3,4-bis(heptafluoropropyl)-1H-pyrazol-1-ylmethyl]-phenyl}-isoindole-1,3-dione,
      • 4-chloro-2-{2-methyl-4-[3,5-bis(heptafluoropropyl)-1H-pyrazol-1-ylmethyl]-phenyl}-isoindole-1,3-dione,
      • 4-chloro-2-[2-methyl-4-(5-trifluoromethyl-1,3,4-oxadiazol-2-yl)-phenyl]-isoindole-1,3-dione,
      • 4-chloro-2-[2-methyl-4-(5-pentafluoroethyl-1,3,4-oxadiazol-2-yl)-phenyl]-isoindole-1,3-dione,
      • 4-chloro-2-[2-methyl-4-(5-heptafluoropropyl-1,3,4-oxadiazol-2-yl)-phenyl]-isoindole-1,3-dione,
      • 4-chloro-2-[2-methyl-4-(5-trifluoromethyl-1,3,4-oxadiazol-2-yl-methyl)-phenyl]-isoindole-1,3-dione,
      • 4-chloro-2-[2-methyl-4-(4-trifluoromethyl-2H-1,2,3-triazol-2-yl-methyl)-phenyl]-isoindole-1,3-dione,
      • 4-chloro-2-[2-methyl-4-(4-(pentafluoroethyl)-thiazol-2-yl-methyl)-phenyl]-isoindole-1,3-dione,
      • 4-chloro-2-{2-methyl-4-[1-methyl-3-(trifluoromethyl)-1H-1,2,4-triazol-5-yl-sulfanyl]-phenyl}-isoindole-1,3-dione,
      • 4-chloro-2-[2-methyl-4-(5-trifluoromethyl-1,2,4-oxadiazol-3-yl)-phenyl]-isoindole-1,3-dione,
      • 4-chloro-2-[2-methyl-4-(1-methyl-5-trifluoromethyl-1H-1,2,4-triazol-3-yl)-phenyl]-isoindole-1,3-dione,
      • 4-iodo-2-[2-methyl-4-(5-trifluoromethyl-1,3,4-oxadiazol-2-yl)-phenyl]-isoindole-1,3-dione and so on.
    • [0274]
      The compounds of the formula (V), used as starting materials in the preparation process (b), are either compounds well known in the field of organic chemistry or can be synthesized according to the process described in DE-A 20 45 905, WO 01/23350.
    • [0275]
      As their specific examples there can be mentioned ethylamine, diethylamine, n-propylamine, isopropylamine, n-butylamine, sec-butylamine, isobutylamine, t-butylamine, t-amylamine, 2-(methylthio)-ethylamine, 2-(ethylthio)-ethylamine, 1-methyl-2-(methylthio)-ethylamine, 1,1-dimethyl-2-(methylthio)-ethylamine and so on.
    • [0276]
      The compounds of the formula (VI), used as starting materials in the preparation process (c), include publicly known compounds and can be easily prepared according to the process described in JP-A 11-240857 (1999), JPA 2001-131141, etc.
    • [0277]
      As their specific examples there can be mentioned the following:
      • N-isopropyl-phthalamic acid,
      • 3-fluoro-N-isopropyl-phthalamic acid,
      • 3-chloro-N-isopropyl-phthalamic acid,
      • 3-bromo-N-isopropyl-phthalamic acid,
      • 3-iodo-N-isopropyl-phthalamic acid,
      • N-(1-methyl-2-methylsulfanyl-ethyl)-phthalamic acid,
      • 3-fluoro-N-(1-methyl-2-methylsulfanyl-ethyl)-phthalamic acid,
      • 3-chloro-N-(1-methyl-2-methylsulfanyl-ethyl)-phthalamic acid,
      • 3-bromo-N-(1-methyl-2-methylsulfanyl-ethyl)-phthalamic acid,
      • 3-iodo-N-(1-methyl-2-methylsulfanyl-ethyl)-phthalamic acid,
      • N-(1,1-dimethyl-2-methylsulfanyl-ethyl)-phthalamic acid,
      • N-(1,1-dimethyl-2-methylsulfanyl-ethyl)-3-fluoro-phthalamic acid,
      • 3-chloro-N-(1,1-dimethyl-2-methylsulfanyl-ethyl)-phthalamic acid,
      • 3-bromo-N-(1,1-dimethyl-2-methylsulfanyl-ethyl)-phthalamic acid,
      • N-(1,1-dimethyl-2-methylsulfanyl-ethyl)-3-iodo-phthalamic acid,
      • N-isopropyl-3-methanesulfonyloxy-phthalamic acid,
      • N-(1-methyl-2-methylsulfanyl-ethyl)-3-methanesulfonyloxy-phthalamic acid,
      • N-(1-methyl-2-methylsulfanyl-ethyl)-3-nitro-phthalamic acid,
      • 3-chloro-N-(2-ethylsulfanyl-1-methyl-ethyl)-phthalamic acid,
      • 3-bromo-N-(2-ethylsulfanyl-1-methyl-ethyl)-phthalamic acid,
      • N-(2-ethylsulfanyl-1-methyl-ethyl)-3-iodo-phthalamic acid,
      • N-(2-ethylsulfanyl-1-methyl-ethyl)-3-nitro-phthalamic acid,
      • N-(2-ethylsulfanyl-1-methyl-ethyl)-3-methanesulfonyloxy-phthalamic acid,
      • N-(1,1-dimethyl-2-methylsulfanyl-ethyl)-3-methanesulfonyloxy-phthalamic acid and so on.
    • [0302]
      The above-mentioned compounds of the formula (VI) can be easily obtained generally by reacting phthalic anhydrides of the aforementioned formula (XII)
    • [0000]
    • [0000]
      wherein X has the same definition as aforementioned,
      with amines of the formula
    • [0000]

      H2N—R1  (XIII)
    • [0000]
      wherein R1 has the same definitions as aforementioned,
    • [0303]
      The compounds of the above-mentioned formula (XIII) are well known in the field of organic chemistry and there can be specifically mentioned, for example, ethylamine, n-propylamine, isopropylamine, n-butylamine, sec-butylamine, isobutylamine, t-butylamine, t-amylamine, 2-(methylthio)ethylamine, 2-(ethylthio)ethylamine, 1-methyl-2-(methylthio)ethylamine, 1,1-dimethyl-2-(methylthio)ethylamine, etc.
    • [0304]
      These amines can be easily obtained also by the process described in DE-A 20 45 905, WO 01/23350, etc.
    • [0305]
      The above-mentioned reaction of the compounds of the formula (XII) with the amines of the formula (XIII) can be conducted according to the process described in, for example, J. Org. Chem., Vol. 46, p. 175 (1981) etc.
    • [0306]
      Said reaction can be conducted in an adequate diluent, and as examples of the diluent used in that case there can be mentioned aliphatic, alicyclic and aromatic hydrocarbons (may be optionally chlorinated), for example, pentane, hexane, cyclohexane, petroleum ether, ligroine, benzene, toluene, xylene, dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane, chlorobenzene, dichlorobenzene, etc.; ethers, for example, ethyl ether, methyl ethyl ether, isopropyl ether, butyl ether, dioxane, dimethoxyethane (DME), tetrahydrofuran (TIM, diethylene glycol dimethyl ether (DGM), etc.; ketones, for example, acetone, methyl ethyl ketone (MEK), methyl isopropyl ketone, methyl isobutyl ketone (MIBK), etc.; nitriles, for example, acetonitrile, propionitrile, acrylonitrile, etc.; esters, for example, ethyl acetate, amyl acetate, etc.
    • [0307]
      The above-mentioned reaction can be conducted in the presence of a base, and as said base there can be mentioned, for example, tertiary amines, dialkylaminoanilines and pyridines, for example, triethylamine, 1,1,4,4-tetramethylethylenediamine (TMEDA), N,N-dimethylaniline, N,N-diethylaniline, pyridine, 4-dimethylaminopyridine (DMAP), 1,4-diazabicyclo[2,2,2]octane (DABCO), 1,8-diazabicyclo[5,4,0]undec-7-ene (DBU), etc.
    • [0308]
      The above-mentioned reaction can be conducted in a substantially wide range of temperature. It is adequate to conduct it at the temperatures in a range of generally from about −70 to about 100° C., preferably from about −50 to about 80° C.
    • [0309]
      Although said reaction is conducted desirably under normal pressure, it can be operated also under elevated pressure or under reduced pressure.
    • [0310]
      In conducting the above-mentioned reaction, the aimed compounds of the formula (VI) can be obtained, for example, by reacting 1-4 moles of the compounds of the formula (XIII) to 1 mole of the compounds of the formula (XII) in a diluent, for example, acetonitrile.
    • [0311]
      The compounds of the formula (VII), used as starting materials in the preparation process (d), are novel compounds and can be easily obtained, for example, by reacting the compounds of the formula (VIII), starting materials in the below-mentioned preparation process (e), according to the process described in J. Med. Chem., Vol. 10, p. 982 (1967) etc. in the presence of a condensing agent.
    • [0312]
      As specific examples of the compounds of the formula (VII), there can be mentioned the following:
      • 1-[4-(4-iodo-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methyl-benzyl]-3,5-bis(trifluoromethyl)-1H-pyrazole,
      • 1-[4-(4-chloro-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methyl-benzyl]-3,5-bis(trifluoromethyl)-1H-pyrazole,
      • 1-[4-(4-iodo-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methyl-benzyl]-3,5-bis(trifluoromethyl)-1,2,4-triazole,
      • 1-[4-(4-iodo-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methylphenyl]-3,5-bis(trifluoromethyl)-1,1-pyrazole,
      • 1-[4-(4-chloro-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methyl-benzyl]-3,4-bis(pentafluoroethyl)-1H-pyrazole,
      • 1-[4-(4-chloro-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methyl-benzyl]-3,5-bis(pentafluoroethyl)-1H-pyrazole,
      • 1-[4-(4-chloro-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methyl-benzyl]-3,4-bis(heptafluoropropyl)-1H-pyrazole,
      • 1-[4-(4-chloro-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methyl-benzyl]-3,5-bis(heptafluoropropyl)-1H-pyrazole,
      • 2-[4-(4-chloro-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methylphenyl]-5-(trifluoromethyl)-1,3,4-oxadiazole,
      • 2-[4-(4-chloro-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methylphenyl]-5-(pentafluoroethyl)-1,3,4-oxadiazole,
      • 2-[4-(4-chloro-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methylphenyl]-5-(heptafluoropropyl)-1,3,4-oxadiazole,
      • 2-[4-(4-chloro-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methylbenzyl]-5-(trifluoromethyl)-1,3,4-oxadiazole,
      • 2-[4-(4-chloro-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methylbenzyl]-4-(trifluoromethyl)-2H-1,2,3-triazole,
      • 2-[4-(4-chloro-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methylbenzyl]-4-(pentafluoroethyl)-thiazole,
      • 5-[4-(4-chloro-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methylphenyl]sulfanyl-1-methyl-3-(trifluoromethyl)-1H-1,2,4-triazole,
      • 3-[4-(4-chloro-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methylphenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole,
      • 3-[4-(4-chloro-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methylphenyl]-1-methyl-5-(trifluoromethyl)-1H-1,2,4-triazole,
      • 2-[4-(4-iodo-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methylphenyl]-5-(trifluoromethyl)-1,3,4-oxadiazole and so on.
    • [0331]
      The compounds of the formula (V), similarly used as starting materials in the preparation process (d), are the same as explained in the aforementioned preparation process (b).
    • [0332]
      The compounds of the formula (VIII), used as starting materials in the preparation process (e), are novel compounds and can be easily obtained, for example, by reacting phthalic anhydrides of the aforementioned formula (XII) with the compounds of the aforementioned formula (III).
    • [0333]
      The above-mentioned reaction can be conducted in an adequate diluent, and as examples of the diluent used in that case there can be mentioned aliphatic, alicyclic and aromatic hydrocarbons (may be optionally chlorinated), for example, pentane, hexane, cyclohexane, petroleum ether, ligroine, benzene, toluene, xylene, dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane, chlorobenzene, dichlorobenzene, etc.; ethers, for example, ethyl ether, methyl ethyl ether, isopropyl ether, butyl ether, dioxane, dimethoxyethane (DME), tetrahydrofuran (THF), diethylene glycol dimethyl ether (DGM), etc.; ketones, for example, acetone, methyl ethyl ketone (MEK), methyl isopropyl ketone, methyl isobutyl ketone (MIBK), etc.; nitriles, for example, acetonitrile, propionitrile; acrylonitrile, etc.; esters, for example, ethyl acetate, amyl acetate, etc.
    • [0334]
      The above-mentioned reaction can be conducted in the presence of a base, and as said base there can be mentioned tertiary amines, dialkylaminoanilines and pyridines, for example, triethylamine, 1,1,4,4-tetramethylethylenediamine (TMEDA), N,N-dimethylaniline, N,N-diethylaniline, pyridine, 4-dimethylaminopyridine (DMAP), 1,4-diazabicyclo[2,2,2]octane (DABCO) and 1,8-diazabicyclo[5,4,0]undec-7-ene (DBU), etc.
    • [0335]
      The above-mentioned reaction can be conducted in a substantially wide range of temperature. It is adequate to conduct it at the temperatures in a range of generally from about −70 to about 100° C., preferably from about −50 to about 80° C.
    • [0336]
      Although said reaction is conducted desirably under normal pressure, it can be operated also under elevated pressure or under reduced pressure.
    • [0337]
      As specific examples of the compounds of the formula (VIII), there can be mentioned the following:
      • N-{4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl-methyl]-2-methyl-phenyl}-6-iodo-phthalamic acid,
      • N-{4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl-methyl]-2-methyl-phenyl}-6-chloro-phthalamic acid,
      • N-{4-[3,5-bis(trifluoromethyl)-(1,2,4)-triazol-1-yl-methyl]-2-methyl-phenyl}-6-iodo-phthalamic acid,
      • N-{4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl]-2-methyl-phenyl}-6-iodo-phthalamic acid,
      • N-{4-[3,4-bis(pentafluoroethyl)-1H-pyrazol-1-yl-methyl]phenyl}-6-chloro-phthalamic acid,
      • N-{4-[3,5-bis(pentafluoroethyl)-1H-pyrazol-1-yl-methyl]-phenyl}-6-chloro-phthalamic acid,
      • N-{4-[3,4-bis(heptafluoropropyl)-1H-pyrazol-1-yl-methyl]-phenyl}-6-chloro-phthalamic acid,
      • N-(4-[3,5-bis(heptafluoropropyl)-1H-pyrazol-1-yl-methyl]-phenyl)-6-chloro-phthalamic acid,
      • N-[2-methyl-4-(5-trifluoromethyl-1,3,4-oxadiazol-2-yl)-phenyl]-6-chloro-phthalamic acid,
      • N-[2-methyl-4-(5-pentafluoroethyl-1,3,4-oxadiazol-2-yl)-phenyl]-6-chloro-phthalamic acid,
      • N-[2-methyl-4-(5-heptafluoropropyl-1,3,4-oxadiazol-2-yl)-phenyl]-6-chloro-phthalamic acid,
      • N-[2-methyl-4-(5-trifluoromethyl-1,3,4-oxadiazol-2-yl-methyl)-phenyl]-6-chloro-phthalamic acid,
      • N-[2-methyl-4-(4-trifluoromethyl-2H-1,2,3-triazol-2-yl-methyl)-phenyl]-6-chloro-phthalamic acid,
      • N-{2-methyl-4-(4-pentafluoroethyl-thiazol-2-yl-methyl)-phenyl}-6-chloro-phthalamic acid,
      • N-{2-methyl-4-[1-methyl-3-(trifluoromethyl)-1H-1,2,4-triazol-5-yl-sufanyl]-phenyl}-6-chlorophthalamic acid,
      • N-[2-methyl-4-(5-trifluoromethyl-1,2,4-oxadiazol-3-yl)-phenyl]-6-chloro-phthalamic acid,
      • N-[2-methyl-4-(1-methyl-5-trifluoromethyl-1H-1,2,4-triazol-3-yl)-phenyl]-6-chloro-phthalamic acid,
      • N-[2-methyl-4-(5-trifluoromethyl-1,3,4-oxadiazol-2-yl)-phenyl]-6-iodo-phthalamic acid and so on.
    • [0356]
      The compounds of the formula (V), similarly used as starting materials in the preparation process (e), can be the same as ones used in the aforementioned preparation processes (b) and (d).
    • [0357]
      The compounds of the formula (If), used as starting materials in the preparation process (f), are compounds included in the formula (I) of the present invention.
    • [0358]
      By oxidizing the group RIf in the compounds of the formula (If), namely, C1-6alkylthio-C1-6alkyl, the compounds of the formula (I), in which the group RIf corresponds to C1-6 alkylsulfinyl-C1-6alkyl or C1-6alkylsulfonyl-C1-6alkyl, can be obtained.
    • [0359]
      The compounds of the formula (If) can be prepared by the processes of the aforementioned preparation processes (a), (b), (c), (d) and/or (e).
    • [0360]
      As specific examples of the compounds of the formula (If), there can be mentioned the following:
      • 3-iodo-N2-(1-methyl-2-methylsulfanyl-ethyl)-N1-{2-methyl-4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-ylmethyl]-phenyl}phthalamide,
      • N2-(1,1-dimethyl-2-methylsulfanyl-ethyl)-3-iodo-N1-{2-methyl-4-[3,5-bis(trifluoro-methyl)-1H-pyrazol-1-ylmethyl]-phenyl}phthalamide,
      • 3-iodo-N2-(1-methyl-2-methylsulfanyl-ethyl)-N1-{2-methyl-4-[3,5-bis(trifluoromethyl)-(1,2,4)-triazol-1-ylmethyl]-phenyl}phthalamide,
      • 3-chloro-N2-(1-methyl-2-methylsulfanyl-ethyl)-N1-{2-methyl-4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-ylmethyl]-phenyl}phthalamide,
      • 3-chloro-N2-(1-methyl-2-methylsulfanyl-ethyl)-N1-{2-methyl-4-[3,4-bis(pentafluoro-ethyl)-1H-pyrazol-1-ylmethyl]-phenyl}phthalamide,
      • 3-chloro-N2-(1-methyl-2-methylsulfanyl-ethyl)-N1-{2-methyl-4-[3,5-bis(pentafluoro-ethyl)-1H-pyrazol-1-ylmethyl]-phenyl}phthalamide,
      • 3-chloro-N2-(1-methyl-2-methylsulfanyl-ethyl)-N1-{2-methyl-4-[3,4-bis(heptafluoro-propyl)-1H-pyrazol-1-ylmethyl]-phenyl}phthalamide,
      • 3-chloro-N2-(1-methyl-2-methylsulfanyl-ethyl)-N1-{2-methyl-4-[3,5-bis(heptafluoro-propyl)-1H-pyrazol-1-ylmethyl]-phenyl}phthalamide and so on
    • [0369]
      The reaction of the aforementioned preparation process (a) can be conducted in an adequate diluent singly or mixed. As examples of the diluent used in that case there can be mentioned water; aliphatic, alicyclic and aromatic hydrocarbons (may be optionally chlorinated), for example, pentane, hexane, cyclohexane, petroleum ether, ligroine, benzene, toluene, xylene, dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane, chlorobenzene, dichlorobenzene, etc.; ethers, for example, ethyl ether, methyl ethyl ether, isopropyl ether, butyl ether, dioxane, dimethoxyethane (DME), tetrahydrofuran (THF), diethylene glycol dimethyl ether (DGM), etc.; nitriles, for example, acetonitrile, propionitrile, acrylonitrile, etc.; esters, for example, ethyl acetate, amyl acetate, etc.
    • [0370]
      The preparation process (a) can be conducted in the presence of an acid catalyst, and as examples of said acid catalyst there can be mentioned mineral acids, for example, hydrochloric acid and sulfuric acid; organic acids, for example, acetic acid, trifluoroacetic acid, propionic acid, methanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic acid, etc.
    • [0371]
      The preparation process (a) can be conducted in a substantially wide range of temperature. It is adequate to conduct it at the temperatures in a range of generally from about −20 to about 100° C., preferably from about 0 to about 100° C.
    • [0372]
      Although said reaction is conducted desirably under normal pressure, it can be operated also under elevated pressure or under reduced pressure.
    • [0373]
      In conducting the preparation process (a), the aimed compounds of the formula (I) can be obtained, for example, by reacting 1 to a little excess mole amount of the compounds of the formula (III) to 1 mole of the compounds of the formula (II) in a diluent, for example, 1,2-dichloroethane in the presence of 0.01-0.1 mole amount of p-toluenesulfonic acid.
    • [0374]
      The reaction of the aforementioned preparation process (b) can be conducted in an adequate diluent. As examples of the diluent used in that case there can be mentioned aliphatic, alicyclic and aromatic hydrocarbons (may be optionally chlorinated), for example, pentane, hexane, cyclohexane, petroleum ether, ligroine, benzene, toluene, xylene, dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane, chlorobenzene, dichlorobenzene, etc.; ethers, for example, ethyl ether, methyl ethyl ether, isopropyl ether, butyl ether, dioxane, dimethoxyethane (DME), tetrahydrofuran (Tiff), diethylene glycol dimethyl ether (DGM), etc.; esters, for example, ethyl acetate, amyl acetate, etc.; acid amides, for example, dimethylformamide (DMF), dimethylacetamide (DMA), N-methylpyrrolidone, 1,3-dimethyl-2-imidazolidinone, hexamethyl phosphoric triamide (HMPA), etc.
    • [0375]
      The preparation process (b) can be conducted in the presence of an acid catalyst and as examples of said acid catalyst there can be mentioned mineral acids, for example, hydrochloric acid and sulfuric acid; organic acids, for example, acetic acid, trifluoroacetic acid, propionic acid, methanesulfonic acid, p-toluenesulfonic acid, etc.
    • [0376]
      The preparation process (b) can be conducted in a substantially wide range of temperature. It is adequate to conduct it at the temperatures in a range of generally from about −20 to about 150° C., preferably from room temperature (20° C.) to about 100° C.
    • [0377]
      Although said reaction is conducted desirably under normal pressure, it can be operated also under elevated pressure or under reduced pressure.
    • [0378]
      In conducting the preparation process (b), the aimed compounds of the formula (I) can be obtained, for example, by reacting 1-25 moles of the compounds of the formula (V) to 1 mole of the compounds of the formula (IV) in a diluent, for example, dioxane in the presence of 0.01-0.5 mole amount of acetic acid.
    • [0379]
      The aforementioned preparation processes (c), (d) and (e) can be conducted under the similar condition as the above-mentioned preparation process (a).
    • [0380]
      The reaction of the aforementioned preparation process (f) can be conducted in an adequate diluent. As examples of the diluent used in that case there can be mentioned aliphatic, alicyclic and aromatic hydrocarbons (may be optionally chlorinated), for example, benzene, toluene, xylene, dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane, chlorobenzene, dichlorobenzene, etc.; alcohols, for example, methanol, ethanol, isopropanol and butanol; acids; formic acid, acetic acid, etc.
    • [0381]
      As the oxidizing agents usable in the aforementioned preparation process (f) there can be mentioned, for example, m-chloroperbenzoic acid, peracetic acid, potassium metaperiodate, potassium hydrogen persulfate (oxon), hydrogen peroxide, etc.
    • [0382]
      The preparation process (f) can be conducted in a substantially wide range of temperature. It is adequate to conduct it at the temperatures in a range of generally from about −50 to about 150° C., preferably from about −10 to about 100° C.
    • [0383]
      Although said reaction is conducted desirably under normal pressure, it can be operated also under elevated pressure or under reduced pressure.
    • [0384]
      In conducting the preparation process (f), the aimed compounds of the corresponding formula (I) can be obtained, for example, by reacting 1-5 moles of an oxidizing agent to 1 mole of the compounds of the formula (If) in a diluent, for example, dichloromethane.
    • [0385]
      The reaction of the aforementioned preparation process (f) can be conducted, for example, according to the process described in JIKKEN KAGAKU KOZA (Lecture on experimental chemistry) edited by the Chemical Society of Japan, 4th ed., Vol. 24, p. 350 (1992) published by MARUZEN or ibid. p. 365.
    • [0386]
      The compounds of the formula (I) of the present invention show strong insecticidal action. The compounds of the formula (I), according to the present invention can, therefore, be used as insecticidal agents. And the active compounds of the formula (I) of the present invention exhibit exact controlling effect against harmful insects without giving phytotoxicity on cultured plants. And the compounds of the present invention can be used for controlling a wide variety of pests, for example, harmful sucking insects, biting insects and other plant-parasitic pests, stored grain pests, hygienic pests, etc. and applied for their extermination.
    • [0387]
      As examples of such pests there can be mentioned the following pests:
    • [0388]
      As insects, there can be mentioned:
    • [0389]
      Coleoptera pests, for example, Callosobruchus Chinensis, Sitophilus zeamais, Tribolium castaneum, Epilachna vigintioctomaculata, Agriotes fuscicollis, Anomala rufocuprea, Leptinotarsa decemlineata, Diabrotica spp., Monochamus alternatus, Lissorhoptrus oryzophilus, Lyctus bruneus;
    • [0390]
      Lepidoptera pests, for example,
    • [0391]
      Lymantria dispar, Malacosoma neustria, Pieris rapae, Spodoptera litura, Mamestra brassicae, Chilo suppressalis, Pyrausta nubilalis, Ephestia cautella, Adoxophyes orana, Carpocapsa pomonella, Agrotis fucosa, Galleria mellonella, Plutella maculipennis, Heliothis virescens, Phyllocnistis citrella;
    • [0392]
      Hemiptera pests, for example,
    • [0393]
      Nephotettix cincticeps, Nilaparvata lugens, Pseudococcus comstocki, Unaspis yanonensis, Myzus persicae, Aphis pomi, Aphis gossypii, Rhopalosiphum pseudobrassicas, Stephanitis nashi, Nazara spp., Trialeurodes vaporariorum, Psylla spp.;
    • [0394]
      Thysanoptera pests, for example,
    • [0395]
      Thrips palmi, Frankliniella occidental;
    • [0396]
      Orthoptera pests, for example,
    • [0397]
      Blatella gennanica, Periplaneta americana, Gryllotalpa africana, Locusta migratoria migratoriodes;
    • [0398]
      Homoptera pests, for example,
    • [0399]
      Reticulitermes speratus, Coptotennes formosanus;
    • [0400]
      Diptera pests, for example,
    • [0401]
      Musca domestica, Aedes aegypti, Hylemia platura, Culex pipiens, Anopheles slnensis, Culex tritaeniorlzynchus, Liriomyzae trifolii etc.
    • [0402]
      Moreover, as mites there can be mentioned, for example,
    • [0403]
      Tetranychus cinnabarinus, Tetranychus urticae, Panonychus citri, Aculops pelekassi, Tarsonemus spp., etc.
    • [0404]
      Furthermore, as nematodes there can be mentioned, for example,
    • [0405]
      Meloidogyne incognita, Bursaphelenchus lignicolus Mamiya et Kiyohara, Aphelenchoides besseyi, Heterodera glycines, Pratylenchus spp., etc.
    • [0406]
      In addition, in the field of veterinary medicine, the novel compounds of the present invention can be effectively used against various harmful animal-parasitic pests (endoparasites and ectoparasites), for example, insects and helminthes. As examples of such animal-parasitic pests there can be mentioned the following pests:
    • [0407]
      As insects there can be mentioned, for example,
    • [0408]
      Gastrophilus spp., Stomoxys spp., Trichodectes spp., Rhodnius spp., Ctenocephalides canis, Cimex lectularius etc.
    • [0409]
      As mites there can be mentioned, for example,
    • [0410]
      Ornithodoros spp., Ixodes spp., Boophilus spp., etc.
    • [0411]
      In the present invention, substances having insecticidal action against pests, which include all of them, are in some cases called as insecticides.
    • [0412]
      All plants and plant parts can be treated in accordance with the invention. Plants are to be understood as meaning in the present context all plants and plant populations such as desired and undesired wild plants or crop plants (including naturally occurring crop plants). Crop plants can be plants which can be obtained by conventional plant breeding and optimization methods or by biotechnological and genetic engineering methods or by combinations of these methods, including the transgenic plants and including the plant cultivars protectable or not protectable by plant breeders' rights. Plant parts are to be understood as meaning all parts and organs of plants above and below the ground, such as shoot, leaf, flower and root, examples which may be mentioned being leaves, needles, stalks, stems, flowers, fruit bodies, fruits, seeds, roots, tubers and rhizomes. The plant parts also include harvested material, and vegetative and generative propagation material, for example cuttings, tubers, rhizomes, offshoots and seeds.
    • [0413]
      Treatment according to the invention of the plants and plant parts with the active compounds is carried out directly or by allowing the compounds to act on the surroundings, environment or storage space by the customary treatment methods, for example by immersion, spraying, evaporation, fogging, scattering, painting on and, in the case of propagation material, in particular in the case of seeds, also by applying one or more coats.
    • [0414]
      The active compounds, according to the present invention, can be converted into the customary formulation forms, when they are used as insecticides. As formulation forms there can be mentioned, for example, solutions, emulsions, wettable powders, water dispersible granules, suspensions, powders, foams, pastes, tablets, granules, aerosols, natural and synthetic materials impregnated with active compound, microcapsules, seed coating agents, formulations used with burning equipment (as burning equipment, for example, fumigation and smoking cartridges, cans, coils, etc.), ULV [cold mist, warm mist], etc.
    • [0415]
      These formulations can be produced according to per se known methods, for example, by mixing the active compounds with extenders, namely liquid diluents or carriers; liquefied gas diluents or carriers; solid diluents or carriers, and optionally with surface-active agents, namely emulsifiers and/or dispersants and/or foam-forming agents.
    • [0416]
      In case that water is used as extender, for example, organic solvents can also be used as auxiliary solvents.
    • [0417]
      As liquid diluents or carriers there can be mentioned, for example, aromatic hydrocarbons (for example, xylene, toluene, alkylnaphthalene, etc.), chlorinated aromatic or chlorinated aliphatic hydrocarbons (for example, chlorobenzenes, ethylene chlorides, methylene chloride, etc.), aliphatic hydrocarbons [for example, cyclohexane etc. or paraffins (for example, mineral oil fractions etc.)], alcohols (for example, butanol, glycols and their ethers, esters, etc.), ketones (for example, acetone, methyl ethyl ketone, methyl isobutyl ketone, cyclohexanone, etc.), strongly polar solvents (for example, dimethylformamide, dimethyl sulfoxide, etc.), and water.
    • [0418]
      Liquefied gas diluents or carriers are substances that are gases at normal temperature and pressure and there can be mentioned, for example, aerosol propellants such as butane, propane, nitrogen gas, carbon dioxide, halogenated hydrocarbons.
    • [0419]
      As solid diluents there can be mentioned, for example, ground natural minerals (for example, kaolin, clay, talc, chalk, quartz, attapulgite, montmorillonite, diatomaceous earth, etc.), ground synthetic minerals (for example, highly dispersed silicic acid, alumina, silicates, etc.).
    • [0420]
      As solid carriers for granules there can be mentioned, for example, crushed and fractionated rocks (for example, calcite, marble, pumice, sepiolite, dolomite, etc.), synthetic granules of inorganic or organic meals, particles of organic materials (for example, saw dust, coconut shells, maize cobs, tobacco stalks, etc.), etc.
    • [0421]
      As emulsifiers and/or foam-forming agents, there can be mentioned, for example, nonionic and anionic emulsifiers [for example, polyoxyethylene fatty acid esters, polyoxyethylene fatty acid alcohol ethers (for example, alkylaryl polyglycol ethers), alkylsulfonates, alkylsulfates, arylsulfonates, etc.], albumin hydrolysis products, etc.
    • [0422]
      Dispersants include, for example, lignin sulfite waste liquor and methyl cellulose.
    • [0423]
      Tackifiers can also be used in formulations (powders, granules, emulsifiable concentrates). As said tackifiers, there can be mentioned, for example, carboxymethyl cellulose, natural or synthetic polymers (for example, gum Arabic, polyvinyl alcohol, polyvinyl acetate, etc.).
    • [0424]
      Colorants can also be used. As said colorants there can be mentioned, for example, inorganic pigments (for example, iron oxide, titanium oxide, Prussian Blue, etc,), organic dyestuffs such as alizarin dyestuffs, azo dyestuffs or metal phthalocyanine dyestuffs, and further trace nutrients such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc.
    • [0425]
      Said formulations can contain the aforementioned active component of the amount in the range of generally 0.1-95% by weight, preferably 0.5-90% by weight.
    • [0426]
      The active compounds of the formula (I) of the present invention can exist also as a mixed agent with other active compounds, for example, insecticides, poisonous baits, bactericides, miticides, nematicides, fungicides, growth regulators or herbicides in the form of their commercially useful formulations and in the application forms prepared from such formulations. Here, as the above-mentioned insecticides, there can be mentioned, for example, organophosphorous agents, carbamate agents, carboxylate type chemicals, chlorinated hydrocarbon type chemicals, insecticidal substances produced by microorganisms, etc.
    • [0427]
      Further, the active compounds of the formula (I) of the present invention can exist also as a mixed agent with a synergist, and such formulations and application forms can be mentioned as commercially useful. Said synergist itself must not be active, but is a compound that enhances the action of the active compound.
    • [0428]
      Particularly favourable mixing components are, for example, the following compounds:
    • Fungicides:
    • [0429]
      2-phenylphenol; 8-hydroxyquinoline sulfate; acibenzolar-S-methyl; aldimorph; amidoflumet; ampropylfos; ampropylfos-potassium; andoprim; anilazine; azaconazole; azoxystrobin; benalaxyl; benalaxyl-M; benodanil; benomyl; benthiavalicarb-isopropyl; benzamacril; benzamacril-isobutyl; bilanafos; binapacryl; biphenyl; bitertanol; blasticidin-S; boscalid; bromuconazole; bupirimate; buthiobate; butylamine; calcium polysulfide; capsimycin; captafol; captan; carbendazim; carboxin; carpropamid; carvone; chinomethionat; chlobenthiazone; chlorfenazole; chloroneb; chlorothalonil; chlozolinate; clozylacon; cyazofamid; cyflufenamid; cymoxanil; cyproconazole; cyprodinil; cyprofuram; Dagger G; debacarb; dichlofluanid; dichlone; dichlorophen; diclocymet; diclomezine; dicloran; diethofencarb; difenoconazole; diflumetorim; dimethirimol; dimethomorph; dimoxystrobin; diniconazole; diniconazole-M; dinocap; diphenylamine; dipyrithione; ditalimfos; dithianon; dodine; drazoxolon; edifenphos; epoxiconazole; ethaboxam; ethirimol; etridiazole; famoxadone; fenamidone; fenapanil; fenarimol; fenbuconazole; fenfuram; fenhexamid; fenitropan; fenoxanil; fenpiclonil; fenpropidin; fenpropimorph; ferbam; fluazinam; flubenzimine; fludioxonil; flumetover, flumorph; fluoromide; fluoxastrobin; fluquinconazole; flurprimidol; flusilazole; flusulfamide; flutolanil; flutriafol; folpet; fosetyl-A1; fosetyl-sodium; fuberidazole; furalaxyl; furametpyr; furcarbanil; furmecyclox; guazatine; hexachlorobenzene; hexaconazole; hymexazol; imazalil; imibenconazole; iminoctadine triacetate; iminoctadine tris(albesilate); iodocarb; ipconazole; iprobenfos; iprodione; iprovalicarb; irumamycin; isoprothiolane; isovaledione; kasugamycin; kresoxim-methyl; mancozeb; maneb; meferimzone; mepanipyrim; mepronil; metalaxyl; metalaxyl-M; metconazole; methasulfocarb; methfuroxam; metiram; metominostrobin; metsulfovax; mildiomycin; myclobutanil; myclozolin; natamycin; nicobifen; nitrothal-isopropyl; noviflumuron; nuarimol; ofurace; orysastrobin; oxadixyl; oxolinic acid; oxpoconazole; oxycarboxin; oxyfenthiin; paclobutrazol; pefurazoate; penconazole; pencycuron; phosdiphen; phthalide; picoxystrobin; piperalin; polyoxins; polyoxorim; probenazole; prochloraz; procymidone; propamocarb; propanosine-sodium; propiconazole; propineb; proquinazid; prothioconazole; pyraclostrobin; pyrazophos; pyrifenox; pyrimethanil; pyroquilon; pyroxyfur; pyrrolnitrin; quinconazole; quinoxyfen; quintozene; simeconazole; spiroxamine; sulfur; tebuconazole; tecloftalam; tecnazene; tetcyclacis; tetraconazole; thiabendazole; thicyofen; thifluzamide; thiophanate-methyl; thiram; tioxymid; tolclofos-methyl; tolylfluanid; triadimefon; triadimenol; triazbutil; triazoxide; tricyclamide; tricyclazole; tridemorph; trifloxystrobin; triflumizole; triforine; triticonazole; uniconazole; validamycin A; vinclozolin; zineb; ziram; zoxamide; (2S)-N-[2-[4-[[3-(4-chlorophenyl)-2-propynyl]oxy]-3-methoxyphenyl]ethyl]-3-methyl-2-[(methylsulfonyl)amino]-butanamide; 1-(1-naphthalenyl)-1H-pyrrol-2,5-dione; 2,3,5,6-tetrachloro-4-(methylsulfonyl)-pyridine; 2-amino-4-methyl-N-phenyl-5-thiazolecarboxamide; 2-chloro-N-(2,3-dihydro-1,1,3-trimethyl-1H-inden-4-yl)-3-pyridinecarboxamide; 3,4,5-trichloro-2,6-pyridinedicarbonitrile; actinovate; cis-1-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-yl)-cycloheptanol; methyl 1-(2,3-dihydro-2,2-dimethyl-1H-inden-1-yl)-1H-imidazole-5-carboxylate; mono potassium carbonate; N-(6-methoxy-3-pyridinyl)-cyclopropane carboxamide; N-butyl-8-(1,1-dimethylethyl)-1-oxaspiro[4.5]decan-3-amine; sodium tetrathiocarbonate; and copper salts and preparations, such as Bordeaux mixture; copper hydroxide; copper naphthenate; copper oxychloride; copper sulphate; cufraneb; copper oxide; mancopper; oxine-copper.
    • Bactericides:
    • [0430]
      bronopol, dichlorophen, nitrapyrin, nickel dimethyldithiocarbamate, kasugamycin, octhilinone, furancarboxylic acid, oxytetracyclin, probenazole, streptomycin, tecloftalam, copper sulphate and other copper preparations.
    • Insecticides/Acaricides/Nematicides:
    • [0431]
      1. Acetylcholinesterase (AChE) inhibitors
    • [0432]
      1.1 Carbamates (e.g. alanycarb, aldicarb, aldoxycarb, allyxycarb, aminocarb, azamethiphos, bendiocarb, benfuracarb, bufencarb, butacarb, butocarboxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan, chloethocarb, coumaphos, cyanofenphos, cyanophos, dimetilan, ethiofencarb, fenobucarb, fenothiocarb, formetanate, furathiocarb, isoprocarb, metam-sodium, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, promecarb, propoxur, thiodicarb, thiofanox, triazamate, trimethacarb, XMC, xylylcarb)
    • [0433]
      1.2 Organophosphates (e.g. acephate, azamethiphos, azinphos (-methyl, -ethyl), bromophos-ethyl, bromfenvinfos (-methyl), butathiofos, cadusafos, carbophenothion, chlorethoxyfos, chlorfenvinphos, chlormephos, chlorpyrifos (-methyl/-ethyl), coumaphos, cyanofenphos, cyanophos, chlorfenvinphos, demeton-s-methyl, demeton-s-methylsulphon, dialifos, diazinon, dichlofenthion, dichloriros/ddvp, dicrotophos, dimethoate, dimethylvinphos, dioxabenzofos, disulfoton, epn, ethion, ethoprophos, etrimfos, famphur, fenamiphos, fenitrothion, fensulfothion, fenthion, flupyrazofos, fonofos, formothion, fosmethilan, fosthiazate, heptenophos, iodofenphos, iprobenfos, isazofos, isofenphos, isopropyl o-salicylate, isoxatbion, malathion, mecarbam, methacrifos, methamidophos, methidathion, mevinphos, monocrotophos, naled, omethoate, oxydemeton-methyl, parathion (-methyl/-ethyl), phenthoate, phorate, phosalone, phosmet, phosphamidon, phosphocarb, phoxim, pirimiphos (-methyl/-ethyl), profenofos, propaphos, propetamphos, prothiofos, prothoate, pyraclofos, pyridaphenthion, pyridathion, quinalphos, sebufos, sulfotep, sulprofos, tebupirimfos, temephos, terbufos, tetrachlorvinphos, thiometon, triazophos, triclorfon, vamidothion)
    • [0434]
      2. Sodium channel modulators/voltage dependant sodium channel blockers
    • [0435]
      2.1 Pyrethroids (e.g. acrinathrin, allethrin (d-cis-trans, d-trans), beta-cyflutbrin, bifenthrin, bioallethrin, bioallethrin-s-cyclopentyl-isomer, bioethanometbrin, biopermethrin, bioresmethrin, chlovaporthrin, cis-cypermethrin, cis-resmethrin, cis-permethrin, clocythrin, cycloprothrin, cyfluthrin, cyhalothrin, cypermethrin (alpha-, beta-, theta-, zeta), cyphenothrin, DDT, deltamethrin, empenthrin (1R-isomer), esfenvalerate, etofenprox, fenfluthrin, fenpropathrin, fenpyrithrin, fenvalerate, flubrocythrinate, flucythrinate, flufenprox, flumetbrin, fluvalinate, fubfenprox, gamma-cyhalothrin, imiprothrin, kadethrin, lambda-cyhalothrin, metofluthrin, permethrin (cis-, trans), phenothrin (1R-trans isomer), prallethrin, proflutbrin, protrifenbute, pyresmethrin, resmethrin, RU 15525, silafluofen, tau-fluvalinate, tefluthrin, terallethrin, tetramethrin (1R-isomer), tralomethrin, transfluthrin, ZXI 8901, pyrethrins (pyrethrum))
    • [0436]
      2.2 Oxadiazine (e.g. indoxacarb)
    • [0437]
      3. Acetylcholine receptor agonists/-antagonists
    • [0438]
      3.1 Chloronicotinyls/neonicotinoids (e.g. acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, nithiazine, thiacloprid, thiamethoxam)
    • [0439]
      3.2 nicotine, bensultap, cartap
    • [0440]
      4. Acetylcholine receptor modulators
    • [0441]
      4.1 Spinosyns (e.g. spinosad)
    • [0442]
      5. GABA gated chloride channel antagonists
    • [0443]
      5.1 Cyclodiene organochlorines (e.g. camphechlor, chlordane, endosulfan, gamma HCH, HCH, heptachlor, lindane, methoxychlor
    • [0444]
      5.2 Fiproles (e.g. acetoprole, ethiprole, fipronil, vaniliprole)
    • [0445]
      6. Chloride channel activators
    • [0446]
      6.1 Mectins (e.g. abaraectin, avermectin, emamectin, emamectin-benzoate, ivermectin, milbemectin, milbemycin)
    • [0447]
      7. Juvenile hormone mimics
    • [0448]
      (e.g. diofenolan, epofenonane, fenoxycarb, hydroprene, kinoprene, methoprene, pyriproxifen, triprene)
    • [0449]
      8. Ecdysone agonists/disruptors
    • [0450]
      8.1 Diacylhydrazines (e.g. chromafenozide, halofenozide, methoxyfenozide, tebufenozide)
    • [0451]
      9. Inhibitors of chitin biosynthesis
    • [0452]
      9.1 Benzoylureas (e.g. bistrifluoron, chlofluazuron, diflubenzuron, fluazuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, penfluoron, teflubenzuron, tifiumuron)
    • [0453]
      9.2 buprofezin
    • [0454]
      9.3 cyromazine
    • [0455]
      10. Inhibitors of oxidative phosphorylation, ATP-disruptors
    • [0456]
      10.1 diafenthiuron
    • [0457]
      10.2 Organotins (e.g. azocyclotin, cyhexatin, fenbutatin-oxide)
    • [0458]
      11. Decoupler of oxidative phoshorylation by diruption of H proton gradient
    • [0459]
      11.1 Pyrroles (e.g. chlorfenapyr)
    • [0460]
      11.2 Dinitrophenoles (e.g. binapacyrl, dinobuton, dinocap, DNOC)
    • [0461]
      12. Site I electron transport inhibitors
    • [0462]
      12.1 METT's (e.g. fenazaquin, fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad, tolfenpyrad)
    • [0463]
      12.2 hydramethyhione
    • [0464]
      12.3 dicofol
    • [0465]
      13. Site II electron transport inhibitors
    • [0466]
      13.1 rotenone
    • [0467]
      14. Site II electron transport inhibitors
    • [0468]
      14.1 acequinocyl, fluacrypyrim
    • [0469]
      15. Microbial disruptors of insect midgut membranes
    • [0470]
      Bacillus thuringiensis strains
    • [0471]
      16. Inhibitors of lipid synthesis
    • [0472]
      16.1 Tetronic acid insecticides (e.g. spirodiclofen, spiromesifen)
    • [0473]
      16.2 Tetramic acid insecticides [e.g. 3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4.5]dec-3-en-4-yl ethyl carbonate (alias: carbonic acid, 3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4.5]-dec-3-en-4-yl ethyl ester, CAS-Reg.-No.: 382608-10-8) and carbonic acid, cis-3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4.5]dec-3-en-4-yl ethyl ester (CAS-Reg.-No.: 203313-25-1)]
    • [0474]
      17. Carboxamides
    • [0475]
      (e.g. flonicamid)
    • [0476]
      18. Octopaminergic agonists
    • [0477]
      (e.g. amitraz)
    • [0478]
      19. Inhibitors of magnesium stimulated ATPase
    • [0479]
      (e.g. propargite)
    • [0480]
      20. Phthalamides
    • [0481]
      (e.g. N2-[1,1-dimethyl-2-(methylsulfonyl)ethyl]-3-iodo-N1-[2-methyl-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl]-1,2-benzenedicarboxamide (CAS-Reg.-No.: 272451-65-7, flubendiamide))
    • [0482]
      21. Nereistoxin analogues
    • [0483]
      (e.g. thiocyclam hydrogen oxalate, thiosultap-sodium)
    • [0484]
      22. Biologica, hormones or pheromones
    • [0485]
      (e.g. azadirachtin, Bacillus spec., Beauveria spec., codlemone, Metarrhizium spec., Paecilomyces spec., thuringiensin, Verticillium spec.)
    • [0486]
      23. Compounds of unknown or non-specific mode of action
    • [0487]
      23.1 Fumigants (e.g. aluminium phosphide, methyl bromide, sulfa yl fluoride)
    • [0488]
      23.2 Selective feeding blockers (e.g. cryolite, flonicamid, pymetrozine)
    • [0489]
      23.3 Mite growth inhibitors (e.g. clofentezine, etoxazole, hexythiazox)
    • [0490]
      23.4 amidoflumet, benclothiaz, benzoximate, bifenazate, bromopropylate, buprofezin, chinomethionat, chlordimeform, chlorobenzilate, chloropicrin, clothiazoben, cycloprene, cyflumetofen, dicyclanil, fenoxacrim, fentrifanil, flubenzimine, flufenerim, flutenzin, gossyplure, hydramethylnone, japonilure, metoxadiazone, petroleum, piperonyl butoxide, potassium oleate, pyrafluprole, pyridalyl, pyriprole, sulfluramid, tetradifon, tetrasul, triarathene, verbutin
    • [0491]
      further the compound 3-methyl-phenyl-propylcarbamate (Tsumacide Z), the compound 3-(5-chloro-3-pyridinyl)-8-(2,2,2-trifluoroethyl)-8-azabicyclo[3.2.1]octan-3-carbonitrile (CAS-Reg.-Nr. 185982-80-3) and the corresponding 3-endo isomer (CAS-Reg.-Nr. 185984-60-5) (cf. WO 96/37494, WO 98/25923), and preparations comprising insecticidal active plant extracts, nematodes, fungi or viruses.
    • [0492]
      A mixture with other known active compounds, such as herbicides, fertilizers, growth regulators, safeners and/or semiochemicals is also possible.
    • [0493]
      When used as insecticides, the active compounds according to the invention can furthermore be present in their commercially available formulations and in the use forms, prepared from these formulations, as a mixture with synergistic agents. Synergistic agents are compounds, which increase the action of the active compounds, without it being necessary for the synergistic agent added to be active itself.
    • [0494]
      When used as insecticides, the active compounds according to the invention can furthermore be present in their commercially available formulations and in the use forms, prepared from these formulations, as a mixture with inhibitors which reduce degradation of the active compound after use in the vicinity of the plant, on the surface of parts of plants or in plant tissues.
    • [0495]
      The content of the active compounds of the formula (I) of the present invention in a commercially useful application form can be varied in a wide range.
    • [0496]
      The concentration of the active compounds of the formula (I) of the present invention at the time of actual usage can be, for example, in the range of 0.0000001-100% by weight, preferably 0.00001-1% by weight.
    • [0497]
      The compounds of the formula (I) of the present invention can be applied by usual methods suitable to the application forms.
    • [0498]
      In case of application against hygiene pests and pests of stored products, the active compounds of the present invention have a good stability against alkali on limed substrates and further show an excellent residual effectiveness on wood and soil.
    • [0499]
      As already mentioned above, it is possible to treat all plants and their parts according to the invention. In a preferred embodiment, wild plant species and plant cultivars, or those obtained by conventional biological breeding methods, such as crossing or protoplast fusion, and parts thereof, are treated. In a further preferred embodiment, transgenic plants and plant cultivars obtained by genetic engineering, if appropriate in combination with conventional methods (Genetically Modified Organisms), and parts thereof are treated. The term “parts” or “parts of plants” or “plant parts” has been explained above.
    • [0500]
      Particularly preferably, plants of the plant cultivars which are in each case commercially available or in use are treated according to the invention. Plant cultivars are to be understood as meaning plants having certain properties (“traits”) which have been obtained by conventional breeding, by mutagenesis or by recombinant DNA techniques. These can be cultivars, bio- or genotypes.
    • [0501]
      Depending on the plant species or plant cultivars, their location and growth conditions (soils, climate, vegetation period, diet), the treatment according to the invention may also result in superadditive (“synergistic”) effects. Thus, for example, reduced application rates and/or a widening of the activity spectrum and/or an increase in the activity of the substances and compositions to be used according to the invention, better plant growth, increased tolerance to high or low temperatures, increased tolerance to drought or to water or soil salt content, increased flowering performance, easier harvesting, accelerated maturation, higher harvest yields, better quality and/or a higher nutritional value of the harvested products, better storage stability and/or processability of the harvested products are possible which exceed the effects which were actually to be expected.
    • [0502]
      The transgenic plants or plant cultivars (i.e. those obtained by genetic engineering) which are preferably to be treated according to the invention include all plants which, in the genetic modification, received genetic material which imparted particularly advantageous useful traits to these plants. Examples of such traits are better plant growth, increased tolerance to high or low temperatures, increased tolerance to drought or to water or soil salt content, increased flowering performance, easier harvesting, accelerated maturation, higher harvest yields, better quality and/or a higher nutritional value of the harvested products, better storage stability and/or processability of the harvested products. Further and particularly emphasized examples of such traits are a better defence of the plants against animal and microbial pests, such as against insects, mites, phytopathogenic fungi, bacteria and/or viruses, and also increased tolerance of the plants to certain herbicidally active compounds. Examples of transgenic plants which may be mentioned are the important crop plants, such as cereals (wheat, rice), maize, soya beans, potatoes, cotton, tobacco, oilseed rape and also fruit plants (with the fruits apples, pears, citrus fruits and grapes), and particular emphasis is given to maize, soya beans, potatoes, cotton, tobacco and oilseed rape. Traits that are emphasized are in particular increased defence of the plants against insects, arachnids, nematodes and worms by toxins formed in the plants, in particular those formed in the plants by the genetic material from Bacillus thuringiensis (for example by the genes CryIA(a), CryIA(b), CryIA(c), CryIIA, CryIIIA, CryIIIB2, Cry9c, Cry2Ab, Cry3Bb and CryIF and also combinations thereof) (hereinbelow referred to as “Bt plants”). Traits that are also particularly emphasized are the increased defence of the plants against fungi, bacteria and viruses by systemic acquired resistance (SAR), systemin, phytoalexius, elicitors and resistance genes and correspondingly expressed proteins and toxins. Traits that are furthermore particularly emphasized are the increased tolerance of the plants to certain herbicidally active compounds, for example imidazolinones, sulphonylureas, glyphosate or phosphinotricin (for example the “PAT” gene). The genes which impart the desired traits in question can also be present in combination with one another in the transgenic plants. Examples of “Bt plants” which may be mentioned are maize varieties, cotton varieties, soya bean varieties and potato varieties which are sold under the trade names YIELD GARD® (for example maize, cotton, soya beans), KnockOut® (for example maize), StarLink® (for example maize), Bollgard® (cotton), Nucotn® (cotton) and NewLeaf® (potato). Examples of herbicide-tolerant plants which may be mentioned are maize varieties, cotton varieties and soya bean varieties which are sold under the trade names Roundup Ready® (tolerance to glyphosate, for example maize, cotton, soya bean), Liberty Link® (tolerance to phosphinotricin, for example oilseed rape), IMI® (tolerance to imidazolinones) and STS® (tolerance to sulphonylureas, for example maize). Herbicide-resistant plants (plants bred in a conventional manner for herbicide tolerance) which may be mentioned include the varieties sold under the name Clearfield® (for example maize). Of course, these statements also apply to plant cultivars having these genetic traits or genetic traits still to be developed, which plants will be developed and/or marketed in the future.
    • [0503]
      The plants listed can be treated according to the invention in a particularly advantageous manner with the compounds of the general formula I and/or the active compound mixtures according to the invention. The preferred ranges stated above for the active compounds or mixtures also apply to the treatment of these plants. Particular emphasis is given to the treatment of plants with the compounds or mixtures specifically mentioned in the present text.
    • [0504]
      Then the present invention will be described more specifically by examples. The present invention, however, should not be restricted only to them in any way.
    • SYNTHESIS EXAMPLES Synthesis Example 1
    • [0505]
    • [0506]
      3-(1,1-Dimethyl-2-methylsulfanyl-ethylimino)-4-iodo-3H-isobenzofuran-1-one (0.53 g) and 1-(3-methyl-4-aminobenzyl)-3,5-bis(trifluoromethyl)-1H-pyrazole (0.45 g) were dissolved in acetonitrile (15 ml), to which p-toluenesulfonic acid monohydrate (0.01 g) was added and the mixture was stirred at 60° C. for 3 hours. After finishing the reaction, the solvent was distilled off under reduced pressure and the residue was purified by silica gel column chromatography to obtaining N1-[4-(3,5-bistrifluoromethylpyrazol-1-ylmethyl)-2-methylphenyl]-N2-(1,1-dimethyl-2-methylsulfanylethyl)-3-iodophthalamide (0.91 g). mp. 83-87° C.
    • Synthesis Example 2
    • [0507]
    • [0508]
      N1-{4-[3,5-Bis(trifluoromethyl)-1H-pyrazol-1-ylmethyl]-2-methylphenyl}-N2-(1,1-dimethyl-2-methylsulfanylethyl)-3-iodophthalamide (0.5 g) was dissolved in dichloromethane, to which m-chloroperbenzoic acid (0.26 g) was added and the mixture was stirred for 5 hours under ice cooling. After finishing the reaction, the mixture was washed successively with aqueous solution of sodium thiosulfate, saturated aqueous solution of sodium bicarbonate and saturated aqueous solution of sodium chloride, and dried with anhydrous magnesium sulfate. After distilling off the solvent, the obtained residue was purified by silica gel column chromatography to obtain N1-{4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-ylmethyl]-2-methylphenyl}-N2-(2-methanesulfinyl-1,1-dimethylethyl)-3-iodophthalamide (0.30 g).
    • [0509]
      1H-NMR (CDCl3, ppm): 1.57 (3H, s), 1.60 (3H, s), 2.20 (3H, s), 2.30 (3H, s), 2.93 (2H, dd), 5.43 (2H, s), 6.57 (1H, s), 6.90 (1H, s), 7.0-8.2 (7H, m).
    • Synthesis Example 3
    • [0510]
    • [0511]
      N1-{4-[3,5-Bis(trifluoromethyl)-1H-pyrazol-1-ylmethyl]-2-methylphenyl}-N2-(1,1-dimethyl-2-methylsulfanylethyl)-3-iodophthalamide (0.30 g) was dissolved in dichloromethane, to which m-chloroperbenzoic acid (0.26 g) was added and the mixture was stirred at room temperature for 5 hours. After finishing the reaction, the mixture was washed successively with aqueous solution of sodium thiosulfate, saturated aqueous solution of sodium bicarbonate and saturated aqueous solution of sodium chloride, and dried with anhydrous magnesium sulfate. After distilling off the solvent, the obtained crude crystals were washed with petroleum ether to obtain N1-{4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-ylmethyl]-2-methylphenyl}-3-iodo-N2-(2-methanesulfonyl-1,1-dimethylethyl)phthalamide (0.25 g). mp. 104-107° C.
    • Synthesis Example 4
    • [0512]
    • [0513]
      A dioxane solution (15 ml) of 2-{4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-ylmethyl]-2-methylphenyl}-4-fluoroisoindole-1,3-dione (0.94 g), (S)-1-methyl-2-methylsulfanylethylamine (0.63 g) and acetic acid (0.12 g) was refluxed for 18 hours. After cooling to room temperature, the solvent was distilled off and the obtained residue was purified by silica gel column chromatography to obtain N1-{4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-ylmethyl]-2-methylphenyl}-3-fluoro-N2-[1-(S)-1-methyl-2-methylsulfanyl-ethyl]-phthalamide (0.19 g) (compound No. 549). mp. 66-68° C.
    • Synthesis Example 5
    • [0514]
    • [0515]
      3-Iodo-N-(1,1-dimethyl-2-methylsulfanyl-ethyl)-phthalamic acid (0.39 g) and N-(3-dimethylaminopropyl)-N1-ethylcarbonyl diimidazole hydrochloride (0.19 g) were stirred in dichloromethane (10 ml) at room temperature for 30 minutes. Then, 2-methyl-4-[1-(3-trifluoromethyl-1H-pyrazol-1-yl)-ethyl]-aniline (0.30 g) and p-toluenesulphonic acid monohydrate (0.02 g) were added thereto and the mixture was stirred at room temperature for 3 hours. After distilling off the solvent under reduced pressure, the obtained residue was purified by silica gel column chromatography to obtain N2-(1,1-dimethyl-2-methylsulfanyl-ethyl)-3-iodo-N1-{2-methyl-4-[1-(3-trifluoromethyl-1H-pyrazol-1-yl)-ethyl]-phenyl}-phthalamide (0.38 g) (compound No. 558). mp. 79-86° C.
    • [0516]
      The compounds of the formula (I), according to the present invention, which can be obtained in the Same manner as the above-mentioned Synthesis Examples 1 to 5 are shown in Table 1, together with the compounds obtained in the above-mentioned Synthesis Examples 1 to 5.
    • [0517]
      NMR data of the compounds, whose mp. column is marked as ***, are collectively shown in Table 2, separately from Table 1.
    • [0000]
      TABLE 1
      No. R1 X Y A m Q R2 R3 R4 mp
      1 C(CH3)2CH2SCH3 3-H 2-CH3 CH2 1 Q1 CF3 CF3 H ***
      2 C(CH3)2CH2SOCH3 3-H 2-CH3 CH2 1 Q1 CF3 CF3 H
      3 C(CH3)2CH2SO2CH3 3-H 2-CH3 CH2 1 Q1 CF3 CF3 H ***
      4 CH(CH3)CH2SCH3 3-H 2-CH3 CH2 1 Q1 CF3 CF3 H
      5 CH(CH3)CH2SOCH3 3-H 2-CH3 CH2 1 Q1 CF3 CF3 H
      6 CH(CH3)CH2SO2CH3 3-H 2-CH3 CH2 1 Q1 CF3 CF3 H
      7 CH(CH3)2 3-Cl 2-CH3 CH2 1 Q1 CF3 CF3 H
      8 C(CH3)2CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 CF3 H ***
      9 C(CH3)2CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 CF3 H 80-84
      10 C(CH3)2CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 CF3 CF3 H 183-186
      11 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 CF3 H ***
      12 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 CF3 H 76-81
      (S)-isomer
      13 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 CF3 H 185-193
      14 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 CF3 H 192-194
      (S)-isomer
      15 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 CF3 CF3 H ***
      16 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 CF3 CF3 H 88-93
      (S)-isomer
      17 CH(CH3)CH2SC2H5 3-Cl 2-CH3 CH2 1 Q1 CF3 CF3 H
      (S)-isomer
      18 CH(CH3)CH2SOC2H5 3-Cl 2-CH3 CH2 1 Q1 CF3 CF3 H
      (S)-isomer
      19 CH(CH3)CH2SO2C2H5 3-Cl 2-CH3 CH2 1 Q1 CF3 CF3 H
      (S)-isomer
      20 C(CH3)2CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      21 C(CH3)2CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      22 C(CH3)2CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      23 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      24 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      (S)-isomer
      25 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      26 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      (S)-isomer
      27 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      28 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      (S)-isomer
      29 CH(CH3)CH2SC2H5 3-Cl 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      (S)-isomer
      30 CH(CH3)CH2SOC2H5 3-Cl 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      (S)-isomer
      31 CH(CH3)CH2SO2C2H5 3-Cl 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      (S)-isomer
      32 C(CH3)2CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 H H C2F5
      33 C(CH3)2CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 H H C2F5
      34 C(CH3)2CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 H H C2F5
      35 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 H H C2F5
      36 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 H H C2F5
      (S)-isomer
      37 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 H H C2F5
      38 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 H H C2F5
      (S)-isomer
      39 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 H H C2F5
      40 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 H H C2F5
      (S)-isomer
      41 CH(CH3)CH2SC2H5 3-Cl 2-CH3 CH2 1 Q1 H H C2F5
      (S)-isomer
      42 CH(CH3)CH2SOC2H5 3-Cl 2-CH3 CH2 1 Q1 H H C2F5
      (S)-isomer
      43 CH(CH3)CH2SO2C2H5 3-Cl 2-CH3 CH2 1 Q1 H H C2F5
      (S)-isomer
      44 CH(CH3)2 3-Br 2-CH3 CH2 1 Q1 CF3 CF3 H
      45 C(CH3)2CH2SCH3 3-Br 2-CH3 CH2 1 Q1 CF3 CF3 H 154-160
      46 C(CH3)2CH2SOCH3 3-Br 2-CH3 CH2 1 Q1 CF3 CF3 H
      47 C(CH3)2CH2SO2CH3 3-Br 2-CH3 CH2 1 Q1 CF3 CF3 H ***
      48 CH(CH3)CH2SCH3 3-Br 2-CH3 CH2 1 Q1 CF3 CF3 H 147-155
      49 CH(CH3)CH2SCH3 3-Br 2-CH3 CH2 1 Q1 CF3 CF3 H 80-86
      (S)-isomer
      50 CH(CH3)CH2SOCH3 3-Br 2-CH3 CH2 1 Q1 CF3 CF3 H
      51 CH(CH3)CH2SOCH3 3-Br 2-CH3 CH2 1 Q1 CF3 CF3 H 207-209
      (S)-isomer
      52 CH(CH3)CH2SO2CH3 3-Br 2-CH3 CH2 1 Q1 CF3 CF3 H ***
      53 CH(CH3)CH2SO2CH3 3-Br 2-CH3 CH2 1 Q1 CF3 CF3 H 77-85
      (S)-isomer
      54 CH(CH3)CH2SC2H5 3-Br 2-CH3 CH2 1 Q1 CF3 CF3 H
      (S)-isomer
      55 CH(CH3)CH2SOC2H5 3-Br 2-CH3 CH2 1 Q1 CF3 CF3 H
      (S)-isomer
      56 CH(CH3)CH2SO2C2H5 3-Br 2-CH3 CH2 1 Q1 CF3 CF3 H
      (S)-isomer
      57 C(CH3)2CH2SCH3 3-Br 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      58 C(CH3)2SOCH3 3-Br 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      59 C(CH3)2CH2SO2CH3 3-Br 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      60 CH(CH3)CH2SCH3 3-Br 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      61 CH(CH3)CH2SCH3 3-Br 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      (S)-isomer
      62 CH(CH3)CH2SOCH3 3-Br 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      63 CH(CH3)CH2SOCH3 3-Br 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      (S)-isomer
      64 CH(CH3)CH2SO2CH3 3-Br 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      65 CH(CH3)CH2SO2CH3 3-Br 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      (S)-isomer
      66 CH(CH3)CH2SC2H5 3-Br 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      (S)-isomer
      67 CH(CH3)CH2SOC2H5 3-Br 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      (S)-isomer
      68 CH(CH3)CH2SO2C2H5 3-Br 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      (S)-isomer
      69 C(CH3)2CH2SCH3 3-Br 2-CH3 CH2 1 Q1 H H C2F5
      70 C(CH3)2CH2SOCH3 3-Br 2-CH3 CH2 1 Q1 H H C2F5
      71 C(CH3)2CH2SO2CH3 3-Br 2-CH3 CH2 1 Q1 H H C2F5
      72 CH(CH3)CH2SCH3 3-Br 2-CH3 CH2 1 Q1 H H C2F5
      73 CH(CH3)CH2SCH3 3-Br 2-CH3 CH2 1 Q1 H H C2F5
      (S)-isomer
      74 CH(CH3)CH2SOCH3 3-Br 2-CH3 CH2 1 Q1 H H C2F5
      75 CH(CH3)CH2SOCH3 3-Br 2-CH3 CH2 1 Q1 H H C2F5
      (S)-isomer
      76 CH(CH3)CH2SO2CH3 3-Br 2-CH3 CH2 1 Q1 H H C2F5
      77 CH(CH3)CH2SO2CH3 3-Br 2-CH3 CH2 1 Q1 H H C2F5
      (S)-isomer
      78 CH(CH3)CH2SC2H5 3-Br 2-CH3 CH2 1 Q1 H H C2F5
      (S)-isomer
      79 CH(CH3)CH2SOC2H5 3-Br 2-CH3 CH2 1 Q1 H H C2F5
      (S)-isomer
      80 CH(CH3)CH2SO2C2H5 3-Br 2-CH3 CH2 1 Q1 H H C2F5
      (S)-isomer
      81 CH(CH3)2 3-I 2-CH3 CH2 1 Q1 CF3 CF3 H ***
      82 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q1 CF3 CF3 H 83-87
      83 C(CH3)2CH2SOCH3 3-I 2-CH3 CH2 1 Q1 CF3 CF3 H ***
      84 C(CH3)2CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 CF3 CF3 H 104-107
      85 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 CF3 CF3 H ***
      86 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 CF3 CF3 H 85-93
      (S)-isomer
      87 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q1 CF3 CF3 H 213-215
      88 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q1 CF3 CF3 H 193-195
      (S)-isomer
      89 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 CF3 CF3 H ***
      90 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 CF3 CF3 H 87-93
      (S)-isomer
      91 CH(CH3)CH2SC2H5 3-I 2-CH3 CH2 1 Q1 CF3 CF3 H 79-83
      (S)-isomer
      92 CH(CH3)CH2SOC2H5 3-I 2-CH3 CH2 1 Q1 CF3 CF3 H
      (S)-isomer
      93 CH(CH3)CH2SO2C2H5 3-I 2-CH3 CH2 1 Q1 CF3 CF3 H 79-91
      (S)-isomer
      94 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q1 H C3F7-n H ***
      95 C(CH3)2CH2SOCH3 3-I 2-CH3 CH2 1 Q1 H C3F7-n H
      96 C(CH3)2CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 H C3F7-n H ***
      97 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 H C3F7-n H ***
      98 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q1 H C3F7-n H
      99 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 H C3F7-n H ***
      100 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      101 C(CH3)2CH2SOCH3 3-I 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      102 C(CH3)2CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      103 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 CF3 OCHF2 H ***
      104 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      (S)-isomer
      105 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      106 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      (S)-isomer
      107 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 CF3 OCHF2 H ***
      108 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      (S)-isomer
      109 CH(CH3)CH2SC2H5 3-I 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      (S)-isomer
      110 CH(CH3)CH2SOC2H5 3-I 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      (S)-isomer
      111 CH(CH3)CH2SO2C2H5 3-I 2-CH3 CH2 1 Q1 CF3 OCHF2 H
      (S)-isomer
      112 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q1 H H C2F5
      113 C(CH3)2CH2SOCH3 3-I 2-CH3 CH2 1 Q1 H H C2F5
      114 C(CH3)2CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 H H C2F5
      115 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 H H C2F5
      116 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 H H C2F5 ***
      (S)-isomer
      117 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q1 H H C2F5
      118 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q1 H H C2F5
      (S)-isomer
      119 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 H H C2F5
      120 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 H H C2F5
      (S)-isomer
      121 CH(CH3)CH2SC2H5 3-I 2-CH3 CH2 1 Q1 H H C2F5
      (S)-isomer
      122 CH(CH3)CH2SOC2H5 3-I 2-CH3 CH2 1 Q1 H H C2F5
      (S)-isomer
      123 CH(CH3)CH2SO2C2H5 3-I 2-CH3 CH2 1 Q1 H H C2F5
      (S)-isomer
      124 C(CH3)2CH2SCH3 3-OSO2CH3 2-CH3 CH2 1 Q1 CF3 CF3 H
      125 C(CH3)2CH2SOCH3 3-OSO2CH3 2-CH3 CH2 1 Q1 CF3 CF3 H
      126 C(CH3)2CH2SO2CH3 3-OSO2CH3 2-CH3 CH2 1 Q1 CF3 CF3 H
      127 CH(CH3)CH2SCH3 3-OSO2CH3 2-CH3 CH2 1 Q1 CF3 CF3 H
      128 CH(CH3)CH2SCH3 3-OSO2CH3 2-CH3 CH2 1 Q1 CF3 CF3 H 177-180
      (S)-isomer
      129 CH(CH3)CH2SOCH3 3-OSO2CH3 2-CH3 CH2 1 Q1 CF3 CF3 H
      130 CH(CH3)CH2SOCH3 3-OSO2CH3 2-CH3 CH2 1 Q1 CF3 CF3 H
      (S)-isomer
      131 CH(CH3)CH2SO2CH3 3-OSO2CH3 2-CH3 CH2 1 Q1 CF3 CF3 H
      132 CH(CH3)CH2SO2CH3 3-OSO2CH3 2-CH3 CH2 1 Q1 CF3 CF3 H 85-93
      (S)-isomer
      133 CH(CH3)CH2SC2H5 3-OSO2CH3 2-CH3 CH2 1 Q1 CF3 CF3 H
      (S)-isomer
      134 CH(CH3)CH2SOC2H5 3-OSO2CH3 2-CH3 CH2 1 Q1 CF3 CF3 H
      (S)-isomer
      135 CH(CH3)CH2SO2C2H5 3-OSO2CH3 2-CH3 CH2 1 Q1 CF3 CF3 H
      (S)-isomer
      136 CH(CH3)2 3-Cl 2-CH3 CH2 1 Q2 CF3 CF3
      137 C(CH3)2CH2SCH3 3-Cl 2-CH3 CH2 1 Q2 CF3 CF3 70-72
      138 C(CH3)2CH2SOCH3 3-Cl 2-CH3 CH2 1 Q2 CF3 CF3 84-90
      139 C(CH3)2CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q2 CF3 CF3 88-95
      140 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q2 CF3 CF3 76-80
      141 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q2 CF3 CF3 72-81
      (S)-isomer
      142 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q2 CF3 CF3 186-188
      143 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q2 CF3 CF3 195-198
      (S)-isomer
      144 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q2 CF3 CF3 116-118
      145 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q2 CF3 CF3 95-99
      (S)-isomer
      146 CH(CH3)CH2SC2H5 3-Cl 2-CH3 CH2 1 Q2 CF3 CF3 73-76
      (S)-isomer
      147 CH(CH3)CH2SOC2H5 3-Cl 2-CH3 CH2 1 Q2 CF3 CF3 180-183
      (S)-isomer
      148 CH(CH3)CH2SO2C2H5 3-Cl 2-CH3 CH2 1 Q2 CF3 CF3 66-72
      (S)-isomer
      149 C(CH3)2CH2SCH3 3-Cl 2-CH3 CH2 1 Q2 C2F5 CF3 ***
      150 C(CH3)2CH2SOCH3 3-Cl 2-CH3 CH2 1 Q2 C2F5 CF3 59-64
      151 C(CH3)2CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q2 C2F5 CF3 82-87
      152 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q2 C2F5 CF3
      153 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q2 C2F5 CF3 ***
      (S)-isomer
      154 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q2 C2F5 CF3
      155 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q2 C2F5 CF3 175-178
      (S)-isomer
      156 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q2 C2F5 CF3
      157 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q2 C2F5 CF3 82-90
      (S)-isomer
      158 CH(CH3)CH2SC2H5 3-Cl 2-CH3 CH2 1 Q2 C2F5 CF3
      (S)-isomer
      159 CH(CH3)CH2SOC2H5 3-Cl 2-CH3 CH2 1 Q2 C2F5 CF3
      (S)-isomer
      160 CH(CH3)CH2SO2C2H5 3-Cl 2-CH3 CH2 1 Q2 C2F5 CF3
      (S)-isomer
      161 C(CH3)2CH2SCH3 3-Cl 2-CH3 CH2 1 Q2 CF3 CHF2
      162 C(CH3)2CH2SOCH3 3-Cl 2-CH3 CH2 1 Q2 CF3 CHF2
      163 C(CH3)2CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q2 CF3 CHF2
      164 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q2 CF3 CHF2
      165 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q2 CF3 CHF2
      (S)-isomer
      166 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q2 CF3 CHF2
      167 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q2 CF3 CHF2
      (S)-isomer
      168 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q2 CF3 CHF2
      169 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q2 CF3 CHF2
      (S)-isomer
      170 CH(CH3)CH2SC2H5 3-Cl 2-CH3 CH2 1 Q2 CF3 CHF2
      (S)-isomer
      171 CH(CH3)CH2SOC2H5 3-Cl 2-CH3 CH2 1 Q2 CF3 CHF2
      (S)-isomer
      172 CH(CH3)CH2SO2C2H5 3-Cl 2-CH3 CH2 1 Q2 CF3 CHF2
      (S)-isomer
      173 CH(CH3)2 3-Br 2-CH3 CH2 1 Q2 CF3 CF3
      174 C(CH3)2CH2SCH3 3-Br 2-CH3 CH2 1 Q2 CF3 CF3 77-82
      175 C(CH3)2CH2SOCH3 3-Br 2-CH3 CH2 1 Q2 CF3 CF3
      176 C(CH3)2CH2SO2CH3 3-Br 2-CH3 CH2 1 Q2 CF3 CF3 151-155
      177 CH(CH3)CH2SCH3 3-Br 2-CH3 CH2 1 Q2 CF3 CF3 167-169
      178 CH(CH3)CH2SCH3 3-Br 2-CH3 CH2 1 Q2 CF3 CF3 68-73
      (S)-isomer
      179 CH(CH3)CH2SOCH3 3-Br 2-CH3 CH2 1 Q2 CF3 CF3
      180 CH(CH3)CH2SOCH3 3-Br 2-CH3 CH2 1 Q2 CF3 CF3 ***
      (S)-isomer
      181 CH(CH3)CH2SO2CH3 3-Br 2-CH3 CH2 1 Q2 CF3 CF3 90-98
      182 CH(CH3)CH2SO2CH3 3-Br 2-CH3 CH2 1 Q2 CF3 CF3  99-112
      (S)-isomer
      183 CH(CH3)CH2SC2H5 3-Br 2-CH3 CH2 1 Q2 CF3 CF3
      (S)-isomer
      184 CH(CH3)CH2SOC2H5 3-Br 2-CH3 CH2 1 Q2 CF3 CF3
      (S)-isomer
      185 CH(CH3)CH2SO2C2H5 3-Br 2-CH3 CH2 1 Q2 CF3 CF3
      (S)-isomer
      186 C(CH3)2CH2SCH3 3-Br 2-CH3 CH2 1 Q2 C2F5 CF3
      187 C(CH3)2CH2SOCH3 3-Br 2-CH3 CH2 1 Q2 C2F5 CF3
      188 C(CH3)2CH2SO2CH3 3-Br 2-CH3 CH2 1 Q2 C2F5 CF3
      189 CH(CH3)CH2SCH3 3-Br 2-CH3 CH2 1 Q2 C2F5 CF3
      190 CH(CH3)CH2SCH3 3-Br 2-CH3 CH2 1 Q2 C2F5 CF3
      (S)-isomer
      191 CH(CH3)CH2SOCH3 3-Br 2-CH3 CH2 1 Q2 C2F5 CF3
      192 CH(CH3)CH2SOCH3 3-Br 2-CH3 CH2 1 Q2 C2F5 CF3
      (S)-isomer
      193 CH(CH3)CH2SO2CH3 3-Br 2-CH3 CH2 1 Q2 C2F5 CF3
      194 CH(CH3)CH2SO2CH3 3-Br 2-CH3 CH2 1 Q2 C2F5 CF3
      (S)-isomer
      195 CH(CH3)CH2SC2H5 3-Br 2-CH3 CH2 1 Q2 C2F5 CF3
      (S)-isomer
      196 CH(CH3)CH2SOC2H5 3-Br 2-CH3 CH2 1 Q2 C2F5 CF3
      (S)-isomer
      197 CH(CH3)CH2SO2C2H5 3-Br 2-CH3 CH2 1 Q2 C2F5 CF3
      (S)-isomer
      198 C(CH3)2CH2SCH3 3-Br 2-CH3 CH2 1 Q2 CF3 CHF2
      199 C(CH3)2CH2SOCH3 3-Br 2-CH3 CH2 1 Q2 CF3 CHF2
      200 C(CH3)2CH2SO2CH3 3-Br 2-CH3 CH2 1 Q2 CF3 CHF2
      201 CH(CH3)CH2SCH3 3-Br 2-CH3 CH2 1 Q2 CF3 CHF2
      202 CH(CH3)CH2SCH3 3-Br 2-CH3 CH2 1 Q2 CF3 CHF2
      (S)-isomer
      203 CH(CH3)CH2SOCH3 3-Br 2-CH3 CH2 1 Q2 CF3 CHF2
      204 CH(CH3)CH2SOCH3 3-Br 2-CH3 CH2 1 Q2 CF3 CHF2
      (S)-isomer
      205 CH(CH3)CH2SO2CH3 3-Br 2-CH3 CH2 1 Q2 CF3 CHF2
      206 CH(CH3)CH2SO2CH3 3-Br 2-CH3 CH2 1 Q2 CF3 CHF2
      (S)-isomer
      207 CH(CH3)CH2SC2H5 3-Br 2-CH3 CH2 1 Q2 CF3 CHF2
      (S)-isomer
      208 CH(CH3)CH2SOC2H5 3-Br 2-CH3 CH2 1 Q2 CF3 CHF2
      (S)-isomer
      209 CH(CH3)CH2SO2C2H5 3-Br 2-CH3 CH2 1 Q2 CF3 CHF2
      (S)-isomer
      210 CH(CH3)2 3-I 2-CH3 CH2 1 Q2 CF3 CF3 102-105
      211 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q2 CF3 CF3 93-97
      212 C(CH3)2CH2SOCH3 3-I 2-CH3 CH2 1 Q2 CF3 CF3 92-93
      213 C(CH3)2CH2SO2CH3 3-I 2-CH3 CH2 1 Q2 CF3 CF3 104-107
      214 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q2 CF3 CF3 92-95
      215 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q2 CF3 CF3 81-90
      (S)-isomer
      216 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q2 CF3 CF3 192-195
      217 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q2 CF3 CF3 192-199
      (S)-isomer
      218 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q2 CF3 CF3  99-104
      219 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q2 CF3 CF3 164-167
      (S)-isomer
      220 CH(CH3)CH2SC2H5 3-I 2-CH3 CH2 1 Q2 CF3 CF3 90-94
      (S)-isomer
      221 CH(CH3)CH2SOC2H5 3-I 2-CH3 CH2 1 Q2 CF3 CF3 201-205
      (S)-isomer
      222 CH(CH3)CH2SO2C2H5 3-I 2-CH3 CH2 1 Q2 CF3 CF3 91-99
      (S)-isomer
      223 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q2 C2F5 CF3
      224 C(CH3)2CH2SOCH3 3-I 2-CH3 CH2 1 Q2 C2F5 CF3
      225 C(CH3)2CH2SO2CH3 3-I 2-CH3 CH2 1 Q2 C2F5 CF3
      226 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q2 C2F5 CF3 89-94
      227 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q2 C2F5 CF3  91-104
      (S)-isomer
      228 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q2 C2F5 CF3
      229 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q2 C2F5 CF3 190-193
      (S)-isomer
      230 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q2 C2F5 CF3  99-116
      231 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q2 C2F5 CF3 126-132
      (S)-isomer
      232 CH(CH3)CH2SC2H5 3-I 2-CH3 CH2 1 Q2 C2F5 CF3
      (S)-isomer
      233 CH(CH3)CH2SOC2H5 3-I 2-CH3 CH2 1 Q2 C2F5 CF3
      (S)-isomer
      234 CH(CH3)CH2SO2C2H5 3-I 2-CH3 CH2 1 Q2 C2F5 CF3
      (S)-isomer
      235 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q2 CF3 CHF2
      236 C(CH3)2CH2SOCH3 3-I 2-CH3 CH2 1 Q2 CF3 CHF2
      237 C(CH3)2CH2SO2CH3 3-I 2-CH3 CH2 1 Q2 CF3 CHF2
      238 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q2 CF3 CHF2 85-88
      239 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q2 CF3 CHF2 160-161
      (S)-isomer
      240 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q2 CF3 CHF2
      241 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q2 CF3 CHF2
      (S)-isomer
      242 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q2 CF3 CHF2 ***
      243 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q2 CF3 CHF2 174-178
      (S)-isomer
      244 CH(CH3)CH2SC2H5 3-I 2-CH3 CH2 1 Q2 CF3 CHF2
      (S)-isomer
      245 CH(CH3)CH2SOC2H5 3-I 2-CH3 CH2 1 Q2 CF3 CHF2
      (S)-isomer
      246 CH(CH3)CH2SO2C2H5 3-I 2-CH3 CH2 1 Q2 CF3 CHF2
      (S)-isomer
      247 C(CH3)2CH2SCH3 3-OSO2CH3 2-CH3 CH2 1 Q2 CF3 CF3
      248 C(CH3)2CH2SOCH3 3-OSO2CH3 2-CH3 CH2 1 Q2 CF3 CF3
      249 C(CH3)2CH2SO2CH3 3-OSO2CH3 2-CH3 CH2 1 Q2 CF3 CF3
      250 CH(CH3)CH2SCH3 3-OSO2CH3 2-CH3 CH2 1 Q2 CF3 CF3
      251 CH(CH3)CH2SCH3 3-OSO2CH3 2-CH3 CH2 1 Q2 CF3 CF3 ***
      (S)-isomer
      252 CH(CH3)CH2SOCH3 3-OSO2CH3 2-CH3 CH2 1 Q2 CF3 CF3
      253 CH(CH3)CH2SOCH3 3-OSO2CH3 2-CH3 CH2 1 Q2 CF3 CF3
      (S)-isomer
      254 CH(CH3)CH2SO2CH3 3-OSO2CH3 2-CH3 CH2 1 Q2 CF3 CF3
      255 CH(CH3)CH2SO2CH3 3-OSO2CH3 2-CH3 CH2 1 Q2 CF3 CF3 207-208
      (S)-isomer
      256 CH(CH3)CH2SC2H5 3-OSO2CH3 2-CH3 CH2 1 Q2 CF3 CF3
      (S)-isomer
      257 CH(CH3)CH2SOC2H5 3-OSO2CH3 2-CH3 CH2 1 Q2 CF3 CF3
      (S)-isomer
      258 CH(CH3)CH2SO2C2H5 3-OSO2CH3 2-CH3 CH2 1 Q2 CF3 CF3
      (S)-isomer
      259 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q3 OCHF2 CHF2 CF3
      260 C(CH3)2CH2SOCH3 3-I 2-CH3 CH2 1 Q3 OCHF2 CHF2 CF3
      261 C(CH3)2CH2SO2CH3 3-I 2-CH3 CH2 1 Q3 OCHF2 CHF2 CF3
      262 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q3 OCHF2 CHF2 CF3 82-90
      263 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q3 OCHF2 CHF2 CF3
      264 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q3 OCHF2 CHF2 CF3 88-99
      265 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q4 OCHF2 CHF2 CF3
      266 C(CH3)2CH2SOCH3 3-I 2-CH3 CH2 1 Q4 OCHF2 CHF2 CF3
      267 C(CH3)2CH2SO2CH3 3-I 2-CH3 CH2 1 Q4 OCHF2 CHF2 CF3
      268 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q4 OCHF2 CHF2 CF3 149-151
      269 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q4 OCHF2 CHF2 CF3
      270 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q4 OCHF2 CHF2 CF3 81-90
      271 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q5 CF3 CF3 OH ***
      272 C(CH3)2CH2SOCH3 3-I 2-CH3 CH2 1 Q5 CF3 CF3 OH
      273 C(CH3)2CH2SO2CH3 3-I 2-CH3 CH2 1 Q5 CF3 CF3 OH
      274 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q5 CF3 CF3 OH
      275 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q5 CF3 CF3 OH
      276 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q5 CF3 CF3 OH
      277 CH(CH3)2 3-I 2-CH3 CH2 1 Q6 Cl Cl H ***
      278 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q6 H CF3 CF3
      279 C(CH3)2CH2SOCH3 3-I 2-CH3 CH2 1 Q6 H CF3 CF3
      280 C(CH3)2CH2SO2CH3 3-I 2-CH3 CH2 1 Q6 H CF3 CF3
      281 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q6 H CF3 CF3 149-158
      (S)-isomer
      282 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q6 H CF3 CF3
      283 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q6 H CF3 CF3
      284 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q7 CH2CF3 CF3
      285 C(CH3)2SOCH3 3-I 2-CH3 CH2 1 Q7 CH2CF3 CF3
      286 C(CH3)2CH2SO2CH3 3-I 2-CH3 CH2 1 Q7 CH2CF3 CF3
      287 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q7 CH2CF3 CF3
      288 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q7 CH2CF3 CF3
      289 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q7 CH2CF3 CF3
      290 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q8 CH2CF3 CF3
      291 C(CH3)2CH2SOCH3 3-I 2-CH3 CH2 1 Q8 CH2CF3 CF3
      292 C(CH3)2CH2SO2CH3 3-I 2-CH3 CH2 1 Q8 CH2CF3 CF3
      293 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q8 CH2CF3 CF3
      294 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q8 CH2CF3 CF3
      295 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q8 CH2CF3 CF3
      296 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q9 CF3 CF3
      297 C(CH3)2CH2SOCH3 3-I 2-CH3 CH2 1 Q9 CF3 CF3
      298 C(CH3)2CH2SO2CH3 3-I 2-CH3 CH2 1 Q9 CF3 CF3
      299 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q9 CF3 CF3 65-79
      (S)-isomer
      300 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q9 CF3 CF3
      301 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q9 CF3 CF3
      302 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q10 CF3 CF3 H
      303 C(CH3)2CH2SOCH3 3-I 2-CH3 CH2 1 Q10 CF3 CF3 H
      304 C(CH3)2CH2SO2CH3 3-I 2-CH3 CH2 1 Q10 CF3 CF3 H
      305 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q10 CF3 CF3 H
      306 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q10 CF3 CF3 H
      307 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q10 CF3 CF3 H
      308 C(CH3)2CH2SCH3 3-I 2-CH3 O 1 Q10 CF3 CF3 H 179-181
      309 C(CH3)2CH2SOCH3 3-I 2-CH3 O 1 Q10 CF3 CF3 H
      310 C(CH3)2CH2SO2CH3 3-I 2-CH3 O 1 Q10 CF3 CF3 H 148-153
      311 CH(CH3)CH2SCH3 3-I 2-CH3 O 1 Q10 CF3 CF3 H
      312 CH(CH3)CH2SOCH3 3-I 2-CH3 O 1 Q10 CF3 CF3 H
      313 CH(CH3)CH2SO2CH3 3-I 2-CH3 O 1 Q10 CF3 CF3 H
      314 C(CH3)2CH2SCH3 3-Cl 2-CH3 0 Q1 CF3 CF3 H
      315 C(CH3)2CH2SOCH3 3-Cl 2-CH3 0 Q1 CF3 CF3 H
      316 C(CH3)2CH2SO2CH3 3-Cl 2-CH3 0 Q1 CF3 CF3 H
      317 CH(CH3)CH2SCH3 3-Cl 2-CH3 0 Q1 CF3 CF3 H
      318 CH(CH3)CH2SCH3 3-Cl 2-CH3 0 Q1 CF3 CF3 H 209-210
      (S)-isomer
      319 CH(CH3)CH2SOCH3 3-Cl 2-CH3 0 Q1 CF3 CF3 H
      320 CH(CH3)CH2SOCH3 3-Cl 2-CH3 0 Q1 CF3 CF3 H
      (S)-isomer
      321 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 0 Q1 CF3 CF3 H
      322 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 0 Q1 CF3 CF3 H 218-219
      (S)-isomer
      323 CH(CH3)CH2SC2H5 3-Cl 2-CH3 0 Q1 CF3 CF3 H
      (S)-isomer
      324 CH(CH3)CH2SOC2H5 3-Cl 2-CH3 0 Q1 CF3 CF3 H
      (S)-isomer
      325 CH(CH3)CH2SO2C2H5 3-Cl 2-CH3 0 Q1 CF3 CF3 H
      (S)-isomer
      326 C(CH3)2CH2SCH3 3-Cl 2-CH3 0 Q1 H C2F5 H
      327 C(CH3)2CH2SOCH3 3-Cl 2-CH3 0 Q1 H C2F5 H
      328 C(CH3)2CH2SO2CH3 3-Cl 2-CH3 0 Q1 H C2F5 H
      329 CH(CH3)CH2SCH3 3-Cl 2-CH3 0 Q1 H C2F5 H
      330 CH(CH3)CH2SCH3 3-Cl 2-CH3 0 Q1 H C2F5 H
      (S)-isomer
      331 CH(CH3)CH2SOCH3 3-Cl 2-CH3 0 Q1 H C2F5 H
      332 CH(CH3)CH2SOCH3 3-Cl 2-CH3 0 Q1 H C2F5 H
      (S)-isomer
      333 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 0 Q1 H C2F5 H
      334 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 0 Q1 H C2F5 H
      (S)-isomer
      335 CH(CH3)CH2SC2H5 3-Cl 2-CH3 0 Q1 H C2F5 H
      (S)-isomer
      336 CH(CH3)CH2SOC2H5 3-Cl 2-CH3 0 Q1 H C2F5 H
      (S)-isomer
      337 CH(CH3)CH2SO2C2H5 3-Cl 2-CH3 0 Q1 H C2F5 H
      (S)-isomer
      338 C(CH3)2CH2SCH3 3-Cl 2-CH3 0 Q1 C2F5 H H
      339 C(CH3)2CH2SOCH3 3-Cl 2-CH3 0 Q1 C2F5 H H
      340 C(CH3)2CH2SO2CH3 3-Cl 2-CH3 0 Q1 C2F5 H H
      341 CH(CH3)CH2SCH3 3-Cl 2-CH3 0 Q1 C2F5 H H
      342 CH(CH3)CH2SCH3 3-Cl 2-CH3 0 Q1 C2F5 H H
      (S)-isomer
      343 CH(CH3)CH2SOCH3 3-Cl 2-CH3 0 Q1 C2F5 H H
      344 CH(CH3)CH2SOCH3 3-Cl 2-CH3 0 Q1 C2F5 H H
      (S)-isomer
      345 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 0 Q1 C2F5 H H
      346 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 0 Q1 C2F5 H H
      (S)-isomer
      347 CH(CH3)CH2SC2H5 3-Cl 2-CH3 0 Q1 C2F5 H H
      (S)-isomer
      348 CH(CH3)CH2SOC2H5 3-Cl 2-CH3 0 Q1 C2F5 H H
      (S)-isomer
      349 CH(CH3)CH2SO2C2H5 3-Cl 2-CH3 0 Q1 C2F5 H H
      (S)-isomer
      350 C(CH3)2CH2SCH3 3-Cl 2-CH3 0 Q1 H H C2F5
      351 C(CH3)2CH2SOCH3 3-Cl 2-CH3 0 Q1 H H C2F5
      352 C(CH3)2CH2SO2CH3 3-Cl 2-CH3 0 Q1 H H C2F5
      353 CH(CH3)CH2SCH3 3-Cl 2-CH3 0 Q1 H H C2F5
      354 CH(CH3)CH2SCH3 3-Cl 2-CH3 0 Q1 H H C2F5
      (S)-isomer
      355 CH(CH3)CH2SOCH3 3-Cl 2-CH3 0 Q1 H H C2F5
      356 CH(CH3)CH2SOCH3 3-Cl 2-CH3 0 Q1 H H C2F5
      (S)-isomer
      357 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 0 Q1 H H C2F5
      358 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 0 Q1 H H C2F5
      (S)-isomer
      359 CH(CH3)CH2SC2H5 3-Cl 2-CH3 0 Q1 H H C2F5
      (S)-isomer
      360 CH(CH3)CH2SOC2H5 3-Cl 2-CH3 0 Q1 H H C2F5
      (S)-isomer
      361 CH(CH3)CH2SO2C2H5 3-Cl 2-CH3 0 Q1 H H C2F5
      (S)-isomer
      362 C(CH3)2CH2SCH3 3-Br 2-CH3 0 Q1 CF3 CF3 H
      363 C(CH3)2CH2SOCH3 3-Br 2-CH3 0 Q1 CF3 CF3 H
      364 C(CH3)2CH2SO2CH3 3-Br 2-CH3 0 Q1 CF3 CF3 H
      365 CH(CH3)CH2SCH3 3-Br 2-CH3 0 Q1 CF3 CF3 H
      366 CH(CH3)CH2SCH3 3-Br 2-CH3 0 Q1 CF3 CF3 H
      (S)-isomer
      367 CH(CH3)CH2SOCH3 3-Br 2-CH3 0 Q1 CF3 CF3 H
      368 CH(CH3)CH2SOCH3 3-Br 2-CH3 0 Q1 CF3 CF3 H
      (S)-isomer
      369 CH(CH3)CH2SO2CH3 3-Br 2-CH3 0 Q1 CF3 CF3 H
      370 CH(CH3)CH2SO2CH3 3-Br 2-CH3 0 Q1 CF3 CF3 H
      (S)-isomer
      371 CH(CH3)CH2SC2H5 3-Br 2-CH3 0 Q1 CF3 CF3 H
      (S)-isomer
      372 CH(CH3)CH2SOC2H5 3-Br 2-CH3 0 Q1 CF3 CF3 H
      (S)-isomer
      373 CH(CH3)CH2SO2C2H5 3-Br 2-CH3 0 Q1 CF3 CF3 H
      (S)-isomer
      374 C(CH3)2CH2SCH3 3-Br 2-CH3 0 Q1 H C2F5 H
      375 C(CH3)2CH2SOCH3 3-Br 2-CH3 0 Q1 H C2F5 H
      376 C(CH3)2CH2SO2CH3 3-Br 2-CH3 0 Q1 H C2F5 H
      377 CH(CH3)CH2SCH3 3-Br 2-CH3 0 Q1 H C2F5 H
      378 CH(CH3)CH2SCH3 3-Br 2-CH3 0 Q1 H C2F5 H
      (S)-isomer
      379 CH(CH3)CH2SOCH3 3-Br 2-CH3 0 Q1 H C2F5 H
      380 CH(CH3)CH2SOCH3 3-Br 2-CH3 0 Q1 H C2F5 H
      (S)-isomer
      381 CH(CH3)CH2SO2CH3 3-Br 2-CH3 0 Q1 H C2F5 H
      382 CH(CH3)CH2SO2CH3 3-Br 2-CH3 0 Q1 H C2F5 H
      (S)-isomer
      383 CH(CH3)CH2SC2H5 3-Br 2-CH3 0 Q1 H C2F5 H
      (S)-isomer
      384 CH(CH3)CH2SOC2H5 3-Br 2-CH3 0 Q1 H C2F5 H
      (S)-isomer
      385 CH(CH3)CH2SO2C2H5 3-Br 2-CH3 0 Q1 H C2F5 H
      (S)-isomer
      386 C(CH3)2CH2SCH3 3-Br 2-CH3 0 Q1 C2F5 H H
      387 C(CH3)2CH2SOCH3 3-Br 2-CH3 0 Q1 C2F5 H H
      388 C(CH3)2CH2SO2CH3 3-Br 2-CH3 0 Q1 C2F5 H H
      389 CH(CH3)CH2SCH3 3-Br 2-CH3 0 Q1 C2F5 H H
      390 CH(CH3)CH2SCH3 3-Br 2-CH3 0 Q1 C2F5 H H
      (S)-isomer
      391 CH(CH3)CH2SOCH3 3-Br 2-CH3 0 Q1 C2F5 H H
      392 CH(CH3)CH2SOCH3 3-Br 2-CH3 0 Q1 C2F5 H H
      (S)-isomer
      393 CH(CH3)CH2SO2CH3 3-Br 2-CH3 0 Q1 C2F5 H H
      394 CH(CH3)CH2SO2CH3 3-Br 2-CH3 0 Q1 C2F5 H H
      (S)-isomer
      395 CH(CH3)CH2SC2H5 3-Br 2-CH3 0 Q1 C2F5 H H
      (S)-isomer
      396 CH(CH3)CH2SOC2H5 3-Br 2-CH3 0 Q1 C2F5 H H
      (S)-isomer
      397 CH(CH3)CH2SO2C2H5 3-Br 2-CH3 0 Q1 C2F5 H H
      (S)-isomer
      398 C(CH3)2CH2SCH3 3-Br 2-CH3 0 Q1 H H C2F5
      399 C(CH3)2CH2SOCH3 3-Br 2-CH3 0 Q1 H H C2F5
      400 C(CH3)2CH2SO2CH3 3-Br 2-CH3 0 Q1 H H C2F5
      401 CH(CH3)CH2SCH3 3-Br 2-CH3 0 Q1 H H C2F5
      402 CH(CH3)CH2SCH3 3-Br 2-CH3 0 Q1 H H C2F5
      (S)-isomer
      403 CH(CH3)CH2SOCH3 3-Br 2-CH3 0 Q1 H H C2F5
      404 CH(CH3)CH2SOCH3 3-Br 2-CH3 0 Q1 H H C2F5
      (S)-isomer
      405 CH(CH3)CH2SO2CH3 3-Br 2-CH3 0 Q1 H H C2F5
      406 CH(CH3)CH2SO2CH3 3-Br 2-CH3 0 Q1 H H C2F5
      (S)-isomer
      407 CH(CH3)CH2SC2H5 3-Br 2-CH3 0 Q1 H H C2F5
      (S)-isomer
      408 CH(CH3)CH2SOC2H5 3-Br 2-CH3 0 Q1 H H C2F5
      (S)-isomer
      409 CH(CH3)CH2SO2C2H5 3-Br 2-CH3 0 Q1 H H C2F5
      (S)-isomer
      410 C(CH3)2CH2SCH3 3-I 2-CH3 0 Q1 CF3 CF3 H
      411 C(CH3)2CH2SOCH3 3-I 2-CH3 0 Q1 CF3 CF3 H
      412 C(CH3)2CH2SO2CH3 3-I 2-CH3 0 Q1 CF3 CF3 H
      413 CH(CH3)CH2SCH3 3-I 2-CH3 0 Q1 CF3 CF3 H 201
      414 CH(CH3)CH2SCH3 3-I 2-CH3 0 Q1 CF3 CF3 H 192-206
      (S)-isomer
      415 CH(CH3)CH2SOCH3 3-I 2-CH3 0 Q1 CF3 CF3 H
      416 CH(CH3)CH2SOCH3 3-I 2-CH3 0 Q1 CF3 CF3 H
      (S)-isomer
      417 CH(CH3)CH2SO2CH3 3-I 2-CH3 0 Q1 CF3 CF3 H ***
      418 CH(CH3)CH2SO2CH3 3-I 2-CH3 0 Q1 CF3 CF3 H
      (S)-isomer
      419 CH(CH3)CH2SC2H5 3-I 2-CH3 0 Q1 CF3 CF3 H
      (S)-isomer
      420 CH(CH3)CH2SOC2H5 3-I 2-CH3 0 Q1 CF3 CF3 H
      (S)-isomer
      421 CH(CH3)CH2SO2C2H5 3-I 2-CH3 0 Q1 CF3 CF3 H
      (S)-isomer
      422 C(CH3)2CH2SCH3 3-I 2-CH3 0 Q1 H C2F5 H ***
      423 C(CH3)2CH2SOCH3 3-I 2-CH3 0 Q1 H C2F5 H
      424 C(CH3)2CH2SO2CH3 3-I 2-CH3 0 Q1 H C2F5 H
      425 CH(CH3)CH2SCH3 3-I 2-CH3 0 Q1 H C2F5 H
      426 CH(CH3)CH2SCH3 3-I 2-CH3 0 Q1 H C2F5 H
      (S)-isomer
      427 CH(CH3)CH2SOCH3 3-I 2-CH3 0 Q1 H C2F5 H
      428 CH(CH3)CH2SOCH3 3-I 2-CH3 0 Q1 H C2F5 H
      (S)-isomer
      428 CH(CH3)CH2SO2CH3 3-I 2-CH3 0 Q1 H C2F5 H
      430 CH(CH3)CH2SO2CH3 3-I 2-CH3 0 Q1 H C2F5 H
      (S)-isomer
      431 CH(CH3)CH2SC2H5 3-I 2-CH3 0 Q1 H C2F5 H
      (S)-isomer
      432 CH(CH3)CH2SOC2H5 3-I 2-CH3 0 Q1 H C2F5 H
      (S)-isomer
      433 CH(CH3)CH2SO2C2H5 3-I 2-CH3 0 Q1 H C2F5 H
      (S)-isomer
      434 C(CH3)2CH2SCH3 3-I 2-CH3 0 Q1 C2F5 H H ***
      435 C(CH3)2CH2SOCH3 3-I 2-CH3 0 Q1 C2F5 H H
      436 C(CH3)2CH2SO2CH3 3-I 2-CH3 0 Q1 C2F5 H H
      437 CH(CH3)CH2SCH3 3-I 2-CH3 0 Q1 C2F5 H H
      438 CH(CH3)CH2SCH3 3-I 2-CH3 0 Q1 C2F5 H H
      (S)-isomer
      439 CH(CH3)CH2SOCH3 3-I 2-CH3 0 Q1 C2F5 H H
      440 CH(CH3)CH2SOCH3 3-I 2-CH3 0 Q1 C2F5 H H
      (S)-isomer
      441 CH(CH3)CH2SO2CH3 3-I 2-CH3 0 Q1 C2F5 H H
      442 CH(CH3)CH2SO2CH3 3-I 2-CH3 0 Q1 C2F5 H H
      (S)-isomer
      443 CH(CH3)CH2SC2H5 3-I 2-CH3 0 Q1 C2F5 H H
      (S)-isomer
      444 CH(CH3)CH2SOC2H5 3-I 2-CH3 0 Q1 C2F5 H H
      (S)-isomer
      445 CH(CH3)CH2SO2C2H5 3-I 2-CH3 0 Q1 C2F5 H H
      (S)-isomer
      446 C(CH3)2CH2SCH3 3-I 2-CH3 0 Q1 H H C2F5 155-157
      447 C(CH3)2CH2SOCH3 3-I 2-CH3 0 Q1 H H C2F5
      448 C(CH3)2CH2SO2CH3 3-I 2-CH3 0 Q1 H H C2F5 162-168
      449 CH(CH3)CH2SCH3 3-I 2-CH3 0 Q1 H H C2F5
      450 CH(CH3)CH2SCH3 3-I 2-CH3 0 Q1 H H C2F5
      (S)-isomer
      451 CH(CH3)CH2SOCH3 3-I 2-CH3 0 Q1 H H C2F5
      452 CH(CH3)CH2SOCH3 3-I 2-CH3 0 Q1 H H C2F5
      (S)-isomer
      453 CH(CH3)CH2SO2CH3 3-I 2-CH3 0 Q1 H H C2F5
      454 CH(CH3)CH2SO2CH3 3-I 2-CH3 0 Q1 H H C2F5
      (S)-isomer
      455 CH(CH3)CH2SC2H5 3-I 2-CH3 0 Q1 H H C2F5
      (S)-isomer
      456 CH(CH3)CH2SOC2H5 3-I 2-CH3 0 Q1 H H C2F5
      (S)-isomer
      457 CH(CH3)CH2SO2C2H5 3-I 2-CH3 0 Q1 H H C2F5
      (S)-isomer
      458 C(CH3)2CH2SCH3 3-I 2-CH3 0 Q1 CH3 CF3 H
      459 C(CH3)2CH2SOCH3 3-I 2-CH3 0 Q1 CH3 CF3 H
      460 C(CH3)2CH2SO2CH3 3-I 2-CH3 0 Q1 CH3 CF3 H
      461 CH(CH3)CH2SCH3 3-I 2-CH3 0 Q1 CH3 CF3 H 178-180
      462 CH(CH3)CH2SOCH3 3-I 2-CH3 0 Q1 CH3 CF3 H
      463 CH(CH3)CH2SO2CH3 3-I 2-CH3 0 Q1 CH3 CF3 H 101-112
      464 C(CH3)2CH2SCH3 3-I 2-CH3 0 Q1 CF3 CH3 H
      465 C(CH3)2CH2SOCH3 3-I 2-CH3 0 Q1 CF3 CH3 H
      466 C(CH3)2CH2SO2CH3 3-I 2-CH3 0 Q1 CF3 CH3 H
      467 CH(CH3)CH2SCH3 3-I 2-CH3 0 Q1 CF3 CH3 H 187-192
      468 CH(CH3)CH2SOCH3 3-I 2-CH3 0 Q1 CF3 CH3 H
      469 CH(CH3)CH2SO2CH3 3-I 2-CH3 0 Q1 CF3 CH3 H 108-116
      470 C(CH3)2CH2SCH3 3-I 2-CH3 0 Q1 C2F5 CF3 H
      471 C(CH3)2CH2SOCH3 3-I 2-CH3 0 Q1 C2F5 CF3 H
      472 C(CH3)2CH2SO2CH3 3-I 2-CH3 0 Q1 C2F5 CF3 H
      473 CH(CH3)CH2SCH3 3-I 2-CH3 0 Q1 C2F5 CF3 H 109-111
      474 CH(CH3)CH2SOCH3 3-I 2-CH3 0 Q1 C2F5 CF3 H
      475 CH(CH3)CH2SO2CH3 3-I 2-CH3 0 Q1 C2F5 CF3 H 103-115
      476 C(CH3)2CH2SCH3 3-I 2-CH3 0 Q1 CF3 H Br
      477 C(CH3)2CH2SOCH3 3-I 2-CH3 0 Q1 CF3 H Br
      478 C(CH3)2CH2SO2CH3 3-I 2-CH3 0 Q1 CF3 H Br
      479 CH(CH3)CH2SCH3 3-I 2-CH3 0 Q1 CF3 H Br 235-237
      480 CH(CH3)CH2SOCH3 3-I 2-CH3 0 Q1 CF3 H Br
      481 CH(CH3)CH2SO2CH3 3-I 2-CH3 0 Q1 CF3 H Br 201-209
      482 C(CH3)2CH2SCH3 3-I 2-CH3 0 Q1 CF3 H H
      483 C(CH3)2CH2SOCH3 3-I 2-CH3 0 Q1 CF3 H H
      484 C(CH3)2CH2SO2CH3 3-I 2-CH3 0 Q1 CF3 H H
      485 CH(CH3)CH2SCH3 3-I 2-CH3 0 Q1 CF3 H H 173-174
      486 CH(CH3)CH2SOCH3 3-I 2-CH3 0 Q1 CF3 H H
      487 CH(CH3)CH2SO2CH3 3-I 2-CH3 0 Q1 CF3 H H 107-109
      488 C(CH3)2CH2SCH3 3-OSO2CH3 2-CH3 0 Q1 CF3 CF3 H
      489 C(CH3)2CH2SOCH3 3-OSO2CH3 2-CH3 0 Q1 CF3 CF3 H
      490 C(CH3)2CH2SO2CH3 3-OSO2CH3 2-CH3 0 Q1 CF3 CF3 H
      491 CH(CH3)CH2SCH3 3-OSO2CH3 2-CH3 0 Q1 CF3 CF3 H
      492 CH(CH3)CH2SCH3 3-OSO2CH3 2-CH3 0 Q1 CF3 CF3 H 175-177
      (S)-isomer
      493 CH(CH3)CH2SOCH3 3-OSO2CH3 2-CH3 0 Q1 CF3 CF3 H
      494 CH(CH3)CH2SOCH3 3-OSO2CH3 2-CH3 0 Q1 CF3 CF3 H
      (S)-isomer
      495 CH(CH3)CH2SO2CH3 3-OSO2CH3 2-CH3 0 Q1 CF3 CF3 H
      496 CH(CH3)CH2SO2CH3 3-OSO2CH3 2-CH3 0 Q1 CF3 CF3 H
      (S)-isomer
      497 C(CH3)2CH2SOCH3 3-I 2-CH3 0 Q5 C2F5 CF3 OH
      498 C(CH3)2CH3SOCH3 3-I 2-CH3 0 Q5 C2F5 CF3 OH
      499 C(CH3)2CH2SO2CH3 3-I 2-CH3 0 Q5 C2F5 CF3 OH
      500 CH(CH3)CH2SCH3 3-I 2-CH3 0 Q5 C2F5 CF3 OH 101-106
      501 CH(CH3)CH2SOCH3 3-I 2-CH3 0 Q5 C2F5 CF3 OH
      502 CH(CH3)CH2SO2CH3 3-I 2-CH3 0 Q5 C2F5 CF3 OH
      503 C(CH3)2CH2SCH3 3-I 2-CH3 0 Q11 CH2CF3 H CF3
      504 C(CH3)2CH2SOCH3 3-I 2-CH3 0 Q11 CH2CF3 H CF3
      505 C(CH3)2CH2SO2CH3 3-I 2-CH3 0 Q11 CH2CF3 H CF3
      506 CH(CH3)CH2SCH3 3-I 2-CH3 0 Q11 CH2CF3 H CF3 106-118
      507 CH(CH3)CH2SOCH3 3-I 2-CH3 0 Q11 CH2CF3 H CF3
      508 CH(CH3)CH2SO2CH3 3-I 2-CH3 0 Q11 CH2CF3 H CF3 127-139
      509 C(CH3)2CH2SCH3 3-I 2-CH3 0 Q11 CHF2 H CF3
      510 C(CH3)2CH2SOCH3 3-I 2-CH3 0 Q11 CHF2 H CF3
      511 C(CH3)2CH2SO2CH3 3-I 2-CH3 0 Q11 CHF2 H CF3
      512 CH(CH3)CH2SCH3 3-I 2-CH3 0 Q11 CHF2 H CF3 138-144
      513 CH(CH3)CH2SOCH3 3-I 2-CH3 0 Q11 CHF2 H CF3
      514 CH(CH3)CH2SO2CH3 3-I 2-CH3 0 Q11 CHF2 H CF3
      515 C(CH3)2CH2SCH3 3-I 2-CH3 0 Q12 CHF2 H OCHF2
      516 C(CH3)2CH2SOCH3 3-I 2-CH3 0 Q12 CHF2 H OCHF2
      517 C(CH3)2CH2SO2CH3 3-I 2-CH3 0 Q12 CHF2 H OCHF2
      518 CH(CH3)CH2SCH3 3-I 2-CH3 0 Q12 CHF2 H OCHF2 83-89
      519 CH(CH3)CH2SOCH3 3-I 2-CH3 0 Q12 CHF2 H OCHF2
      520 CH(CH3)CH2SO2CH3 3-I 2-CH3 0 Q12 CHF2 H OCHF2 91-97
      521 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 H C2F5 H ***
      522 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 H C2F5 H ***
      523 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q1 H C2F5 H ***
      524 C(CH3)2CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 H C2F5 H
      525 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 H H
      526 C(CH3)2CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 H H
      527 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 C2F5 H H
      528 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 C2F5 H H
      529 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q1 C2F5 H H ***
      530 C(CH3)2CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 C2F5 H H ***
      531 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C3F7-n H H
      532 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C3F7-n H H ***
      (S)-isomer
      533 C(CH3)2CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C3F7-n H H
      534 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 C3F7-n H H ***
      535 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 C3F7-n H H
      (S)-isomer
      536 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 C3F7-n H H ***
      537 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q1 C3F7-n H H ***
      538 C(CH3)2CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 C3F7-n H H ***
      539 CH(CH3)CH2SCH(CH3)2 3-I 2-CH3 CH2 1 Q1 CF3 CF3 H 81-83
      (S)-isomer
      540 CH(CH3)CH2SOCH(CH3)2 3-I 2-CH3 CH2 1 Q1 CF3 CF3 H
      (S)-isomer
      541 CH(CH3)CH2SO2CH(CH3)2 3-I 2-CH3 CH2 1 Q1 CF3 CF3 H
      (S)-isomer
      542 CH(CH3)CH2SCH(CH3)2 3-Cl 2-CH3 CH2 1 Q1 CF3 CF3 H
      (S)-isomer
      543 CH(CH3)CH2SCH3 3-NO2 2-CH3 CH2 1 Q1 CF3 CF3 H 161-171
      (S)-isomer
      544 CH(CH3)CH2SOCH3 3-NO2 2-CH3 CH2 1 Q1 CF3 CF3 H 227-229
      (S)-isomer
      545 CH(CH3)CH2SO2CH3 3-NO2 2-CH3 CH2 1 Q1 CF3 CF3 H 215-216
      (S)-isomer
      546 CH(CH3)CH2SCH3 3-NO2 2-CH3 CH2 1 Q2 CF3 CF3 175-179
      (S)-isomer
      547 CH(CH3)CH2SOCH3 3-NO2 2-CH3 CH2 1 Q2 CF3 CF3 225-228
      (S)-isomer
      548 CH(CH3)CH2SO2CH3 3-NO2 2-CH3 CH2 1 Q2 CF3 CF3 206-208
      (S)-isomer
      549 CH(CH3)CH2SCH3 3-F 2-CH3 CH2 1 Q1 CF3 CF3 H 66-68
      (S)-isomer
      550 CH(CH3)2 3-SCH3 2-CH3 CH2 1 Q1 CF3 CF3 H ***
      551 CH(CH3)CH2SCH3 3-SCH3 2-CH3 CH2 1 Q1 CF3 CF3 H
      (S)-isomer
      552 CH(CH3)CH2SCH3 3-SO2CH3 2-CH3 CH2 1 Q1 CF3 CF3 H ***
      (S)-isomer
      553 CH(CH3)CH2SCH3 3-SCH2CH3 2-CH3 CH2 1 Q1 CF3 CF3 H ***
      (S)-isomer
      554 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 CF3 CF3 I ***
      (S)-isomer
      555 CH(CH3)CH2SCH3 3-I 2-CH3 CH(CH3) 1 Q1 CF3 H H
      556 CH(CH3)CH2SCH3 3-I 2-CH3 CH(CH3) 1 Q1 CF3 H H 78-89
      (S)-isomer
      557 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH(CH3) 1 Q1 CF3 H H 150-152
      (S)-isomer
      558 C(CH3)2CH2SCH3 3-I 2-CH3 CH(CH3) 1 Q1 CF3 H H 79-86
      559 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH(CH3) 1 Q1 CF3 CF3 H 80-91
      (S)-isomer
      560 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH(CH3) 1 Q1 CF3 CF3 H
      (S)-isomer
      561 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH(CH3) 1 Q1 CF3 CF3 H 103-105
      (S)-isomer
      562 CH(CH3)CH2SCH3 3-I 2-CH3 CH(CH3) 1 Q1 CF3 CF3 H 84-89
      (S)-isomer
      563 CH(CH3)CH2SOCH3 3-I 2-CH3 CH(CH3) 1 Q1 CF3 CF3 H 177-179
      (S)-isomer
      564 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH(CH3) 1 Q1 CF3 CF3 H 101-105
      (S)-isomer
      565 C(CH3)2CH2SCH3 3-I 2-CH3 CH(CH3) 1 Q1 CF3 CF3 H  98-106
      566 C(CH3)2CH2SOCH3 3-I 2-CH3 CH(CH3) 1 Q1 CF3 CF3 H 132-136
      567 C(CH3)2CH2SO2CH3 3-I 2-CH3 CH(CH3) 1 Q1 CF3 CF3 H 173-174
      568 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH(CH3) 1 Q2 CF3 CF3 87-92
      (S)-isomer
      569 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH(CH3) 1 Q2 CF3 CF3 ***
      (S)-isomer
      570 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH(CH3) 1 Q2 CF3 CF3 91-95
      (S)-isomer
      571 CH(CH3)CH2SCH3 3-I 2-CH3 CH(CH3) 1 Q2 CF3 CF3  98-105
      (S)-isomer
      572 CH(CH3)CH2SOCH3 3-I 2-CH3 CH(CH3) 1 Q2 CF3 CF3  98-105
      (S)-isomer
      573 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH(CH3) 1 Q2 CF3 CF3 103-106
      (S)-isomer
      574 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH(CH3) 1 Q2 CF3 C2F5 ***
      (S)-isomer
      575 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH(CH3) 1 Q2 CF3 C2F5
      (S)-isomer
      576 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH(CH3) 1 Q2 CF3 C2F5
      (S)-isomer
      577 CH(CH3)CH2SCH3 3-I 2-CH3 CH(CH3) 1 Q2 CF3 C2F5
      (S)-isomer
      578 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH(CH3) 1 Q2 C2F5 CF3 83-85
      (S)-isomer
      579 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH(CH3) 1 Q2 C2F5 CF3 121-124
      (S)-isomer
      580 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH(CH3) 1 Q2 C2F5 CF3 87-94
      (S)-isomer
      581 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH(CH3) 1 Q2 C2F5 C2F5
      (S)-isomer
      582 CH(CH3)CH2SCH3 3-I 2-CH3 CH(CH3) 1 Q2 C2F5 C2F5
      (S)-isomer
      583 CH(CH3)CH2SCH3 3-Cl 2-CH3 S 1 Q10 CF3 CF3 H
      (S)-isomer
      584 CH(CH3)CH2SCH3 3-I 2-CH3 S 1 Q10 CF3 CF3 H
      (S)-isomer
      585 CH(CH3)CH2SCH3 3-Cl 2-CH3 S 1 Q10 C2F5 C2F5 H
      (S)-isomer
      586 CH(CH3)CH2SCH3 3-I 2-CH3 S 1 Q10 C2F5 C2F5 H
      (S)-isomer
      587 CH(CH3)CH2SCH3 3-Cl 2-CH3 S 1 Q13 CF3 CF3
      (S)-isomer
      588 CH(CH3)CH2SCH3 3-I 2-CH3 S 1 Q13 CF3 CF3 223-225
      (S)-isomer
      589 CH(CH3)CH2SCH3 3-I 2-CH3 SO2 1 Q13 CF3 CF3
      (S)-isomer
      590 C(CH3)2CH2SCH3 3-Cl 2-CH3 CH2 1 Q7 CH3 CHF2
      591 C(CH3)2CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q7 CH3 CHF2
      592 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q7 CH3 CHF2  99-101
      593 C(CH3)2CH2SO2CH3 3-I 2-CH3 CH2 1 Q7 CH3 CHF2 83-94
      594 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q14 H COCF3 H ***
      (S)-isomer
      595 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q14 I COCF3 H ***
      (S)-isomer
      596 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q14 C2F5 COCF3 H ***
      (S)-isomer
      597 C(CH3)2CH2SCH3 3-I 2-CH3 0 Q1 H H C3F7-n
      598 C(CH3)2CH2SCH3 3-I 2-CH3 0 Q1 H H C4F9-n
      599 C(CH3)2CH2SCH3 3-I 2-CH3 0 Q1 H H C6F13-n
      600 C(CH3)2CH2SCH3 3-I 2-CH3 0 Q1 H H C8F17-n
      601 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 H H C3F7-n
      (S)-isomer
      602 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 H H C4F9-n 69-72
      (S)-isomer
      603 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 H H C6F13-n
      (S)-isomer
      604 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 H H C8F17-n
      (S)-isomer
      605 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q1 CH3 H C3F7-n
      606 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q1 CH3 H C4F9-n
      607 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q1 CH3 H C6F13-n
      608 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 CF3 H 74-78
      (S)-isomer
      609 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 CF3 H 176-177
      (S)-isomer
      610 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 CF3 H 81-87
      (S)-isomer
      611 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 C2F5 CF3 H
      (S)-isomer
      612 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q1 C2F5 CF3 H
      (S)-isomer
      613 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 C2F5 CF3 H
      (S)-isomer
      614 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C3F7-n CF3 H
      (S)-isomer
      615 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 C3F7-n CF3 H
      (S)-isomer
      616 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 C3F7-n CF3 H
      (S)-isomer
      617 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 C3F7-n CF3 H
      (S)-isomer
      618 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q1 C3F7-n CF3 H
      (S)-isomer
      619 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 C3F7-n CF3 H
      (S)-isomer
      620 C(CH3)2CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 C2F5 H
      621 C(CH3)2CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 C2F5 H
      622 C(CH3)2CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 C2F5 H
      623 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q1 C2F5 C2F5 H
      624 C(CH3)2CH2SOCH3 3-I 2-CH3 CH2 1 Q1 C2F5 C2F5 H
      625 C(CH3)2CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 C2F5 C2F5 H
      626 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 C2F5 H ***
      (S)-isomer
      627 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 C2F5 H
      (S)-isomer
      628 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 C2F5 H
      (S)-isomer
      629 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 C2F5 C2F5 H
      (S)-isomer
      630 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q1 C2F5 C2F5 H
      (S)-isomer
      631 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 C2F5 C2F5 H
      (S)-isomer
      632 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 CF3 H Cl ***
      (S)-isomer
      633 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 H Cl ***
      (S)-isomer
      634 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C3F7-n H Cl ***
      (S)-isomer
      635 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 H Br ***
      (S)-isomer
      636 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 H I ***
      (S)-isomer
      637 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 H C2F5 73-78
      (S)-isomer
      638 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 H C2F5 81-84
      (S)-isomer
      639 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 CF3 H C2F5 87-90
      (S)-isomer
      640 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 CF3 H C2F5 ***
      (S)-isomer
      641 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q1 CF3 H C2F5 164-166
      (S)-isomer
      642 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 CF3 H C2F5 75-85
      (S)-isomer
      643 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 H C3F7-n 73-75
      (S)-isomer
      644 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 CF3 H C3F7-n 86-88
      (S)-isomer
      645 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 H C4F9-n 79-82
      (S)-isomer
      646 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 H C4F9-n 73-76
      (S)-isomer
      647 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 CF3 H C4F9-n 83-88
      (S)-isomer
      648 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 CF3 H C4F9-n 88-92
      (S)-isomer
      649 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q1 CF3 H C4F9-n 84-90
      (S)-isomer
      650 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 CF3 H C4F9-n 75-78
      (S)-isomer
      651 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 H C2F5 ***
      (S)-isomer
      652 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 H C2F5 124-125
      (S)-isomer
      653 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 H C2F5 88-91
      (S)-isomer
      654 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 C2F5 H C2F5 ***
      (S)-isomer
      655 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q1 C2F5 H C2F5 87-92
      (S)-isomer
      656 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 C2F5 H C2F5 100-107
      (S)-isomer
      657 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 H C3F7-n 64-65
      (S)-isomer
      658 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 H C3F7-n ***
      (S)-isomer
      659 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 H C3F7-n 78-81
      (S)-isomer
      660 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 C2F5 H C3F7-n ***
      (S)-isomer
      661 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q1 C2F5 H C3F7-n 83-85
      (S)-isomer
      662 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 C2F5 H C3F7-n 92-96
      (S)-isomer
      663 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 H C4F9-n 72-74
      (S)-isomer
      664 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 C2F5 H C4F9-n 84-88
      (S)-isomer
      665 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C3F7-n H C2F5 78-85
      (S)-isomer
      666 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 C3F7-n H C2F5 78-85
      (S)-isomer
      667 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C3F7-n H C3F7-n 70-74
      (S)-isomer
      668 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 C3F7-n H C3F7-n 73-77
      (S)-isomer
      669 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 C3F7-n H C3F7-n 77-82
      (S)-isomer
      670 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 C3F7-n H C3F7-n 86-90
      (S)-isomer
      671 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q1 C3F7-n H C3F7-n 81-84
      (S)-isomer
      672 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 C3F7-n H C3F7-n 147-148
      (S)-isomer
      673 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 H C2F5 CF3
      (S)-isomer
      674 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 H C2F5 CF3
      (S)-isomer
      675 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 H C2F5 C2F5 ***
      (S)-isomer
      676 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 H C2F5 C2F5
      (S)-isomer
      677 C(CH3)2CH2SCH3 3-Cl 2-CH3 CH2 1 Q2 C2F5 C2F5
      678 C(CH3)2CH2SOCH3 3-Cl 2-CH3 CH2 1 Q2 C2F5 C2F5
      679 C(CH3)2CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q2 C2F5 C2F5
      680 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q2 C2F5 C2F5
      681 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q2 C2F5 C2F5 ***
      (S)-isomer
      682 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q2 C2F5 C2F5
      683 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q2 C2F5 C2F5 162-164
      (S)-isomer
      684 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q2 C2F5 C2F5
      685 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q2 C2F5 C2F5 103-106
      (S)-isomer
      686 CH(CH3)CH2SC2H5 3-Cl 2-CH3 CH2 1 Q2 C2F5 C2F5
      (S)-isomer
      687 CH(CH3)CH2SOC2H5 3-Cl 2-CH3 CH2 1 Q2 C2F5 C2F5
      (S)-isomer
      688 CH(CH3)CH2SO2C2H5 3-Cl 2-CH3 CH2 1 Q2 C2F5 C2F5
      (S)-isomer
      689 C(CH3)2CH2SCH3 3-Br 2-CH3 CH2 1 Q2 C2F5 C2F5
      690 C(CH3)2CH2SOCH3 3-Br 2-CH3 CH2 1 Q2 C2F5 C2F5
      691 C(CH3)2CH2SO2CH3 3-Br 2-CH3 CH2 1 Q2 C2F5 C2F5
      692 CH(CH3)CH2SCH3 3-Br 2-CH3 CH2 1 Q2 C2F5 C2F5
      693 CH(CH3)CH2SCH3 3-Br 2-CH3 CH2 1 Q2 C2F5 C2F5
      (S)-isomer
      694 CH(CH3)CH2SOCH3 3-Br 2-CH3 CH2 1 Q2 C2F5 C2F5
      695 CH(CH3)CH2SOCH3 3-Br 2-CH3 CH2 1 Q2 C2F5 C2F5
      (S)-isomer
      696 CH(CH3)CH2SO2CH3 3-Br 2-CH3 CH2 1 Q2 C2F5 C2F5
      697 CH(CH3)CH2SO2CH3 3-Br 2-CH3 CH2 1 Q2 C2F5 C2F5
      (S)-isomer
      698 CH(CH3)CH2SC2H5 3-Br 2-CH3 CH2 1 Q2 C2F5 C2F5
      (S)-isomer
      699 CH(CH3)CH2SOC2H5 3-Br 2-CH3 CH2 1 Q2 C2F5 C2F5
      (S)-isomer
      700 CH(CH3)CH2SO2C2H5 3-Br 2-CH3 CH2 1 Q2 C2F5 C2F5
      (S)-isomer
      701 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q2 C2F5 C2F5
      702 C(CH3)2CH2SOCH3 3-I 2-CH3 CH2 1 Q2 C2F5 C2F5
      703 C(CH3)2CH2SO2CH3 3-I 2-CH3 CH2 1 Q2 C2F5 C2F5
      704 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q2 C2F5 C2F5
      705 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q2 C2F5 C2F5
      (S)-isomer
      706 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q2 C2F5 C2F5
      707 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q2 C2F5 C2F5
      (S)-isomer
      708 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q2 C2F5 C2F5
      709 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q2 C2F5 C2F5
      (S)-isomer
      710 CH(CH3)CH2SC2H5 3-I 2-CH3 CH2 1 Q2 C2F5 C2F5
      (S)-isomer
      711 CH(CH3)CH2SOC2H5 3-I 2-CH3 CH2 1 Q2 C2F5 C2F5
      (S)-isomer
      712 CH(CH3)CH2SO2C2H5 3-I 2-CH3 CH2 1 Q2 C2F5 C2F5
      (S)-isomer
      713 C(CH3)2CH2SCH3 3-Cl 2-CH3 CH2 1 Q2 C3F7-n CF3
      714 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q2 C3F7-n CF3 ***
      (S)-isomer
      715 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q2 C3F7-n CF3
      (S)-isomer
      716 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q2 C3F7-n C2F5
      (S)-isomer
      717 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q2 C3F7-n C2F5
      (S)-isomer
      718 C(CH3)2CH2SCH3 3-F 2-CH3 CH2 1 Q1 CF3 CF3 H
      719 C(CH3)2CH2SOCH3 3-F 2-CH3 CH2 1 Q1 CF3 CF3 H
      720 C(CH3)2CH2SO2CH3 3-F 2-CH3 CH2 1 Q1 CF3 CF3 H
      721 CH(CH3)CH2SOCH3 3-F 2-CH3 CH2 1 Q1 CF3 CF3 H
      (S)-isomer
      722 CH(CH3)CH2SO2CH3 3-F 2-CH3 CH2 1 Q1 CF3 CF3 H
      (S)-isomer
      723 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 H H C4F9-n 63-69
      (S)-isomer
      724 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 H H C4F9-n 95-97
      (S)-isomer
      725 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 H CF3 C3F7-n 76-81
      (S)-isomer
      726 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 H CF3 C3F7-n ***
      (S)-isomer
      727 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 H CF3 C3F7-n ***
      (S)-isomer
      728 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 H C2F5 C2F5 68-72
      (S)-isomer
      729 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 H C2F5 C2F5 ***
      (S)-isomer
      730 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 CHF2 CHF2 H ***
      (S)-isomer
      731 C(CH3)2CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 H CF3
      732 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 H CF3
      (S)-isomer
      733 C(CH3)2CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 H CF2CHF2
      734 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 H CF2CHF2
      (S)-isomer
      735 C(CH3)2CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 H C4F9-n
      736 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 H C4F9-n
      737 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 H C6F13-n 78-82
      (S)-isomer
      738 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 H C8F17-n 79-82
      (S)-isomer
      739 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 CF3 CF3
      (S)-isomer
      740 C(CH3)2CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 CF2CHF2 H C2F5
      741 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 CF2CHF2 H C2F5 ***
      (S)-isomer
      742 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 CF2CHF2 H C2F5 64-67
      (S)-isomer
      743 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 CF2CHF2 H C2F5 83-89
      (S)-isomer
      744 C(CH3)2CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 H CF3
      745 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 H CF3 75-80
      (S)-isomer
      746 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 H CF2CHF2
      (S)-isomer
      747 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 H CF2CHF2
      (S)-isomer
      748 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 H CF2CHF2
      (S)-isomer
      749 C(CH3)2CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 H C2F5
      750 C(CH3)2CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 H C2F5
      751 C(CH3)2CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 H C2F5
      752 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 H C2F5
      753 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 H C2F5
      754 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 H C2F5
      755 CH(CH3)CH2SCH3 3-Cl 2-CH3 0 Q1 C2F5 H C2F5  95-100
      (S)-isomer
      756 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH(CH3) 1 Q1 C2F5 H C2F5
      (S)-isomer
      757 CH(CH3)CH2SOCH3 3-Cl 2-CH3 0 Q1 C2F5 H C2F5 89-94
      (S)-isomer
      758 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH(CH3) 1 Q1 C2F5 H C2F5
      (S)-isomer
      759 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 0 Q1 C2F5 H C2F5 195-195
      (S)-isomer
      760 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH(CH3) 1 Q1 C2F5 H C2F5
      (S)-isomer
      761 CH(CH3)CH2SC2H5 3-Cl 2-CH3 CH2 1 Q1 C2F5 H C2F5 70-74
      (S)-isomer
      762 CH(CH3)CH2SOC2H5 3-Cl 2-CH3 CH2 1 Q1 C2F5 H C2F5 79-84
      (S)-isomer
      763 CH(CH3)CH2SO2C2H5 3-Cl 2-CH3 CH2 1 Q1 C2F5 H C2F5 185-188
      (S)-isomer
      764 C(CH3)2CH2SCH3 3-Cl 2-CH3 CH(CH3) 1 Q1 C2F5 H C3F7-n
      765 C(CH3)2CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 H C3F7-n
      766 C(CH3)2CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 H C3F7-n
      767 C(CH3)2CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 H C3F7-n
      768 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 H C3F7-n
      769 C(CH3)2CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 H C4F9-n
      770 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 H C4F9
      771 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 H C4F9-n 81-85
      (S)-isomer
      772 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 H C4F9-n
      (S)-isomer
      773 C(CH3)2CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 F CF3
      774 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 F CF3
      775 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 F CF3 142-146
      (S)-isomer
      776 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 F CF3
      (S)-isomer
      777 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 F CF3
      (S)-isomer
      778 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 CH3 C2F5 ***
      (S)-isomer
      779 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C2F5 C2F5 C2F5
      (S)-isomer
      780 C(CH3)2CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C3F7-n H C2F5
      781 C(CH3)2CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 C3F7-n H C2F5
      782 C(CH3)2CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 C3F7-n H C2F5
      783 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C3F7-n H C2F5
      784 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 C3F7-n H C2F5 81-83
      (S)-isomer
      785 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 C3F7-n H C2F5 85-90
      (S)-isomer
      786 C(CH3)2CH2SCH3 3-Cl 2-CH3 CH(CH3) 1 Q1 C3F-n H C3F7-n
      787 C(CH3)2CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C3F-n H C3F7-n
      788 C(CH3)2CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 C3F-n H C3F7-n
      789 C(CH3)2CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 C3F-n H C3F7-n
      790 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C3F-n H C3F7-n
      791 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 C3F-n H C3F7-n
      792 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 C3F-n H C3F7-n
      793 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 C3F7-n C3F7-n H 74-78
      (S)-isomer
      794 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 C3F7-n C3F7-n H 72-76
      (S)-isomer
      795 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 C3F7-n C3F7-n H 149-150
      (S)-isomer
      796 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q2 CHFCF3 CF3 66-69
      (S)-isomer
      797 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q2 CHFCF3 CF3 80-85
      (S)-isomer
      798 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q2 CHFCF3 CF3 81-86
      (S)-isomer
      799 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q2 CF2CHF2 CF2CHF2 ***
      (S)-isomer
      800 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q2 CF2CHF2 CF2CHF2 159-163
      (S)-isomer
      801 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q2 CF2CHF2 CF2CHF2 77-83
      (S)-isomer
      802 C(CH3)2CH2SCH3 3-Cl 2-CH3 CH2 1 Q2 C3F7-n C3F7-n
      803 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q2 C4F9-n H 218-210
      (S)-isomer
      804 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q2 SC3F7-n CF3 73-76
      (S)-isomer
      805 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q6 CF3 CF3 CF3
      (S)-isomer
      806 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q6 CF3 CF3 CF3
      (S)-isomer
      807 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q6 CF3 CF3 CF3
      (S)-isomer
      808 C(CH3)2CH2SCH3 3-Cl 2-CH3 CH2 1 Q9 CF3 CF3
      809 C(CH3)2CH2SOCH3 3-Cl 2-CH3 CH2 1 Q9 CF3 CF3
      810 C(CH3)2CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q9 CF3 CF3
      811 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q9 CF3 CF3
      812 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q9 CF3 CF3
      813 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q9 CF3 CF3
      814 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q9 CF3 CF3
      (S)-isomer
      815 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q9 CF3 CF3
      (S)-isomer
      816 CH(CH3)CH2SC2H5 3-Cl 2-CH3 CH2 1 Q9 CF3 CF3
      (S)-isomer
      817 CH(CH3)CH2SOC2H5 3-Cl 2-CH3 CH2 1 Q9 CF3 CF3
      (S)-isomer
      818 CH(CH3)CH2SO2C2H5 3-Cl 2-CH3 CH2 1 Q9 CF3 CF3
      (S)-isomer
      819 C(CH3)2CH2SCH3 3-Cl 2-CH3 CH2 1 Q9 C2F5 CF3
      820 C(CH3)2CH2SOCH3 3-Cl 2-CH3 CH2 1 Q9 C2F5 CF3
      821 C(CH3)2CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q9 C2F5 CF3
      822 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q9 C2F5 CF3
      823 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q9 C2F5 CF3
      824 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q9 C2F5 CF3
      825 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q9 C2F5 CF3
      (S)-isomer
      826 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q9 C2F5 CF3
      (S)-isomer
      827 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q9 C2F5 CF3
      (S)-isomer
      828 CH(CH3)CH2SC2H5 3-Cl 2-CH3 CH2 1 Q9 C2F5 CF3
      (S)-isomer
      829 CH(CH3)CH2SOC2H5 3-Cl 2-CH3 CH2 1 Q9 C2F5 CF3
      (S)-isomer
      830 CH(CH3)CH2SO2C2H5 3-Cl 2-CH3 CH2 1 Q9 C2F5 CF3
      (S)-isomer
      831 C(CH3)2CH2SCH3 3-Cl 2-CH3 CH2 1 Q9 C2F5 C2F5
      832 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q9 C2F5 C2F5
      833 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q9 C2F5 C2F5
      (S)-isomer
      834 C(CH3)2CH2SCH3 3-Cl 2-CH3 CH2 1 Q9 C3F7-n CF3
      835 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q9 C3F7-n CF3
      (S)-isomer
      836 CH(CH3)CH2SCH3 3-Cl 2-CH3 S 1 Q18 CF3 CH3
      (S)-isomer
      837 CH(CH3)CH2SCH3 3-Cl 2-CH3 0 Q19 CF3 CH3
      (S)-isomer
      838 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q17 CF3 H
      839 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q15 H C2F5
      840 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q15 H C2F5 71-75
      (S)-isomer
      841 CH(CH3)CH2SCH3 3-Cl 2-CH3 0 Q20 CF3
      (S)-isomer
      842 CH(CH3)CH2SCH3 3-Cl 2-CH3 0 Q16 C2F5
      843 CH(CH3)CH2SCH3 3-Cl 2-CH3 0 Q16 C3F7-n
      844 C(CH3)2CH2SCH3 3-Br 2-CH3 CH2 1 Q1 CF3 H C2F5
      845 C(CH3)2CH2SCH3 3-Br 2-CH3 CH2 1 Q1 CF3 H C4F9-n
      846 CH(CH3)CH2SCH3 3-Br 2-CH3 CH2 1 Q1 CF3 H C4F9-n
      847 C(CH3)2CH2SCH3 3-Br 2-CH3 CH2 1 Q1 CF2CHF2 H C2F5
      848 C(CH3)2CH2SCH3 3-Br 2-CH3 CH2 1 Q1 C2F5 H C2F5
      849 C(CH3)2CH2SOCH3 3-Br 2-CH3 CH2 1 Q1 C2F5 H C2F5
      850 C(CH3)2CH2SO2CH3 3-Br 2-CH3 CH2 1 Q1 C2F5 H C2F5
      851 CH(CH3)CH2SCH3 3-Br 2-CH3 CH2 1 Q1 C2F5 H C2F5
      852 CH(CH3)CH2SOCH3 3-Br 2-CH3 CH2 1 Q1 C2F5 H C2F5
      853 CH(CH3)CH2SO2CH3 3-Br 2-CH3 CH2 1 Q1 C2F5 H C2F5
      854 C(CH3)2CH2SCH3 3-Br 2-CH3 CH2 1 Q1 C2F5 H C4F9-n
      855 CH(CH3)CH2SCH3 3-Br 2-CH3 CH2 1 Q1 C2F5 H C4F9-n
      856 CH(CH3)CH2SCH3 3-Br 2-CH3 CH2 1 Q1 C3F7-n H C2F5
      857 C(CH3)2CH2SCH3 3-Br 2-CH3 CH2 1 Q1 C3F7-n H C3F7-n
      858 C(CH3)2CH2SOCH3 3-Br 2-CH3 CH2 1 Q1 C3F7-n H C3F7-n
      859 CH(CH3)2CH2SO2CH3 3-Br 2-CH3 CH2 1 Q1 C3F7-n H C3F7-n
      860 CH(CH3)CH2SCH3 3-Br 2-CH3 CH2 1 Q1 C3F7-n H C3F7-n
      861 CH(CH3)CH2SOCH3 3-Br 2-CH3 CH2 1 Q1 C3F7-n H C3F7-n
      862 CH(CH3)CH2SO2CH3 3-Br 2-CH3 CH2 1 Q1 C3F7-n H C3F7-n
      863 C(CH3)2CH2SCH3 3-Br 2-CH3 CH2 1 Q9 CF3 CF3
      864 C(CH3)2CH2SOCH3 3-Br 2-CH3 CH2 1 Q9 CF3 CF3
      865 C(CH3)2CH2SO2CH3 3-Br 2-CH3 CH2 1 Q9 CF3 CF3
      866 CH(CH3)CH2SCH3 3-Br 2-CH3 CH2 1 Q9 CF3 CF3
      867 CH(CH3)CH2SOCH3 3-Br 2-CH3 CH2 1 Q9 CF3 CF3
      868 CH(CH3)CH2SO2CH3 3-Br 2-CH3 CH2 1 Q9 CF3 CF3
      869 C(CH3)2CH2SCH3 3-Br 2-CH3 CH2 1 Q9 C2F5 CF3
      870 C(CH3)2CH2SOCH3 3-Br 2-CH3 CH2 1 Q9 C2F5 CF3
      871 C(CH3)2CH2SO2CH3 3-Br 2-CH3 CH2 1 Q9 C2F5 CF3
      872 CH(CH3)CH2SCH3 3-Br 2-CH3 CH2 1 Q9 C2F5 CF3
      873 CH(CH3)CH2SOCH3 3-Br 2-CH3 CH2 1 Q9 C2F5 CF3
      874 CH(CH3)CH2SO2CH3 3-Br 2-CH3 CH2 1 Q9 C2F5 CF3
      875 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 H H C4F9-n 80-85
      (S)-isomer
      876 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q1 H H C4F9-n 160-162
      (S)-isomer
      877 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 H H C4F9-n 85-89
      (S)-isomer
      878 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 CHF2 CHF2 H ***
      (S)-isomer
      879 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q1 CF3 H CF3
      880 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q1 CF3 H CF2CHF2
      881 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 CF3 H CF2CHF2
      (S)-isomer
      882 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q1 CF3 H C2F5
      883 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 CF3 H C2F5
      884 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q1 CF3 H C4F9-n
      885 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 CF3 H C4F9-n
      886 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q1 CF3 CF3 CF3
      887 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 CF3 CF3 CF3
      888 C(CH3)2CH2SCH3 3-I 2-CH3 CH(CH3) 1 Q1 CF2CHF2 H C2F5
      889 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q1 CF2CHF2 H C2F5
      890 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 CF2CHF2 H C2F5
      (S)-isomer
      891 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q1 CF2CHF2 H C2F5
      (S)-isomer
      892 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 CF2CHF2 H C2F5
      (S)-isomer
      893 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q1 C2F5 H CF3
      894 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 C2F5 H CF2CHF2
      (S)-isomer
      895 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q1 C2F5 H CF2CHF2
      (S)-isomer
      896 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 C2F5 H CF2CHF2
      (S)-isomer
      897 C(CH3)2CH2SCH3 3-I 2-CH3 CH(CH3) 1 Q1 C2F5 H C2F5
      898 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q1 C2F5 H C2F5
      899 C(CH3)2CH2SOCH3 3-I 2-CH3 CH2 1 Q1 C2F5 H C2F5
      900 C(CH3)2CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 C2F5 H C2F5
      901 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 C2F5 H C2F5
      902 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q1 C2F5 H C2F5
      903 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 C2F5 H C2F5
      904 CH(CH3)CH2SC2H5 3-I 2-CH3 CH2 1 Q1 C2F5 H C2F5
      (S)-isomer
      905 CH(CH3)CH2SOC2H5 3-I 2-CH3 CH2 1 Q1 C2F5 H C2F5
      (S)-isomer
      906 CH(CH3)CH2SO2C2H5 3-I 2-CH3 CH2 1 Q1 C2F5 H C2F5
      (S)-isomer
      907 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q1 C2F5 H C3F7-n
      908 C(CH3)2CH2SOCH3 3-I 2-CH3 CH2 1 Q1 C2F5 H C3F7-n
      909 C(CH3)2CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 C2F5 H C3F7-n
      910 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 C2F5 H C3F7-n
      911 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q1 C2F5 H C4F9-n
      912 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 C2F5 H C4F9-n
      913 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q1 C2F5 H C4F9-n 90-96
      (S)-isomer
      914 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 C2F5 H C4F9-n 92-97
      (S)-isomer
      915 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q1 C2F5 F CF3
      916 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q1 C3F7-n H C2F5
      917 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 C3F7-n H C2F5
      918 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q1 C3F7-n H C2F5
      919 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 C3F7-n H C2F5
      920 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q1 C3F7-n H C2F5 89-96
      (S)-isomer
      921 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 C3F7-n H C2F5 92-96
      (S)-isomer
      922 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q1 C3F7-n H C3F7-n
      923 C(CH3)2CH2SOCH3 3-I 2-CH3 CH2 1 Q1 C3F7-n H C3F7-n
      924 C(CH3)2CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 C3F7-n H C3F7-n
      925 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q1 C3F7-n H C3F7-n
      926 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q1 C3F7-n H C3F7-n
      927 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 C3F7-n H C3F7-n
      928 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q2 C3F7-n C3F7-n
      929 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q6 CF3 CF3 CF3
      (S)-isomer
      930 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q6 CF3 CF3 CF3
      (S)-isomer
      931 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q6 CF3 CF3 CF3
      (S)-isomer
      932 C(CH3)2CH2SCH3 3-I 2-CH3 CH(CH3) 1 Q9 CF3 CF3
      933 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q9 CF3 CF3
      934 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q9 CF3 CF3
      935 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q9 CF3 CF3
      936 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q9 CF3 CF3
      (S)-isomer
      937 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q9 CF3 CF3
      (S)-isomer
      938 CH(CH3)CH2SC2H5 3-I 2-CH3 CH2 1 Q9 CF3 CF3
      (S)-isomer
      939 CH(CH3)CH2SOC2H5 3-I 2-CH3 CH2 1 Q9 CF3 CF3
      (S)-isomer
      940 CH(CH3)CH2SO2C2H5 3-I 2-CH3 CH2 1 Q9 CF3 CF3
      (S)-isomer
      941 C(CH3)2CH2SCH3 3-I 2-CH3 CH(CH3) 1 Q9 C2F5 CF3
      942 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q9 C2F5 CF3
      943 C(CH3)2CH2SOCH3 3-I 2-CH3 CH2 1 Q9 C2F5 CF3
      944 C(CH3)2CH2SO2CH3 3-I 2-CH3 CH2 1 Q9 C2F5 CF3
      945 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q9 C2F5 CF3
      946 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q9 C2F5 CF3
      947 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q9 C2F5 CF3
      948 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q9 C2F5 CF3
      (S)-isomer
      949 CH(CH3)CH2SOCH3 3-I 2-CH3 CH2 1 Q9 C2F5 CF3
      (S)-isomer
      950 CH(CH3)CH2SO2CH3 3-I 2-CH3 CH2 1 Q9 C2F5 CF3
      (S)-isomer
      951 CH(CH3)CH2SC2H5 3-I 2-CH3 CH2 1 Q9 C2F5 CF3
      (S)-isomer
      952 CH(CH3)CH2SOC2H5 3-I 2-CH3 CH2 1 Q9 C2F5 CF3
      (S)-isomer
      953 CH(CH3)CH2SO2C2H5 3-I 2-CH3 CH2 1 Q9 C2F5 CF3
      (S)-isomer
      954 C(CH3)2CH2SCH3 3-I 2-CH3 CH(CH3) 1 Q9 C2F5 C2F5
      955 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q9 C2F5 C2F5
      956 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q9 C2F5 C2F5
      957 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q9 C2F5 C2F5
      (S)-isomer
      958 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q9 C3F7-n CF3
      959 CH(CH3)CH2SCH3 3-I 2-CH3 CH2 1 Q9 C3F7-n CF3
      (S)-isomer
      960 C(CH3)2CH2SCH3 3-I 2-CH3 S 1 Q18 CF3 CH3
      961 C(CH3)2CH2SCH3 3-I 2-CH3 0 Q19 CF3 CH3
      962 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q17 CF3 H
      963 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q15 H C2F5
      964 C(CH3)2CH2SCH3 3-I 2-CH3 0 Q20 CF3
      965 CH(CH3)CH2SCH3 3-I 2-CH3 0 Q16 CF3
      966 C(CH3)2CH2SCH3 3-Cl 2-F CH2 1 Q1 CF3 CF3 H
      967 C(CH3)2CH2SOCH3 3-Cl 2-F CH2 1 Q1 CF3 CF3 H
      968 C(CH3)2CH2SO2CH3 3-Cl 2-F CH2 1 Q1 CF3 CF3 H
      969 C(CH3)2CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 CF3 H
      970 C(CH3)2CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 CF3 H
      971 C(CH3)2CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 CF3 CF3 H
      972 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 CF3 H
      973 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 CF3 H
      974 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 CF3 CF3 H
      975 CH(CH3)CH2SCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 CF3 H
      (S)-isomer
      976 CH(CH3)CH2SOCH3 3-Cl 2-CH3 CH2 1 Q1 CF3 CF3 H
      (S)-isomer
      977 CH(CH3)CH2SO2CH3 3-Cl 2-CH3 CH2 1 Q1 CF3 CF3 H
      (S)-isomer
      978 CH(CH3)CH2SCH3 3-Cl 2-Cl CH2 1 Q1 C2F5 CF3 H
      (S)-isomer
      979 CH(CH3)CH2SOCH3 3-Cl 2-Cl CH2 1 Q1 C2F5 CF3 H
      (S)-isomer
      980 CH(CH3)CH2SO2CH3 3-Cl 2-Cl CH2 1 Q1 C2F5 CF3 H
      (S)-isomer
      981 C(CH3)2CH2SCH3 3-Cl 2-Cl CH2 1 Q1 CF3 H C2F5
      982 C(CH3)2CH2SCH3 3-Cl 2-Cl CH2 1 Q1 CF3 H C3F7-n
      983 C(CH3)2CH2SCH3 3-Cl 2-Cl CH2 1 Q1 CF3 H C4F9-n
      984 C(CH3)2CH2SCH3 3-Cl 2-Cl CH2 1 Q1 CF3 H C6F13-n
      985 CH(CH3)CH2SCH3 3-Cl 2-Cl CH2 1 Q1 C2F5 H C2F5
      (S)-isomer
      986 CH(CH3)CH2SOCH3 3-Cl 2-Cl CH2 1 Q1 C2F5 H C2F5
      (S)-isomer
      987 CH(CH3)CH2SO2CH3 3-Cl 2-Cl CH2 1 Q1 C2F5 H C2F5
      (S)-isomer
      988 CH(CH3)CH2SCH3 3-Cl 2-Cl CH2 1 Q1 C2F5 H C3F7-n
      (S)-isomer
      989 CH(CH3)CH2SOCH3 3-Cl 2-Cl CH2 1 Q1 C2F5 H C3F7-n
      (S)-isomer
      990 CH(CH3)CH2SO2CH3 3-Cl 2-Cl CH2 1 Q1 C2F5 H C3F7-n
      (S)-isomer
      991 CH(CH3)CH2SCH3 3-Cl 2-Cl CH2 1 Q2 CF3 CF3
      (S)-isomer
      992 CH(CH3)CH2SCH3 3-Cl 2-Cl CH2 1 Q2 C2F5 CF3
      (S)-isomer
      993 CH(CH3)CH2SCH3 3-Cl 2-Cl CH2 1 Q9 CF3 CF3
      (S)-isomer
      994 CH(CH3)CH2SCH3 3-Cl 2-Cl CH2 1 Q9 C2F5 CF3
      (S)-isomer
      995 C(CH3)2CH2SCH3 3-I 2-F CH2 1 Q1 CF3 CF3 H ***
      996 C(CH3)2CH2SOCH3 3-I 2-F CH2 1 Q1 CF3 CF3 H
      997 C(CH3)2CH2SO2CH3 3-I 2-F CH2 1 Q1 CF3 CF3 H 113-115
      998 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q1 CF3 CF3 H 157-159
      999 C(CH3)2CH2SOCH3 3-I 2-CH3 CH2 1 Q1 CF3 CF3 H
      1000 C(CH3)2CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 CF3 CF3 H 129-134
      1001 C(CH3)2CH2SCH3 3-I 2-CH3 CH2 1 Q1 C2F5 CF3 H
      1002 C(CH3)2CH2SOCH3 3-I 2-CH3 CH2 1 Q1 C2F5 CF3 H
      1003 C(CH3)2CH2SO2CH3 3-I 2-CH3 CH2 1 Q1 C2F5 CF3 H
      1004 C(CH3)2CH2SCH3 3-I 2-Cl CH2 1 Q1 C2F5 C2F5 H
      1005 C(CH3)2CH2SOCH3 3-I 2-Cl CH2 1 Q1 C2F5 C2F5 H
      1006 C(CH3)2CH2SO2CH3 3-I 2-Cl CH2 1 Q1 C2F5 C2F5 H
      1007 CH(CH3)CH2SCH3 3-I 2-Cl CH2 1 Q1 C2F5 H C2F5
      (S)-isomer
      1008 CH(CH3)CH2SCH3 3-I 2-Cl CH2 1 Q1 C2F5 H C3F7-n
      (S)-isomer
      1009 CH(CH3)CH2SCH3 3-I 2-Cl CH2 1 Q1 C2F5 H C4F9-n
      (S)-isomer
      1010 CH(CH3)CH2SCH3 3-I 2-Cl CH2 1 Q1 C2F5 H C6F13-n
      (S)-isomer
      1011 CH(CH3)CH2SCH3 3-I 2-Cl CH2 1 Q2 CF3 CF3
      (S)-isomer
      1012 CH(CH3)CH2SCH3 3-I 2-Cl CH2 1 Q2 C2F5 CF3
      (S)-isomer
      1013 CH(CH3)CH2SCH3 3-I 2-Cl CH2 1 Q2 C2F5 C2F5
      (S)-isomer
      1014 CH(CH3)CH2SCH3 3-I 2-Cl CH2 1 Q2 C3F7-n CF3
      (S)-isomer
      indicates data missing or illegible when filed
    • [0000]
      TABLE 2
      No.
      1 1H-NMR (CDCl3, ppm): 1.4 (6H, s), 2.0 (3H, s), 2.3 (3H, s), 2.9 (2H, s), 5.4 (2H, s), 6.2 (1H, s), 6.9 (1H,
      s), 7.3-8.7 (8H, m)
      3 1H-NMR (CDCl3, ppm): 1.5 (6H, s), 2.2 (3H, s), 2.6 (3H, s), 3.7 (2H, s), 5.4 (2H, s), 6.4 (1H, s), 6.9 (1H,
      s), 7.3-8.2 (8H, m)
      8 1H-NMR (CDCl3, ppm): 1.4 (6H, s), 2.0 (3H, s), 2.3 (3H, s), 2.9 (2H, s), 5.4 (2H, s), 6.1 (1H, s), 6.9 (1H,
      s), 7.3-8.4 (7H, m)
      11 1H-NMR (CDCl3, ppm): 1.2 (3H, d), 1.9 (3H, s), 2.3 (3H, s), 2.7 (2H, dd), 4.2 (1H, m), 5.4 (2H, s), 6.4
      (1H, d), 6.9 (1H, s), 7.3-8.4 (7H, m)
      15 1H-NMR (CDCl3, ppm): 1.3 (3H, d), 2.2 (3H, s), 2.8 (3H, s), 3.2 (2H, m), 4.6 (1H, m), 5.4 (2H, s), 6.4
      (1H, d), 6.9-8.4 (8H, m)
      47 1H-NMR (CDCl3, ppm): 1.6 (6H, s), 2.3 (3H, s), 2.5 (3H, s), 3.5 (2H, s), 5.4 (2H, s), 6.6 (1H, s), 6.9 (1H,
      s), 7.3-8.2 (7H, m)
      52 1H-NMR (CDCl3, ppm): 1.4 (3H, d), 2.2 (3H, s), 2.7 (3H, s), 3.2 (2H, m), 4.4 (1H, m), 5.4 (2H, s),
      6.9-8.2 (9H, m)
      81 1H-NMR (CDCl3, ppm): 1.1 (6H, d), 2.2 (3H, s), 4.2 (1H, m), 5.3 (2H, s), 5.9 (1H, d), 6.9-8.2 (8H, m)
      83 1H-NMR (CDCl3, ppm): 1.57 (3H, s), 1.60 (3H, s), 2.20 (3H, s), 2.30 (3H, s), 2.93 (2H, dd), 5.43 (2H, s),
      6.57 (1H, s), 6.90 (1H, s), 7.0-8.2 (7H, m)
      85 1H-NMR (CDCl3, ppm): 1.2 (3H, d), 1.8 (3H, s), 2.2 (3H, s), 2.6 (2H, dd), 4.2 (1H, m), 5.3 (2H, s), 6.5
      (1H, d), 6.9 (1H, s), 7.3-8.4 (7H, m)
      89 1H-NMR (CDCl3, ppm): 1.4 (3H, d), 2.2 (3H, s), 2.7 (3H, s), 3.2 (2H, m), 4.5 (1H, m), 5.3 (2H, s), 6.6
      (1H, d), 6.9-7.9 (8H, m)
      94 1H-NMR (CDCl3, ppm): 1.57 (3H, s), 1.60 (3H, s), 2.20 (3H, s), 2.30 (3H, s), 2.93 (2H, dd), 5.43 (2H, s),
      6.57 (1H, s), 6.90 (1H, s), 7.0-8.2 (7H, m)
      96 1H-NMR (CDCl3, ppm): 1.63 (6H, s), 2.27 (3H, s), 2.50 (3H, s), 3.47 (2H, s), 5.30 (2H, s), 6.23 (1H, s),
      6.57 (1H, s), 7.0-8.1 (8H, m)
      97 1H-NMR (CDCl3, ppm): 1.27 (3H, d), 1.93 (3H, s), 2.30 (3H, s), 2.63 (2H, m), 4.33 (1H, m), 5.37 (2H,
      s), 6.07 (1H, m), 6.60 (1H, s), 6.9-8.2 (8H, m)
      99 1H-NMR (CDCl3, ppm): 1.50 (3H, d), 2.27 (3H, s), 2.70 (3H, s), 3.0-3.5 (2H, m), 4.60 (1H, m), 5.37 (2H,
      s), 6.5-8.0 (10H, m)
      103 1H-NMR (CDCl3, ppm): 1.27 (3H, d), 1.93 (3H, s), 2.30 (3H, s), 2.60 (2H, m), 4.33 (1H, m), 5.20 (2H,
      s), 6.17 (1H, s), 6.47 (1H, t), 7.1-8.3 (8H, m)
      107 1H-NMR (CDCl3, ppm): 1.50 (3H, d), 1.93 (3H, s), 2.30 (3H, s), 2.60 (2H, m), 4.33 (1H, m), 5.20 (2H,
      s), 6.17 (1H, s), 6.47 (1H, t), 6.67 (1H, m), 7.0-8.1 (7H, m)
      116 1H-NMR (CDCl3, ppm): 1.2 (3H, d), 1.9 (3H, s), 2.2 (3H, s), 2.6 (2H, dd), 4.2 (1H, m), 5.2 (2H, s), 6.4
      (1H, d), 7.0-8.3 (9H, m)
      149 1H-NMR (CDCl3, ppm): 1.34 (6H, s), 1.95 (3H, s), 2.33 (3H, s), 2.86 (2H, s), 5.48 (2H, s), 6.11 (1H, s),
      7.56-7.00 (4H, m), 7.84-7.72 (1H, m), 8.23 (1H, d), 8.49 (1H, s)
      153 1H-NMR (CDCl3, ppm): 1.22 (3H, d), 2.05 (3H, s), 2.30 (3H, s), 2.61-2.53 (2H, m), 4.40-4.29 (1H, m),
      5.44 (2H, s), 6.19 (1H, d), 7.17 (2H, t), 7.54-7.48 (2H, m), 7.73 (1H, d), 8.15 (1H, d), 8.44 (1H, s)
      180 1H-NMR (CDCl3, ppm): 1.3 (3H, d), 2.2 (3H, s), 2.3 (3H, s), 2.8 (2H, d), 4.5 (1H, m), 5.4 (2H, s), 7.1-8.3
      (8H, m)
      242 1H-NMR (CDCl3, ppm): 1.4 (3H, d), 2.2 (3H, s), 2.8 (3H, s), 3.2 (2H, m), 4.6 (1H, m), 5.5 (2H, s),
      6.2-8.2 (9H, m)
      251 1H-NMR (CDCl3, ppm): 1.25 (3H, d), 1.95 (3H, s), 2.28 (3H, s), 2.63-2.51 (2H, m), 3.28 (3H, s),
      4.36-4.26 (1H, m), 5.43 (2H, s), 6.38 (1H, d, J = 9.3 Hz), 7.39-7.16 (2H, m), 7.62-7.53 (2H,
      m), 7.81-7.74 (1H, m), 8.38 (1H, s)
      271 1H-NMR (CDCl3, ppm): 1.47 (6H, s), 2.00 (3H, s), 2.30 (3H, s), 2.83 (2H, s), 3.30 (1H, m), 4.2-4.6 (4H,
      m), 6.07 (1H, s), 7.1-8.2 (7H, m)
      277 1H-NMR (CDCl3, ppm): 1.1 (6H, d), 2.2 (3H, s), 4.1 (1H, m), 5.0 (2H, s), 6.0 (1H, d), 7.0-8.4 (8H, m)
      417 1H-NMR (CDCl3, ppm): 1.5 (3H, d), 2.3 (3H, s), 2.8 (3H, s), 3.2 (2H, dd), 4.7 (1H, m), 6.5 (1H, m), 7.0
      (1H, s), 7.3-8.3 (6H, m)
      422 1H-NMR (CDCl3, ppm): 1.47 (6H, s), 2.03 (3H, s), 2.40 (3H, s), 2.87 (2H, s), 6.03 (1H, s), 6.80 (1H, m),
      7.1-8.6 (8H, m)
      434 1H-NMR (CDCl3, ppm): 1.40 (6H, s), 2.03 (3H, s), 2.40 (3H, s), 2.87 (2H, s), 6.07 (1H, s), 6.77 (1H, m),
      7.2-8.5 (8H, m)
      521 1H-NMR (CDCl3, ppm): 1.23 (3H, d), 1.90 (3H, s), 2.26 (3H, s), 2.50-2.67 (2H, m), 4.10-4.50 (1H, m),
      5.37 (2H, s), 6.15 (1H, d), 6.60 (1H, bs), 6.90-7.20 (3H, m), 7.57 (1H, bs), 7.70 (1H, d),
      7.80-8.23 (3H, m)
      522 1H-NMR (CDCl3, ppm): 1.50 (3H, d), 2.30 (3H, s), 2.70 (3H, s), 2.97-3.50 (2H, m), 4.56 (1H, m), 5.43
      (2H, s), 6.60-8.03 (10H, m)
      523 1H-NMR (CDCl3, ppm): 1.40 (6H, s), 1.98 (3H, s), 2.30 (3H, s), 2.73 (2H, s), 5.40 (2H, s), 6.03 (1H, bs),
      6.60-7.20 (4H, m), 7.50-8.20 (5H, m)
      529 1H-NMR (CDCl3, ppm): 1.42 (6H, s), 1.98 (3H, s), 2.30 (3H, s), 2.71 (2H, s), 5.30 (2H, s), 6.03 (1H, bs),
      6.52 (1H, d), 7.03-7.35 (4H, m), 7.73 (1H, d), 7.93 (1H, d), 8.10-8.40 (2H, m)
      530 1H-NMR (CDCl3, ppm): 1.63 (6H, s), 2.30 (3H, s), 2.57 (3H, s), 3.47 (2H, s), 5.30 (2H, s), 6.40 (1H, bs),
      6.57 (1H, d), 7.03-8.17 (8H, m)
      532 1H-NMR (CDCl3, ppm): 1.30 (4H, dd), 1.97 (3H, s), 2.28 (3H, s), 2.73-2.42 (2H, m), 4.37-4.28 (1H, m),
      5.28 (2H, s), 6.42 (1H, d), 6.55 (1H, d), 7.09 (2H, t), 7.42-7.39 (2H, m), 7.51 (1H, d), 7.70 (1H,
      t), 8.02 (1H, d), 8.49 (1H, d)
      534 1H-NMR (CDCl3, ppm): 1.24 (3H, d), 1.93 (3H, s), 2.30 (3H, s), 2.50-2.66 (2H, m), 4.23-4.40 (1H, m),
      5.32 (2H, s), 6.16 (1H, d), 6.54 (1H, d), 7.06 (1H, bs), 7.11 (1H, d), 7.22 (1H, t), 7.40 (1H, d),
      7.78 (1H, d), 7.97 (1H, d), 8.17 (1H, d), 8.30 (1H, bs)
      536 1H-NMR (CDCl3, ppm): 1.50 (3H, d), 2.28 (3H, s), 2.73 (3H, s), 2.97-3.50 (2H, m), 4.60 (1H, m), 5.30
      (2H, s), 6.53 (1H, d), 6.73 (1H, d), 7.00-8.07(8H, m)
      537 1H-NMR (CDCl3, ppm): 1.40(6H, s), 1.98 (3H, s), 2.31 (3H, s), 2.81 (2H, s), 5.32 (2H, s), 6.08 (1H, bs),
      6.54 (1H, d), 7.04 (1H, bs) 7.11 (1H, d), 7.20 (1H, t), 7.38 (1H, d), 7.79 (1H, d), 7.96 (1H, d),
      8.22 (1H, d), 8.38 (1H, bs)
      538 1H-NMR (CDCl3, ppm): 1.66(6H, s), 2.30 (3H, s), 2.60 (3H, s), 3.52 (2H, s), 5.30 (2H, s), 6.47 (1H, bs),
      6.57 (1H, d), 7.03-8.23 (8H, m)
      550 1H-NMR (CDCl3, ppm): 1.48 (6H, d), 2.21 (3H, s), 2.48 (3H, s), 4.13 (1H, m), 5.42 (2H, s), 6.18(1H, d),
      6.91 (1H, s), 7.1-7.6 (6H, m), 8.08 (1H, d)
      552 1H-NMR (CDCl3, ppm): 1.17 (3H, d), 1.89 (3H, s), 2.29 (3H, s), 2.42 (1H, dd), 2.60 (1H, dd), 3.29 (3H,
      s), 4.24 (1H, m), 5.42 (2H, s), 6.41 (1H, d), 6.92 (1H, s), 7.1-7.2 (2H, m). 7.6-8.2 (5H, m)
      553 1H-NMR (CDCl3, ppm): 1.21 (3H, d), 1.32 (3H, t), 1.95 (3H, s), 2.29 (3H, s), 2.51 (1H, dd), 2.60 (1H,
      dd), 3.00 (2H, q), 4.31 (1H, m), 5.41 (2H, s), 6.28 (1H, d), 6.91 (1H, s), 7.1-7.2 (2H, m),
      7.4-7.6 (3H, m), 8.09 (1H, d), 8.34 (1H, s)
      554 1H-NMR (CDCl3, ppm): 1.25 (5H, dd), 1.91 (3H, s), 2.29 (3H, s), 2.60-2.54 (2H, m), 4.32-4.27 (1H, m),
      5.44 (2H, s), 6.40 (1H, d), 7.06 (2H, d, J = 7.5 Hz), 7.19-7.12 (1H, m), 7.71 (1H, d), 7.94-7.91
      (1H, m), 8.08 (1H, d), 8.36 (1H, s)
      569 1H-NMR (CDCl3, ppm): 8.50 (1H, m), 7.95 (1H, m), 7.79-7.49 (4H, m), 7.44-7.38 (1H, m), 7.22 (1H, m),
      5.75 (1H, q), 4.38 (1H, m), 2.79 (2H, m), 2.29 (3H, s), 2.20 (3H, s), 2.00 (3H, d), 1.43-1.18 (3H, d)
      574 1H-NMR (CDCl3, ppm): 1.31 (3H, d), 1.95 (3H, s), 2.30 (3H, s), 2.61-2.57 (2H, m), 4.37-4.27 (1H, m),
      5.79-5.73 (1H, m), 6.48 (1H, d), 7.02 (1H, s), 7.25-7.21 (2H, m), 7.52-7.36 (3H, m), 7.84-7.69
      (2H, m), 8.04 (1H, d), 8.50 (1H, s)
      594 1H-NMR (CDCl3, ppm): 1.22 (3H, d), 1.93 (3H, s), 2.26 (3H, s), 2.61-2.55 (2H, m), 4.36-4.27 (1H, m),
      5.49 (2H, d), 6.07 (1H, d), 6.34-6.30 (1H, m), 6.98 (2H, d), 7.13 (1H, t), 7.27-7.22 (3H, m),
      7.79 (1H, d), 7.97 (1H, dd), 8.08 (1H, d), 8.23 (1H, s)
      595 1H-NMR (CDCl3, ppm): 1.25 (3H, d), 1.94 (3H, s), 2.27 (3H, s), 2.60-2.54 (2H, m), 4.34-4.25 (1H, m),
      5.49 (2H, d), 6.42 (1H, d), 7.04-6.99 (2H, m), 7.21-7.14 (2H, m), 7.35-7.32 (1H, m), 7.72 (1H,
      d), 7.93 (1H, dd), 8.05 (1H, d), 8.36 (1H, s)
      596 1H-NMR (CDCl3, ppm): 1.24 (3H, d), 1.97 (3H, s), 2.33 (3H, s), 2.63-2.54 (2H, m), 4.35-4.30 (1H, m),
      5.52 (2H, s), 6.05 (1H, d), 7.02-7.00 (2H, m), 7.26-7.21 (1H, m), 7.35-7.32 (1H, m), 7.42-7.39
      (1H, m), 7.80 (1H, t), 7.98 (1H, d), 8.18 (1H, t), 8.32 (1H, d)
      626 1H-NMR (CDCl3, ppm): 1.22 (3H, d), 1.92 (3H, s), 2.30 (3H, s), 2.54 (1H, dd), 2.61 (1H, dd), 4.32 (1H,
      m), 5.46 (2H, s), 6.23 (1H, m), 6.94 (1H, s), 7.0-7.1 (2H, m), 7.45 (1H, m), 7.54 (1H, d), 7.72
      (1H, d), 8.07 (1H, d), 8.38 (1H, bs)
      632 1H-NMR (CDCl3, ppm): 1.26 (3H, dd), 1.96 (3H, s), 2.32 (3H, s), 2.61-2.55 (2H, m), 4.34-4.29 (1H, m),
      5.22 (2H, s), 6.22 (1H, d), 7.21-7.13 (3H, m), 7.36 (1H, d), 7.78 (1H, d), 7.97 (1H, dd), 8.16
      (1H, d), 8.35 (1H, s)
      633 1H-NMR (CDCl3, ppm): 1.23 (3H, dd), 1.97 (3H, s), 2.31 (3H, s), 2.61-2.56 (2H, m), 4.37-4.32 (1H, m),
      5.25 (2H, s), 6.13 (1H, d), 7.11 (2H, dd), 7.37 (1H, t), 7.48 (1H, dd), 7.61-7.53 (1H, m), 7.79
      (1H, dt), 8.15 (1H, d), 8.43 (1H, d)
      634 1H-NMR (CDCl3, ppm): 1.25 (4H, dd), 1.98 (3H, s), 2.33 (3H, s), 2.61-2.56 (2H, m), 8.41 (1H, s),
      4.38-4.31 (1H, m), 5.24 (2H, s), 6.17 (1H, d), 7.13-7.11 (2H, m), 7.38 (1H, s), 7.46 (1H, t), 7.56
      (1H, dd), 7.79 (1H, t), 8.14 (1H, d)
      635 1H-NMR (CDCl3, ppm): 1.26 (3H, dd), 1.94 (3H, s), 2.31 (3H, s), 2.61-2.52 (2H, m), 4.33-4.29 (1H, m),
      524 (2H, s), 6.34 (1H, d), 7.21-7.11 (3H, m), 7.39 (1H, d), 7.75 (1H, d), 7.95 (1H, dd), 8.13
      (1H, d,)8.38 (1H, s)
      636 1H-NMR (CDCl3, ppm): 1.25 (3H, dd), 1.93 (2H, s), 2.31 (3H, s), 2.65-2.52 (2H, m), 4.32-4.29 (1H, m),
      5.26 (2H, s), 6.40 (1H, d), 7.21-7.11 (3H, m), 8.39 (1H, s), 7.42 (1H, s), 7.74 (1H, d), 7.94 (1H,
      d), 8.11 (1H, d)
      640 1H-NMR (CDCl3, ppm): 1.29 (3H, dd), 1.95 (3H, s), 2.32 (3H, s), 2.62-2.54 (2H, m), 4.34-4.27 (1H, m),
      5.31 (2H, s), 6.21 (1H, d), 7.96 (1H, d), 8.19 (1H, t), 7.21-7.13 (3H, m), 7.62 (1H, s), 7.78 (1H,
      d), 8.37 (1H, d)
      651 1H-NMR (CDCl3, ppm): 1.24 (3H, dd), 1.96 (3H, s), 2.31 (3H, s), 2.60-2.55 (2H, m), 4.36-4.31 (1H, m),
      5.31 (2H, s), 6.34 (1H, d), 7.16-7.14 (2H, m), 7.43 (1H, t), 7.53 (1H, dd), 7.64 (1H, s), 7.71
      (1H, d), 8.12 (1H, d), 8.50 (1H, s)
      654 1H-NMR (CDCl3, ppm): 1.26 (3H, dd), 1.93 (3H, s), 2.34 (3H, d), 2.62-2.55 (2H, m), 4.34-4.29 (1H, m),
      5.31 (2H, s), 6.23 (1H, d), 7.24-7.14 (3H, m), 7.63 (1H, s), 7.78 (1H, d), 7.97 (1H, dd), 8.20
      (1H, d), 8.37 (1H, s)
      658 1H-NMR (CDCl3, ppm): 1.44-1.38 (3H, m), 2.35-2.30 (6H, m), 2.90-2.77 (2H, m), 4.56-4.48 (1H, m),
      5.32 (2H, s), 7.18-7.14 (3H, m), 7.44-7.37 (1H, m), 7.56-7.52 (1H, m), 7.67-7.64 (2H, m),
      8.10-8.07 (1H, m), 8.44-8.39 (1H, m)
      660 1H-NMR (CDCl3, ppm): 1.25 (4H, dd), 1.90 (3H, s), 2.31 (3H, s), 2.63-2.55 (2H, m), 4.37-4.28 (1H, m),
      5.34 (2H, s), 6.12 (1H, d), 7.22-7.15 (2H, m), 7.63 (1H, d), 7.83 (1H, t), 7.98 (1H, dt), 8.25
      (1H, t), 8.34 (1H, s)
      675 1H-NMR (CDCl3, ppm): 1.23 (3H, d), 1.97 (3H, s), 2.33 (3H, s), 2.63-2.54 (2H, m), 4.38-4.29 (1H, m),
      5.41 (2H, s), 6.21 (1H, d), 7.09 (2H, d), 7.44 (1H, t), 7.54 (1H, d), 7.73 (1H, d), 7.84 (1H, s),
      8.07 (1H, d), 8.38 (1H, s)
      681 1H-NMR (CDCl3, ppm): 1.25 (3H, d), 1.95 (3H, s), 2.32 (3H, s), 2.62-2.54 (2H, m), 4.36-4.32 (1H, m),
      5.52 (2H, s), 6.13 (1H, d), 7.18-7.16 (2H, m), 7.57-7.47 (2H, m), 7.76 (1H, d), 8.17 (1H, d),
      8.41 (1H, s)
      714 1H-NMR (CDCl3, ppm): 1.24 (3H, d), 1.99 (3H, s), 2.30 (3H, s), 2.64-2.52 (2H, m), 4.38-4.29 (1H, m),
      5.49 (2H, s), 6.15 (1H, d), 7.17-7.15 (2H, m), 7.57-7.43 (2H, m), 7.75 (1H, d), 8.17 (1H, d),
      8.41 (1H, s)
      726 1H-NMR (CDCl3, ppm): 1.45-1.37 (3H, m), 2.32-2.30 (6H, m), 2.87-2.83 (2H, m), 4.61-4.46 (1H, m),
      5.44 (2H, s), 6.90-6.88 (1H, m), 7.12-7.09 (2H, m), 7.45-7.42 (1H, m), 7.55-7.52 (1H, m),
      7.68-7.66 (1H, m), 7.79-7.77 (1H, m), 8.06-8.04 (1H, m), 8.32-8.24 (1H, m)
      727 1H-NMR (CDCl3, ppm): 1.44 (3H, d), 2.30 (3H, s), 2.75 (3H, s), 3.24-3.21 (2H, m), 4.62-4.53 (1H, m),
      5.44 (2H, s), 6.87-6.85 (1H, m), 7.08-7.06 (2H, m), 7.42-7.32 (1H, m), 7.50-7.47 (1H, m),
      7.60-7.57 (1H, m), 7.77 (1H, s), 7.91-7.87 (1H, m), 8.17-8.14 (1H, m)
      729 1H-NMR (CDCl3, ppm): 1.45 (3H, d), 2.29 (3H, s), 2.75 (3H, s), 3.34-3.12 (2H, m), 4.59-4.54 (1H, m),
      5.38 (2H, s), 6.86 (1H, d), 7.09-7.06 (2H, m), 7.43-7.33 (1H, m), 7.52-7.46 (1H, m), 7.59 (1H,
      d), 7.84 (1H, s), 7.90 (1H, d), 8.15 (1H, s)
      730 1H-NMR (CDCl3, ppm): 1.23 (3H, d), 1.96 (3H, s), 2.29 (3H, s), 2.5-2.7 (2H, m), 4.31 (1H, m), 5.34
      (2H, s), 6.31 (1H, d), 6.4-7.2 (5H, s), 7.4-7.8 (3H, m), 8.06 (1H, d), 8.41 (1H, bs)
      741 1H-NMR (CDCl3, ppm): 1.26 (3H, d), 1.95 (3H, s), 2.18 (3H, s), 2.30 (3H, s), 2.66-2.48 (2H, m),
      4.39-4.20 (1H, m), 5.31 (2H, s), 6.25 (1H, d), 7.07-7.01 (2H, m), 7.44-7.41 (2H, m), 7.55-7.51
      (2H, m), 7.71 (1H, d), 8.01 (1H, d), 8.32 (1H, s)
      778 1H-NMR (CDCl3, ppm): 1.31 (3H, d), 1.95 (3H, s), 2.33 (3H, t), 2.61-2.56 (2H, m), 4.40-4.29 (1H, m),
      5.28 (2H, s), 6.50-6.11 (2H, m), 7.15-7.12 (2H, m), 7.45-7.42 (1H, m), 7.55-7.52 (1H, m), 7.64
      (1H, s), 7.72 (1H, d), 8.12 (1H, d), 8.50 (1H, s)
      799 1H-NMR (CDCl3, ppm): 1.23 (3H, d), 1.93 (3H, s), 2.32 (3H, s), 2.56 (2H, m), 4.22 (1H, m), 5.52 (2H,
      s), 6.55-6.02 (3H, m), 7.21 (2H, m), 7.57-7.43 (2H, m), 7.76 (1H, d), 8.15 (1H, d), 8.39 (1H, s)
      1H-NMR (CDCl3, ppm): 1.24 (3H, d), 1.94 (3H, s), 2.28 (3H, s), 2.52 (1H, dd), 2.62 (1H, dd), 4.30 (1H,
      m), 5.38 (2H, s), 6.4-7.2 (7H, m), 7.72 (1H, d), 7.93 (1H, d), 8.06 (1H, d), 8.41 (1H, bs)
      1H-NMR (CDCl3, ppm): 1.40 (6H, s), 1.93 (3H, s), 2.77 (2H, s), 5.40 (2H, s), 5.93 (1H, bs), 6.87-7.23
      (4H, m), 7.63-7.95 (2H, m), 8.35-8.65 (2H, m)
    • Synthesis Example 6 Starting material
    • [0518]
    • [0519]
      3-Methyl-4-nitrobenzyl chloride (1.81 g), 3,5-bis(trifluoromethyl)-1H-pyrazole (2.0 g) and potassium carbonate (1.63 g) were stirred in DMF (20 ml) at 60° C. for 1 hour. After finishing the reaction, water (100 ml) was added thereto and the mixture was extracted with ethyl acetate. The organic layer was washed with saturated aqueous solution of sodium chloride (100 ml) and dried with anhydrous sodium sulfate. After distilling off the solvent, the obtained residue was purified by silica gel column chromatography to obtain 1-(3-methyl-4-nitrobenzyl)-3,5-bis-(trifluoromethyl)-1H-pyrazole (3.3 g).
    • [0520]
      1H-NMR (CDCl3, ppm): 2.59 (3H, s), 5.50 (2H, s), 6.90 (1H, s), 7.1-7.2 (2H, m), 8.00 (1H, d).
    • Synthesis Example 7 Starting Material
    • [0521]
    • [0522]
      To a mixture of 1-(3-methyl-4-nitrobenzyl)-3,5-bis(trifluoromethyl)-1H-pyrazole (1.4 g), ammonium acetate (30.5 g), acetone (60 ml) and water (30 ml), 20% aqueous solution of titanium trichloride (27.5 g) was added at room temperature and the mixture was stirred at room temperature for 12 hours. After finishing the reaction, the mixture was extracted with ethyl acetate, washed with saturated aqueous solution of sodium chloride and dried with anhydrous sodium sulfate. After distilling off the solvent, the obtained residue was purified by silica gel column chromatography to obtain 1-(3-methyl-aminobenzyl)-3,5-bis(trifluoromethyl)-1H-pyrazole (1.19 g).
    • [0523]
      1H-NMR (CDCl3, ppm): 2.14 (3H, s), 3.66 (2H, m), 5.32 (2H, s), 6.62 (1H, d), 6.89 (1H, s), 6.8-7.1 (2H, m).
    • Synthesis Example 8 Starting material
    • [0524]
    • [0525]
      1-(3-Methyl-4-nitrobenzyl)-3,5-bis(trifluoromethyl)-1H-pyrazole (17.66 g) and iron powder (13.69 g) were heated and stirred in acetic acid (150 ml) at 40° C. for 5 hours. After finishing the reaction, an insoluble matter was filtered with Celite and the filtrate was concentrated under the reduced pressure. To the residue, 1N aqueous solution of sodium hydrate (200 ml) and ethyl acetate (200 ml) were added. The organic layer was separated, washed with water, and then, dried with anhydrous magnesium sulfate. After distilling off the solvent, 1-(3-methyl-4-aminobenzyl)-3,5-bis(trifluoromethyl)-1H-pyrazole (13.0 g), which was the same as that obtained in Synthesis Example 7, was obtained.
    • Synthesis Example 9 Starting Material
    • [0526]
    • [0527]
      3-Fluorophthalic anhydride (4.98 g) and 1-(3-methyl-4-aminobenzyl)-3,5-bis(trifluoromethyl)-1H-pyrazole (9.70 g) were refluxed in acetic acid (43 ml) for 3 hours. After finishing the reaction, the acetic acid was distilled off wader the reduced pressure and the obtained crude crystals were washed with t-butyl methyl ether to obtain the aimed 2-{4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-ylmethyl]-2-methylphenyl}-4-fluoroisoindol-1,3-dione (10.80 g). mp. 158-159° C.
    • Synthesis Example 10 Starting Material
    • [0528]
    • [0529]
      3-Methyl-4-nitrobenzyl chloride (0.56 g), 5-(difluoromethyl)-1,2-dihydro-2-methyl-3H-1,2,4-(triazol)-3-one (0.45 g) and potassium carbonate (0.61 g) were stirred in DMF (10 ml) at 50° C. for 5 hours. After finishing the reaction, the reaction mixture was poured into ice water and extracted with ethyl acetate. The organic layer was washed with saturated aqueous solution of sodium chloride and then dried with anhydrous magnesium sulfate, and the solvent was distilled off under the reduced pressure. The obtained residue was purified by silica gel column chromatography to obtain the aimed 5-difluoromethyl-2-methyl-4-(3-methyl-4-nitrobenzyl)-2,4-dihydro-[1,2,4]triazol-3-one (0.45 g).
    • [0530]
      1H-NMR (CDCl3, ppm): 2.5 (3H, s), 3.5 (3H, s), 4.9 (2H, s), 6.4 (1H, t), 72-7.3 (2H, m), 7.8-7.9 (1H, m).
    • Synthesis Example 11 Starting Material
    • [0531]
    • [0532]
      3-Methyl-nitrobenzyl chloride (0.43 g), 3-heptafluoropropylsulfanyl-5-trifluoromethyl-1H-(1,2,4)-triazole (0.70 g), tetrabutylammonium iodide (0.09 g), 18-crown-6 (0.06 g) and potassium carbonate (0.48 g) were refluxed in acetonitrile (10 ml) for 2 hours. After cooling, the reaction solution was diluted with ethyl acetate and washed with water and saturated aqueous solution of sodium chloride. After drying the organic layer with magnesium sulfate, the solvent was distilled off under the reduced pressure and the obtained residue was purified by silica gel column chromatography to obtain 3-hepta fluoropropylsulfanyl-1-(3-methyl-4-nitrobenzyl)-5-trifluoromethyl-1H-(1,2,4)-triazole (0.30 g).
    • [0533]
      1H-NMR (CDCl3, ppm): 2.64 (3H, s), 5.62 (2H, s), 7.31-7.25 (2H, m), 8.05-7.86 (1H, m)
    • Synthesis Example 12 Starting Material
    • [0534]
    • [0535]
      To a mixture of 3-heptafluoropropylsulfanyl-1-(3-methyl-4-nitrophenyl)-5-trifluoromethyl-1H-(1,2,4)-triazole (0.3 g), ammonium acetate (4.8 g), acetone (20 ml) and water (10 ml), 20% aqueous solution of titanium trichloride (4.3 g) was added at room temperature and the mixture was stirred at room temperature for 12 hours. After finishing the reaction, the mixture was extracted with ethyl acetate, washed with saturated aqueous solution of sodium chloride and dried with anhydrous sodium sulfate. After distilling off the solvent, the obtained residue was purified by silica gel column chromatography to obtain 4-(3-heptafluoropropylsulfanyl-5-trifluoromethyl-[1,2,4]triazol-1-ylmethyl)-2-methyl-phenylamine (0.28 g)
    • [0536]
      1H-NMR (CDCl3, ppm): 2.17 (3H, s), 4.16 (1H, brs), 5.40 (2H, s), 6.63-6.59 (2H, m), 7.13-6.99 (1H, m).
    • Synthesis Example 13 Starting Material
    • [0537]
    • [0538]
      An acetonitrile solution (30 ml) of 3-trifluoromethyl-1H-pyrazole (5.0 g), dicerium ammonium nitrate (10.0 g) and iodine (5.6 g) was refluxed for 1 hour. After cooling, the reaction solution was washed with saturated aqueous solution of sodium thiosulfate and saturated aqueous solution of sodium chloride. After drying the organic layer with magnesium sulfate, the solvent was distilled off under the reduced pressure to obtain 4-iodo-3-trifluoromethyl-1H-pyrazole (93 g).
    • [0539]
      1H-NMR (CDCl3, ppm): 7.77 (1H, s).
    • Synthesis Example 14 Starting Material
    • [0540]
    • [0541]
      3-Methyl-4-nitrobenzyl chloride (0.77 g), 4-iodo-3-trifluoromethyl-1H-pyrazole (0.99 g) and potassium carbonate (0.63 g) were stirred in DMF (10 ml) at 60° C. for 1 hour. After cooling, the reaction solution was diluted with ethyl acetate and washed with water and saturated aqueous solution of sodium chloride. After drying the organic layer with magnesium sulfate, the solvent was distilled off under the reduced pressure and the obtained residue was purified by silica gel column chromatography to obtain 4-iodo-1-(3-methyl-4-nitrobenzyl)-3-trifluoromethyl-1H-pyrazole (1.0 g).
    • [0542]
      1H-NMR (CDCl3, ppm): 2.62 (3H, s), 5.36 (2H, s), 7.21-7.18 (2H, m), 7.52 (1H, s), 7.98 (1H, d).
    • Synthesis Example 15 Starting Material
    • [0543]
    • [0544]
      4-Iodo-1-(3-methyl-4-nitrobenzyl)-3-trifluoromethyl-1H-pyrazole (2.06 g), copper powder (0.95 g), iodopentafluoroethane (4.92 g) and DMF (13 ml) were set in an autoclave and heated and stirred for 8 hours, maintaining the inside temperature of 130-135° C. After cooling to room temperature, the reaction mixture was diluted with ethyl acetate (50 ml) and an insoluble matter was filtered with Celite and washed with ethyl acetate. The filtrate was concentrated under the reduced pressure and the obtained residue was purified by silica gel column chromatography to obtain 1-(3-methyl-4-nitrobenzyl)-4-pentafluoroethyl-3-trifluoromethyl-1H-pyrazole (1.39 g)
    • [0545]
      1H-NMR (CDCl3, ppm): 2.63 (3H, s), 5.38 (2H, s), 7.21-7.27 (2H, m), 7.74 (1H, s), 8.00 (1H, d).
    • Synthesis Example 16 Starting Material
    • [0546]
    • [0547]
      3-Methyl-4-nitrobenzyl chloride (8.57 g), 4-iodo-3-pentafluoroethyl-1H-pyrazole (16.00 g) and potassium carbonate (7.66 g) were stirred in DMF (70 ml) at 70° C. for 1 hour. After cooling, the reaction solution was poured into water and extracted with ethyl acetate. The organic phase was washed with water and saturated aqueous solution of sodium chloride. After drying the organic layer with sodium sulfate, the solvent was distilled off under the reduced pressure and the obtained residue was purified by silica gel column chromatography to obtain 4-iodo-1-(3-methyl-4-nitrobenzyl)-3-pentafluoroethyl-1H-pyrazole (4.60 g).
    • [0548]
      1H-NMR (CDCl3, ppm): 2.60 (3H, s), 5.38 (2H, s), 7.22-7.15 (2H, m), 7.53 (1H, s), 7.98 (1H, d).
    • Synthesis Example 17 Starting Material
    • [0549]
    • [0550]
      4-Iodo-1-(3-methyl-4-nitrobenzyl)-3-pentafluoroethyl-1H-pyrazole (1.84 g), (trifluoromethyl)trimethylsilane (1.14 g), copper(I) iodide (1.52 g), potassium fluoride (0.28 g) were stirred in DMF (8 ml) at 100° C. for 8 hours. After cooling, the mixture was poured into water and extracted with ethyl acetate. The combined organic phase was washed with saturated aqueous solution of sodium chloride. After drying the organic layer with sodium sulfate, the solvent was distilled off under the reduced pressure and the obtained residue was purified by silica gel column chromatography to obtain 1-(3-methyl-4-nitro-benzyl)-3-pentafluoroethyl-4-trifluoromethyl-1H-pyrazole (0.32 g).
    • [0551]
      1H-NMR (CDCl3, ppm): 2.61 (3H, s), 5.41 (2H, s), 7.31-7.18 (2H, m), 7.78 (1H, s), 8.00 (1H, d).
    • Synthesis Example 18 Starting Material
    • [0552]
    • [0553]
      4-Iodo-1-(3-methyl-4-nitrobenzyl)-3-trifluoromethyl-1H-pyrazole (2.06 g), copper powder (0.95 g), heptafluoro-1-iodopropane (2.96 g) and DMF (14 ml) were set in an autoclave and heated and stirred for 8 hours, maintaining the inside temperature of 130-135° C. After cooling to room temperature, the reaction mixture was diluted with ethyl acetate (50 ml) and an insoluble matter was filtered with Celite and washed with ethyl acetate. The filtrate was concentrated under the reduced pressure and the obtained residue was purified by silica gel column chromatography to obtain 1-(3-methyl-4-nitrobenzyl)-4-pentafluoropropyl-3-trifluoromethyl-1H-pyrazole (0.80 g).
    • [0554]
      1H-NMR (CDCl3, ppm): 2.62 (3H, s), 5.42 (2H, s), 7.19-7.20 (2H, m), 7.74 (1H, s), 8.02 (1H, d).
    • Synthesis Example 19 Starting Material
    • [0555]
    • [0556]
      4-Iodo-1-(3-methyl-4-nitrobenzyl)-3-trifluoromethyl-1H-pyrazole (2.47 g), copper powder (1.14 g), nonafluoro-1-iodobutane (4.15 g) and DMF (16 ml) were set in an autoclave and heated and stirred for 8 hours, maintaining the inside temperature of 130-135° C. After cooling to room temperature, the reaction mixture was diluted with toluene (50 ml) and an insoluble matter was filtered with Celite and washed with toluene. The filtrate was concentrated under the reduced pressure and the obtained residue was purified by silica gel column chromatography to obtain 1-(3-methyl-4-nitrobenzyl)-4-nonafluorobutyl-3-trifluoromethyl-1H-pyrazole (1.50 g).
    • [0557]
      1H-NMR (CDCl3, ppm): 2.62 (3H, s), 5.42 (2H, s), 7.18-7.24 (2H, m), 7.74 (1H, s), 8.00 (1H, d).
    • Synthesis Example 20 Starting Material
    • [0558]
    • [0559]
      An acetonitrile solution (20 ml) of 3-trifluoromethyl-1H-pyrazole (1.0 g), dicerium ammonium nitrate (2.0 g) and bromine (0.7 g) was refluxed for 2 hours. After cooling, the reaction solution was washed with saturated aqueous solution of sodium thiosulfate and saturated aqueous solution of sodium chloride. After drying the organic layer with magnesium sulfate, the solvent was distilled off under the reduced pressure to obtain 4-bromo-3-trifluoromethyl-1H-pyrazole (1.6 g).
    • [0560]
      1H-NMR (CDCl3, ppm): 7.73 (1H, s), 12.86 (1H, brs).
    • Synthesis Example 21 Starting Material
    • [0561]
    • [0562]
      3-Methyl-4-nitrobenzyl chloride (0.77 g), 4-bromo-3-trifluoromethyl-1H-pyrazole (0.90 g) and potassium carbonate (0.57 g) were stirred in DMF (10 ml) at room temperature for 2 hours. The reaction solution was diluted with ethyl acetate and washed with water and saturated aqueous solution of sodium chloride. After drying the organic layer with magnesium sulfate, the solvent was distilled off under the reduced pressure and the obtained residue was purified by silica gel column chromatography to obtain 1-(3-methyl-4-nitrobenzyl)-4-bromo-3-trifluoromethyl-1H-pyrazole (0.9 g).
    • [0563]
      1H-NMR (CDCl3, ppm): 2.58 (3H, s), 5.35 (2H, s), 7.24-7.21 (2H, m), 7.49 (1H, s), 7.98 (1H, d).
    • Synthesis Example 22 Starting Material
    • [0564]
    • [0565]
      An acetonitrile solution (20 ml) of 3-trifluoromethyl-1H-pyrazole (0.5 g), dicerium ammonium nitrate (1.0 g) and N-chlorosuccinimide (0.7 g) was refluxed for 3 hours. After cooling, the reaction solution was washed with saturated aqueous solution of sodium thiosulfate and saturated aqueous solution of sodium chloride. After drying an organic layer with magnesium sulfate, the solvent was distilled off under the reduced pressure to obtain 4-chloro-3-trifluoromethyl-1H-pyrazole (0.9 g).
    • [0566]
      1H-NMR (CDCl3, ppm): 7.80 (1H, s).
    • Synthesis Example 23 Starting Material
    • [0567]
    • [0568]
      3-Methyl-4-nitrobenzyl chloride (0.82 g), 4-chloro-3-trifluoromethyl-1H-pyrazole (0.63 g) and potassium carbonate (0.61 g) were stirred in DMF (10 ml) at room temperature for 2 hours. The reaction solution was diluted with ethyl acetate and washed with water and saturated aqueous solution of sodium chloride. After drying the organic layer with magnesium sulfate, the solvent was distilled off under the reduced pressure and the obtained residue was purified by silica gel column chromatography to obtain 1-(3-methyl-4-nitrobenzyl)-4-chloro-3-trifluoromethyl-1H-pyrazole (0.98 g).
    • [0569]
      1H-NMR (CDCl3, ppm): 2.62 (3H, s), 5.33 (2H, s), 7.21-7.19 (2H, m), 7.46 (1H, s), 7.98 (1H, d).
    • Synthesis Example 24 Starting Material
    • [0570]
    • [0571]
      2-(Trifluoroacetyl)-1H-pyrrole (0.97 g) was added to DMF solution (10 ml) of 60% sodium hydride (0.16 g) and the mixture was stirred at room temperature for 30 mutes. 3-Methyl-4-nitrobenzyl chloride (1.0 g) was added thereto and the mixture was stirred at room temperature for 2 hours. The reaction solution was diluted with ethyl acetate and washed with water and saturated aqueous solution of sodium chloride. After drying the organic layer with magnesium sulfate, the solvent was distilled off under the reduced pressure and the obtained residue was purified by silica gel column chromatography to obtain 1-(3-methyl-4-nitrobenzyl)-2-(trifluoroacetyl)-1H pyrrole (1.53 g).
    • [0572]
      1H-NMR (CDCl3, ppm): 2.55 (3H, s), 5.59 (2H, s), 6.44-6.41 (1H, m), 6.99 (1H, d), 7.04 (1H, s), 7.22-7.19 (1H, m), 7.35-7.32 (1H, m), 7.93 (1H, d).
    • Synthesis Example 25 Starting Material
    • [0573]
    • [0574]
      An acetonitrile solution (20 ml) of 2-(trifluoroacetyl)-1H pyrrole (0.5 g), dicerium ammonium nitrate (0.84 g) and iodine (0.47 g) was refluxed for 2 hours. After cooling, the reaction solution was washed with saturated aqueous solution of sodium thiosulfate and saturated aqueous solution of sodium chloride. After drying the organic layer with magnesium sulfate, the solvent was distilled off under the reduced pressure to obtain 4-iodo-2-(trifluoroacetyl)-1H pyrrole (0.6 g).
    • [0575]
      1H-NMR (CDCl3, ppm): 7.28-7.35 (2H, m), 9.52 (1H, brs).
    • Synthesis Example 26 Starting Material
    • [0576]
    • [0577]
      3-Methyl-4-nitrobenzyl chloride (0.63 g), 4-iodo-2-(trifluoroacetyl)pyrrole (0.89 g) and potassium carbonate (0.57 g) were stirred in DMF (10 ml) at room temperature for 2 hours. The reaction solution was diluted with ethyl acetate and washed with water and saturated aqueous solution of sodium chloride. After drying the organic layer with magnesium sulfate, the solvent was distilled off under the reduced pressure and the obtained residue was purified by silica gel column chromatography to obtain 4-iodo-1-(3-methyl-4-nitrobenzyl)-2-trifluoroacetyl-1H-pyrrole (0.45 g).
    • [0578]
      1H-NMR (CDCl3, ppm): 2.60 (3H, s), 5.56 (2H, s), 7.05-7.12 (2H, m), 7.21 (1H, d), 7.39 (1H, s), 7.94 (1H, d).
    • Synthesis Example 27 Starting Material
    • [0579]
    • [0580]
      4-Iodo-1-(3-methyl-4-nitrobenzyl)-2-trifluoroacetyl-1H-pyrrole (1.75 g), copper powder (5.08 g), iodopentafluoroethane (5.92 g) and DMSO (6 ml) were set in an autoclave and heated and stirred for 8 hours, maintaining the inside temperature of 120° C. After finishing the reaction, the reaction mixture was poured into ice water and an insoluble matter was filtered with Celite, and then, it was extracted with ethyl acetate. The extracted solution was washed with water and then dried with anhydrous sodium sulfate. After distilling off the solvent, the obtained residue was purified by silica gel column chromatography to obtain 1-(3-methyl-4-nitrophenyl)-4-pentafluoroethyl-1H-pyrrole (1.35 g).
    • [0581]
      1H-NMR (CDCl3, ppm): 2.59 (3H, s), 5.62 (2H, s), 7.00-7.10 (2H, m), 7.43-7.50 (2H, m), 7.96 (1H, d).
    • [0582]
      Some specific examples of other processes to synthesize the compounds of the aforementioned formula (IX) are shown below.
    • Synthesis Example 28 Starting Material
    • [0583]
    • [0584]
      To a toluene suspension of ethyl 4,4,4-trifluoroacetoacetate (5.0 g), sodium hydride (1.1 g) was slowly added and the mixture was stirred for 1 hour. After adding 4-chloromethyl-2-methyl-1-nitro-benzene (5.5 g) and potassium iodide dissolved in acetone (0.5 g), the reaction solution was refluxed for 5 hours. After cooling, the solvent was distilled off under reduced pressure. The residue was suspended in ethyl acetate and washed with 1N aqueous solution of hydrochloric acid. After drying the organic layer with sodium sulfate, the solvent was distilled off and the obtained residue was purified by silica gel column chromatography to obtain ethyl 4,4,4-trifluoro-2-(3-methyl-4-nitro-benzyl)-3-oxo-butyrate (6.3 g). nD 20 1.4970
    • Synthesis Example 29 Starting Material
    • [0585]
    • [0586]
      Ethyl 4,4,4-trifluoro-2-(3-methyl-4-nitro benzyl)-3-oxo-butyrate (2.0 g), hydrazine monohydrate (0.5 g) and a small amount of p-toluenesulfonic acid were dissolved in toluene, and the mixture was refluxed for 4 hours. After cooling, the solvent was distilled off under reduced pressure. The residue was suspended in ethyl acetate and washed with 1N aqueous solution of hydrochloric acid. After drying the organic layer with sodium sulfate, the solvent was distilled off and the obtained residue was purified by silica gel column chromatography to obtain 4-(3-methyl-4-nitro-benzyl)-5-trifluoromethyl-2,4-dihydro-pyrazol-3-one (1.0 g).
    • [0587]
      1H-NMR (DMSO-d6, 90 MHz): δ2.2 (3H, s), 3.8 (2H, s), 7.0 (1H, d, J=5.5 Hz), 7.2 (1H, s), 7.8 (1H, d, J=5.5 Hz), 11.2 (1H, brs).
    • Synthesis Example 30 Starting Material
    • [0588]
    • [0589]
      To a DMF suspension of 4-(3-methyl-4-nitro-benzyl)-5-trifluoromethyl-2,4-dihydro-pyrazol-3-one (1.0 g) and potassium carbonate (1.5 g), chlorodifluoromethane (5.7 g) was sealed in by using a balloon. After 5 hours, after the gas in the solution was saturated, the vessel was tightly closed and the mixture was stirred at 50° C. for 5 hours. After cooling, the solvent was distilled off and the obtained residue was dissolved in ethyl acetate and washed with water and saturated aqueous solution of sodium chloride. After drying the organic layer with sodium sulfate, the solvent was distilled off and the obtained residue was purified by silica gel column chromatography to obtain 5-difluoromethoxy-1-difluoromethyl-4-(3-methyl-4-nitro-benzyl)-3-trifluoromethyl-1H-pyrazole (IX-1) (0.5 g) and 3-difluoromethoxy-1-difluoromethyl-4-(3-methyl-4-nitro-benzyl)-5-trifluoromethyl-1H-pyrazole (IX-2) (0.4 g) respectively.
    • [0590]
      (IX-1): nD 20 1.4780, (IX-2): nD 20 1.4855.
    • Synthesis Example 31 Starting Material
    • [0591]
    • [0592]
      (3-Methyl-4-nitrophenyl)-hydrazine (3.0 g) and hexafluoroacetylacetone (3.7 g) were dissolved in toluene and the solution was refluxed for 6 hours. After cooling, the solvent was distilled off and the obtained residue was purified by silica gel column chromatography to obtain 1-(3-methyl-4-nitrophenyl)-3,5-bis(trifluoromethyl)-1H-pyrazole (5.6 g). nD 20 1.4890.
    • Synthesis Example 32 Starting Material
    • [0593]
    • [0594]
      (3-Methyl-4-nitro-phenyl)-hydrazine (2.0 g) and 1,1,1,5,5,6,6,6-octafluoro-2,4-hexanedione (3.1 g) were dissolved in toluene and the solution was refluxed for 6 hours. After cooling, the solvent was distilled off and the obtained residue was purified by silica gel column chromatography to obtain 1-(3-methyl-4-nitro-phenyl)-3-pentafluoroethyl-5-trifluoromethyl-1H-pyrazole (IX-3) (3.0 g) and 2-(3-methyl-nitro-phenyl)-5-pentafluoroethyl-3-trifluoromethyl-3,4-dihydro-2H-pyrazol-3-ol (IX-4) (0.5 g), respectively.
    • [0595]
      (IX-3): nD 20 1.4690,
    • [0596]
      (IX-4): 1H-NMR (CDCl3, 90 MHz): δ2.6 (3H, s), 3.3 (1H, br d, J=16 Hz), 3.7 (1H, br d, J=16 Hz), 4.1 (1H, s), 7.2 (2H, m), 7.8 (1H, d, J=7.8 Hz).
    • Synthesis Example 33 Starting Material
    • [0597]
    • [0598]
      To a THF suspension of 1-(3-methyl-4-nitro-phenyl)-ethanone (2.0 g), sodium hydride (0.6 g) was slowly added and the mixture was stirred for 1 hour. After adding ethyl trifluoroacetate (1.6 g), the reaction mixture was refluxed for 5 hours. After cooling, the solvent was distilled off under reduced pressure. The residue was suspended in ethyl acetate and washed with 1N aqueous solution of hydrochloric acid. After drying the organic layer with sodium sulfate, the solvent was distilled off and the obtained residue was purified by silica gel column chromatography to obtain 4,4,4-trifluoro-1-(3-methyl-4-nitro-phenyl)-butane-1,3-dione (2.5 g).
    • [0599]
      1H NMR (CDCl3, 90 MHz): δ2.6 (3H, s), 6.5 (1H, s), 7.7-8.1 (3H, m).
    • Synthesis Example 34 Starting Material
    • [0600]
    • [0601]
      A toluene solution of 4,4,4-trifluoro-1-(3-methyl-4-nitro-phenyl)-butane-1,3-dione (1.8 g), 2,2,2-trifluoroethylhydrazine (1.2 g) and a catalytic amount of p-toluenesulfonic acid were refluxed for 6 hours. After cooling, the solvent was distilled off and the obtained residue was purified by silica gel column chromatography to obtain 3-(3-methyl-4-nitro-phenyl)-1-(2,2,2-trifluoro-ethyl)-5-trifluoro-methyl-1H-pyrazole (IX-5) (1.1 g) and 5-(3-methyl-4-nitro phenyl)-1-(2,2,2-trifluoro-ethyl)-3-trifluoromethyl-1H-pyrazole (IX-6) (0.5 g), respectively.
    • [0602]
      (IX-5) mp; 98-104° C., (IX-6) mp; 50-53° C.
    • Synthesis Example 35 Starting Material
    • [0603]
    • [0604]
      To a dichloromethane solution of 2,2-dimethyl-1,3-dioxane-4,6-dione (10 g) and dimethylaminopyridine (17 g), a dichloromethane solution of 3-methyl-4-nitro-benzoyl chloride (14 g) was added dropwise under ice cooling. After stirring at room temperature for 3 hours and then adding 100 ml of ethanol, the mixture was refluxed for 2 hours. After cooling, the solvent was distilled off under the reduced pressure. The residue was dissolved in ethyl acetate and washed with 1N aqueous solution of hydrochloric acid. After drying the organic layer with sodium sulfate, the solvent was distilled off and the obtained residue was purified by silica gel column chromatography to obtain ethyl 3-(3-methyl-4-nitro-phenyl)-3-oxo-propionate (12.4 g). mp; 207-211° C.
    • Synthesis Example 36 Starting Material
    • [0605]
    • [0606]
      To an ethanol solution of ethyl 3-(3-methyl-4-nitro-phenyl)-3-oxo propionate (3.0 g), hydrazine monohydrate (0.9 g) and a small amount of p-toluenesulfonic acid were added and the mixture was refluxed for 5 hours. After cooling, the solvent was distilled off under the reduced pressure and the obtained residue was purified by silica gel column chromatography to obtain 5-(3-methyl-4-nitro-phenyl)-2,4-dihydro-pyrazol-3-one (2.6 g). mp; 218-219° C.
    • Synthesis Example 37 Starting Material
    • [0607]
    • [0608]
      To a DMF suspension of 5-(3-methyl-4-nitro-phenyl)-2,4-dihydro-1H-pyrazol-3-one (2.0 g) and potassium carbonate (6.3 g), chlorodifluoromethane (8.7 g) was sealed in by using a balloon. After 5 hours, after the gas in the solution was saturated, the vessel was tightly closed and the mixture was stirred at 50° C. for 5 hours. After cooling, the solvent was distilled off and the obtained residue was dissolved in ethyl acetate and washed with water and saturated aqueous solution of sodium chloride. After drying with sodium sulfate, the solvent was distilled off and the obtained residue was purified by silica gel column chromatography to obtain 5-difluoromethoxy-1-difluoromethyl-3-(3-methyl-4-nitro-phenyl)-1H-pyrazole (IX-7) (0.7 g) and 3-difluoromethoxy-1-difluoromethyl-5-(3-methyl-4-nitro-phenyl)-1H-pyrazole (IX-8) (0.5 g), respectively.
    • [0609]
      (IX-7) rap; 80-82° C., (IX-8) mp; 99-100° C.
    • Synthesis Example 38 Starting Material
    • [0610]
    • [0611]
      To an ethanol solution (60 ml) of hydrazine monohydrate (5.00 g), an ethanol solution (20 ml) of 3-methyl-4-nitrobenzyl chloride (3.71 g) was added dropwise while refluxing it, and the mixture was continuously refluxed for 6 hours. After finishing the reaction, the solvent was distilled off and (3-methyl-4-nitrobenzyl)-hydrazine (3.50 g) was obtained.
    • [0612]
      1H-NMR (CDCl3, ppm): 2.60 (3H, s), 2.65-3.35 (3H, m), 3.95 (2H, s), 7.20-7.40 (2H, m), 7.98 (1H, d).
    • Synthesis Example 39 Starting Material
    • [0613]
    • [0614]
      (3-Methyl-4-nitrobenzyl)-hydrazine (1.81 g) and 5-ethoxy-1,1,1,2,2-pentafluoro-4-penten-3-one (2.18 g) were refluxed in ethanol (60 ml) for 8 hours, and p-toluenesulfonic acid (0.10 g) was added thereto and the mixture was further refluxed for 6 hours. After finishing the reaction, the solvent was distilled off and the obtained residue was purified by silica gel column chromatography (mixed solvent of n-hexane and ethyl acetate) to obtain 1-(3-methyl-4-nitrobenzyl)-5-pentafluoroethyl-1H-pyrazole (0.96 g) as the first elution portion and 1-(3-methyl-4-nitrobenzyl)-3-pentafluoroethyl-1H-pyrazole (0.50 g) as the second elution portion.
    • [0615]
      (IX-9): 1H-NMR (CDCl3, ppm): 2.61 (3H, s), 5.49 (2H, s), 6.70 (1H, bs), 7.05-7.15 (2H, m), 7.66 (1H, bs), 7.94 (1H, d).
    • [0616]
      (IX-10): 1H-NMR (CDCl3, ppm): 2.64 (3H, s), 5.40 (2H, s), 6.63 (1H, d), 7.07-7.20 (2H, m), 7.52 (1H, d), 7.95 (1H, d).
    • Synthesis Example 40 Starting Material
    • [0617]
    • [0618]
      A mixture of 5-fluoro-2-nitrotoluene (2.33 g), 4-iodo-1H-pyrazole (2.91 g) and potassium carbonate (2.49 g) was heated and stirred in DMF (30 ml) at 140° C. for 4 hours. After cooling to room temperature, the reaction mixture was poured into ice water to separate out crystals. The obtained crystals were filtered, washed with water and dried, and 4-iodo-1-(3-methyl-4-nitrophenyl)-1H-pyrazole (4.60 g) was obtained.
    • [0619]
      1H-NMR (CDCl3, ppm): 2.70 (3H, s), 7.50-7.70 (3H, m), 7.95-8.15 (2H, m).
    • Synthesis Example 41 Starting Material
    • [0620]
    • [0621]
      4-Iodo-1-(3-methyl-4-nitrophenyl)-1H-pyrazole (1.98 g), copper powder (1.14 g), iodopentafluoroethane (8.85 g) and DMSO (9 ml) were set in an autoclave and heated and stirred for 8 hours, maintaining the inside temperature of 100° C. After finishing the reaction, the reaction mixture was poured into ice water and an insoluble matter was filtered with Celite, and then, it was extracted with ethyl acetate. The extracted solution was washed with water and dried with anhydrous sodium sulfate. After distilling off the solvent, the obtained residue was purified by silica gel column chromatography to obtain 1-(3-methyl-4-nitrophenyl)-4-pentafluoroethyl-1H-pyrazole (0.72 g).
    • [0622]
      1H-NMR (CDCl3, ppm): 2.70 (3H, s), 7.60-7.73 (2H, m), 7.93 (1H, s), 8.13 (1H, d), 8.23 (1H, s).
    • Synthesis Example 42 Starting Material
    • [0623]
    • [0624]
      To a suspension of methanol (300 ml) of 3-methyl-4-nitroacetophenone (26.88 g), sodium borohydride (8.51 g) was added at 0° C. over a period of 1 hour. The mixture was further stirred at room temperature for 8 hours. After finishing the reaction, the reaction mixture was poured into ice water (1,000 ml) and extracted with ether. The organic layer was washed with saturated aqueous solution of sodium chloride and dried with anhydrous magnesium sulfate. After distilling off the solvent, the aimed 1-(3-methyl-4-nitrophenyl)-ethanol (23.33 g) was obtained.
    • [0625]
      1H-NMR (CDCl3, ppm): 1.51 (3H, d), 1.98 (1H, d), 2.62 (3H, s), 4.90-5.01 (1H, m), 7.28-7.35 (2H, m), 7.98 (1H, d).
    • Synthesis Example 43 Starting Material
    • [0626]
    • [0627]
      Into a THF solution (35 ml) of 1-(3-methyl-4-nitrophenyl)-ethanol (5.44 g) and triethylamine (3.95 g), a THF solution (10 ml) of methanesulfonyl chloride (3.48 g) was added dropwise at 5° C. over a period of 30 minutes. Further, the mixture was stirred at room temperature for 8 hours. After finishing the reaction, the solvent was distilled off and the residue was dissolved in ethyl acetate (100 ml). It was washed with 2N aqueous solution of hydrochloric acid and saturated aqueous solution of sodium bicarbonate and then dried with anhydrous magnesium sulfate. After distilling off the solvent, the aimed 1-(3-methyl-4-nitrophenyl)-ethyl methanesulfonate (5.80 g) was obtained.
    • [0628]
      1H-NMR (CDCl3, ppm): 1.74 (3H, d), 2.65 (3H, s), 2.95 (3H, s), 5.76 (1H, q), 7.35-7.45 (2H, m), 8.01 (1H, d).
    • Synthesis Example 44 Starting Material
    • [0629]
    • [0630]
      1-(3-Methyl-4-nitrophenyl)-ethyl methanesulfonate (2.59 g), 3-trifluoromethyl-1H-pyrazole (1.09 g), potassium carbonate (1.66 g) and 18-crown-6 (0.26 g) were refluxed in acetonitrile (100 ml) for 6 hours. After finishing the reaction, water (100 ml) was added to the mixture and extracted with ethyl acetate. The organic layer was washed with saturated aqueous solution of sodium bicarbonate and then dried with anhydrous sodium sulfate. After distilling off the solvent, the obtained residue was purified by silica gel column chromatography to obtain 1-[1-(3-methyl-4-nitrophenyl)-ethyl]-3-trifluoromethyl-1H-pyrazole (1.60 g).
    • [0631]
      1H-NMR (CDCl3, ppm): 1.95 (3H, d), 2.59 (3H, s), 5.59 (1H, q), 6.57 (1H, bs), 7.13-7.20 (2H, m), 7.47 (1H, bs), 8.00 (1H, d).
    • Synthesis Example 45 Starting Material
    • [0632]
    • [0633]
      Ethyl pentafluoropropylenate (14.6 g) and hydrazine monohydrate (3.6 g) were refluxed in tetrahydrofuran (300 ml) for 1 hour. After cooling to room temperature, trifluoroacetamidine (10.0 g) was added dropwise to the mixture and it was refluxed for 3 hours. After finishing the reaction, saturated aqueous solution of sodium hydrogen carbonate was added thereto and the mixture was extracted with ethyl acetate. After drying the organic layer with anhydrous magnesium sulfate, the solvent was distilled off to obtain crude 3-pentafluoroethyl-5-trifluoromethyl-1H-(1,2,4)-triazole (7.9 g).
    • Synthesis Example 46 Starting Material
    • [0634]
    • [0635]
      1-(3-Methyl-4-nitrophenyl)-ethyl methanesulfonate (2.5 g), 3-pentafluoroethyl-5-trifluoromethyl-1H-(1,2,4)-triazole (2.2 g), potassium carbonate (1.6 g) and 18-crown-6 (0.26 g) were refluxed in acetonitrile (100 mil) for 6 hours. After finishing the reaction, water (100 ml) was added thereto and the mixture was extracted with ethyl acetate. The organic layer was washed with saturated aqueous solution of sodium chloride (100 ml) and then dried with anhydrous sodium sulfate. After distilling off the solvent, the obtained residue was purified by silica gel column chromatography (mixed solvent of n-hexane and ethyl acetate) to obtain (IX-11) 1-([1-(3-methyl-4-nitro phenyl)-ethyl]-5-pentafluoroethyl-3-trifluoromethyl-1H-(1,2,4)-triazole (0.95 g) as the first elution portion and (IX-12) 1-([1-(3-methyl-4-nitro-phenyl)-ethyl]-3-pentafluoroethyl-5-trifluoromethyl-1H-(1,2,4)-triazole (1.35 g) as the second elution portion.
    • [0636]
      (IX-11)
    • [0637]
      1H-NMR (CDCl3) δ: 8.03-7.97 (1H, m), 7.37 (2H, t, J=5.4 Hz), 5.86 (1H, q, J=7.0 Hz), 2.62 (3H, s), 2.00 (3H, d, J=7.0 Hz).
    • [0638]
      (IX-12)
    • [0639]
      1H-NMR (CDCl3) δ: 7.98 (1H, d; J=8.2 Hz), 7.34 (2H, t, J=7.1 Hz), 5.81 (1H, q, J=7.0 Hz), 2.63 (3H, s), 2.01 (3H, d, J=7.0 Hz).
    • Synthesis Example 47 Starting Material
    • [0640]
    • [0641]
      Sodium hydride (0.10 g) was added to a DMF solution (12 ml) of 4-methyl-5-pentafluoroethyl-4H-[1,2,4]triazol-3-thiol (0.70 g), and the mixture was stirred at room temperature until the generation of hydrogen gas stopped. Continuously, 5-fluoro-2-nitrotoluene (0.47 g) was added thereto and the mixture was further stirred at room temperature for 1 hour. After cooling to room temperature, the reaction mixture was poured into ice water and extracted with ethyl acetate. The organic layer was washed with saturated aqueous solution of sodium chloride and then dried with anhydrous sodium sulfate. After distilling off the solvent, the obtained residue was purified by silica gel column chromatography (mixed solvent of n-hexane and ethyl acetate) to obtain the aimed 4-methyl-3-(3-methyl-4-nitrophenyl sulfanyl)-5-pentafluoroethyl-4H-(1,2,4)-triazole (0.55 g).
    • [0642]
      1H-NMR (CDCl3, ppm): 2.70 (3H, s), 3.80 (3H, s), 8.10-8.30 (3H, m).
    • Synthesis Example 48 Starting Material
    • [0643]
    • [0644]
      A mixture of 2-methylmelcapto-4.6-bistrifluoromethyl-pyrimidine (36 g), oxone (126 g), water (500 ml) and chloroform (110 ml) was refluxed for 2 days. After cooling to room temperature, the mixture was extracted with dichloromethane. The obtained organic layer was washed with water and then dried with anhydrous sodium sulfate. After distilling off the solvent, the obtained crude crystals were washed with petroleum ether to obtain 2-methanesulfonyl-4.6-bistrifluoromethyl-pyrimidine (7.5 g).
    • [0645]
      1H-NMR (CDCl3, ppm): 3.48 (3H, s), 8.19 (1H, s).
    • Synthesis Example 49 Starting Material
    • [0646]
    • [0647]
      4-Nitro-m-cresol (0.77 g), 2-methanesulfonyl-4,6-bistrifluoromethyl-pyrimidine (1.77 g) and potassium carbonate (1.04 g) were refluxed in acetonitrile (15 ml) for 5 hours. After finishing the reaction, the reaction mixture was poured into ice to separate out crystals. The obtained crystals were filtered and dried to obtain 2-(3-methyl-4-nitrophenoxy)-4,6-bistrifluoromethyl-pyrimidine (1.03 g).
    • [0648]
      1H-NMR (CDCl3, ppm): 2.60 (3H, s), 7.1-7.3 (2H, m), 7.67 (1H, s), 8.10 (1H, d).
    • Synthesis Example 50 Starting Material
    • [0649]
    • [0650]
      (3-Methyl-4-nitrophenyl)-acetonitrile (3.52 g) was dissolved in pyridine (30 ml), thereto excess H2S was bubbled into at room temperature for 3 hours. Then the mixture was poured onto ice. The precipitate was collected by suction, washed with water and dried to obtain 2-(3-methyl-4-nitro-phenyl)-thioacetamide (1.69 g).
    • [0651]
      1H-NMR (CDCl3, ppm): 2.60 (3H, s), 4.06 (2H, s), 6.40-8.00 (5H, m)
    • Synthesis Example 51 Starting Material
    • [0652]
    • [0653]
      2-(3-Methyl-4-nitrophenyl)-thioacetamide (1.00 g), 1-bromo-3,3,4,4,4-pentafluoro-2-butanone (1.15 g) and potassium carbonate (0.79 g) were stirred in DMF (10 ml) at room temperature for 1 hour. The reaction solution was diluted with ethyl acetate and washed with water and saturated aqueous solution of sodium chloride. After drying the organic layer with magnesium sulfate, the solvent was distilled off under the reduced pressure and the obtained residue was purified by silica gel column chromatography to obtain 2-(3-Methyl-4-nitro-phenyl)-thioacetimidic acid 3,3,4,4,4-pentafluoro-2-oxo-butyl ester (1.30 g).
    • [0654]
      1H-NMR (CDCl3, ppm): 2.55 (3H, s), 3.57 (2H, dd), 3.90 (2H, d), 7.24-7.22 (2H, m), 7.91-7.89 (1H, m)
    • Synthesis Example 52 Starting Material
    • [0655]
    • [0656]
      Trifluoroacetic anhydride (1.47 g) was added to 2-(3-Methyl-4-nitro-phenyl)-thioacetimidic acid 3,3,4,4,4-pentafluoro ester (130 g) and triethylamine (0.71 g) in dichloromethane (10 ml), and stirred at room temperature for 20 minutes. The reaction solution was washed with water, and the solvent was distilled off under the reduced pressure and the obtained residue was purified by silica gel column chromatography to obtain 2-(3-methyl-4-nitro-benzyl)-4-perfluoroethyl-thiazole (0.70 g).
    • [0657]
      1H-NMR (CDCl3, ppm): 2.63 (3H, s), 4.43 (2H, s), 7.30-7.28 (2H, m), 7.75 (1H, s), 7.98 (1H, d)
    • Synthesis Example 53 Starting Material
    • [0658]
    • [0659]
      An acetonitrile solution (20 ml) of 3-pentafluoroethyl-1H-pyrazole (2.0 g), dicerium ammonium nitrate (3.0 g) and iodine (1.6 g) was refluxed for 3 hours. After cooling, the reaction solution was washed with saturated aqueous solution of sodium thiosulfate and saturated aqueous solution of sodium chloride. After drying the organic layer with magnesium sulfate, the solvent was distilled off under the reduced pressure to obtain 4-iodo-3-pentafluoroethyl-1H-pyrazole (32 g).
    • [0660]
      1H-NMR (CDCl3, ppm): 7.77 (1H, s), 11.11 (1H, m)
    • Synthesis Example 54 Starting Material
    • [0661]
    • [0662]
      4-Iodo-3-pentafluoroethyl-1H-pyrazole (6.24 g), copper powder (3.81 g), Iodo-1,1,2,2-tetrafluoroethane (9.12 g) and DMF (30 ml) were set in an autoclave and heated and stirred for 8 hours, maintaining the inside temperature of 120-125° C. After cooling to room temperature, the insoluble material was filtered off through Celite and washed with diethyl ether. The filtrate was diluted with water and extracted with diethyl ether. The organic phase was washed with water and dried over sodium sulfate, and concentrated under the reduced pressure. The crude product was distilled under reduced pressure to obtain 3-pentafluoroethyl-4-(1,1,2,2-tetrafluoroethyl)-1H-pyrazole (0.60 g), bp. 125-135° C./20 mbar.
    • [0663]
      1H-NMR (CDCl3, ppm): 5.98 (1H, tt), 7.96 (1H, s), 12.22 (1H, m)
    • Synthesis Example 55 Starting Material
    • [0664]
    • [0665]
      4-Iodo-3-pentafluoroethyl-1H-pyrazole (12.48 g), copper powder (7.63 g), iodopentafluoroethane (29.50 g) and DMF (60 ml) were set in an autoclave and heated and stirred for 8 hours, maintaining the inside temperature of 120-125° C. After cooling to room temperature, the insoluble material was filtered off through Celite and washed with diethyl ether. The filtrate was diluted with water and extracted with diethyl ether. The organic phase was washed with water and dried over sodium sulfate, and concentrated under the reduced pressure. The crude product was distilled under reduced pressure to obtain 3,4-bis-pentafluoroethyl-1H-pyrazole (1.20 g), bp. 110-115° C./20 mbar.
    • [0666]
      1H-NMR (CDCl3, ppm): 7.99 (1H, s), 12.31 (1H, m).
    • Synthesis Example 56 Starting Material
    • [0667]
    • [0668]
      An acetonitrile solution (20 ml) of 4-methyl-1H-pyrazole (0.5 g), dicerium ammonium nitrate (1.7 g) and iodine (1.9 g) was refluxed for 3 hours. After cooling, the reaction solution was washed with saturated aqueous solution of sodium thiosulfate and saturated aqueous solution of sodium chloride. After drying the organic layer with magnesium sulfate, the solvent was distilled off under the reduced pressure to obtain 3,5-diiodo-4-methyl-1H-pyrazole (1.2 g).
    • [0669]
      1H-NMR (CDCl3, ppm): 2.03 (3H, s), 6.96 (1H, br s)
    • Synthesis Example 57 Starting Material
    • [0670]
    • [0671]
      5-Trifluoromethyl-1H-(1,2,4)-triazole-3-thiol (1.0 g), heptafluoro-1-iodopropane (3.5 g) and triethylamine (0.90 g) were stirred in DMF (10 ml) at 90° C. for 24 hours. After cooling to room temperature; the reaction mixture was diluted with ethyl acetate and washed with water and saturated aqueous solution of sodium chloride. After drying the organic layer with magnesium sulfate, the solvent was distilled off under the reduced pressure to obtain 3-heptafluoropropylsulfanyl-5-trifluoromethyl-1H-(1,2,4)-triazole (0.70 g).
    • USE EXAMPLES Biological Test Example 1 Test Against Larva of Spodoptera litura Preparation of Test Solution:
    • [0672]
    • [0000]
      Solvent: Dimethylformamide: 3 parts by weight
      Emulsifier: Polyoxyethylene alkyl phenyl ether: 1 part by weight
    • [0673]
      In order to make an appropriate formulation of an active compound, 1 part by weight of the active compound was mixed with the above-mentioned amount of solvent containing the above-mentioned amount of emulsifier and the mixture was diluted with water to a prescribed concentration.
    • Test Method:
    • [0674]
      Leaves of sweet potato were soaked in the test solution diluted to a prescribed concentration with water, dried in the air and put in a dish of 9 cm diameter.
    • [0675]
      10 larvae of Spodoptera litura at the third instar were placed on the leaves and kept in a room at the constant temperature of 25° C. After 2 and 4 days further leaves of sweet potato were added and after 7 days the number of dead larvae was counted and the rate of death was calculated.
    • [0676]
      In this test the results of 2 dishes at 1 section were averaged.
    • Biological Test Example 2 Test Against Larva of Cnaphalocrocis medinalis Guenee Test Method:
    • [0677]
      Paddy rice (variety: Tamanishiki) planted in a pot was treated by spraying 50 ml per pot of the diluted aqueous solution of the prescribed concentration of the active compound prepared in the same manner as in the above-mentioned Biological Test Example 1. After the treated rice plant was dried in the air, their foliage part was cut in 4-5 cm length, which were put in a dish with 9 cm diameter with a sheet of filter paper and 2 ml of water. Five larvae of Cnaphalocrocis medinalis Guenee at the second instar were put in the dish that was placed in a room at the constant temperature of 25° C. After 2 and 4 days; each rest (each ⅓ amount) of foliage parts of rice plant were cut in the same manner and added to the dish. After 7 days the number of dead larvae was counted and the rate of death was calculated. In this test the results of 2 dishes at 1 section were averaged.
    • Test Results:
    • [0678]
      In the above Biological Test Examples 1 and 2, as specific examples, the compounds of the aforementioned compound Nos. 8, 9, 10, 11, 12, 13, 14, 15, 16, 45, 47, 48, 49, 51, 52, 53, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 93, 103, 107, 116, 128, 132, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 153, 155, 157, 174, 176, 177, 178, 180, 181, 182, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 226, 227, 229, 230, 231, 238, 239, 242, 243, 251, 253, 262, 264, 268, 270, 281, 299, 308, 310, 318, 322, 413, 414, 417, 422, 434, 446, 448, 473, 475, 492, 506, 508, 512, 518, 520, 539, 543, 544, 545, 546, 547, 548, 549, 552, 554, 559, 561, 562, 563, 564, 565, 566, 567, 568, 570, 571, 572, 573, 574, 578, 579, 580, 626, 637, 638, 639, 640, 641, 642, 643, 644, 645, 646, 647, 648, 649, 650, 655, 656, 657, 658, 659, 660, 661, 662, 663, 664, 665, 666, 667, 668, 669, 670, 671, 672, 681, 761, 762, 763, 804 and 920 showed controlling effect of 100% of rate of death at 20 ppm concentration of the active component.
    • Biological Test Example 3 Test Against Myzus persicae Resistant to Organophosphorous Agents and Carbamates Test Method:
    • [0679]
      About 30 bred Myzus persicae resistant to organophosphorous agents and carbamates were inoculated per 1 seedling of eggplant planted in a vinyl pot of 6 cm diameter. One day after the inoculation, a sufficient amount of a diluted aqueous solution of a prescribed concentration of an active compound prepared as mentioned above, was sprayed by using a spray gun. After spraying it was placed in a green house of 28° C. and the rate of death was calculated 7 days after the spraying. Test was repeated twice.
    • Test Results
    • [0680]
      The compounds of the aforementioned compound Nos. 140, 141, 144, 146, 147, 148, 174, 176, 177, 178, 180, 181, 211, 213, 214, 215, 218, 220, 222, 226, 239, 243, 569, 570, 572, 579, 761, 797 and 920 offered to the test as specific examples showed controlling effect of 100% of rate of death at 100 ppm concentration of the effective component.
    • Formulation Example 1 Granule
    • [0681]
      To a mixture of 10 parts of the compound of the present invention (No. 8), 30 parts of bentonite (montmorillonite), 58 parts of talc and 2 parts of ligninsulfonate salt, 25 parts of water are added, well kneaded, made into granules of 10-40 mesh by an extrusion granulator and dried at 40-50° C. to obtain granules.
    • Formulation Example 2 Granules
    • [0682]
      95 Parts of clay mineral particles having particle diameter distribution in the range of 0.2-2 mm are put in a rotary mixer. While rotating it, 5 parts of the compound of the present invention (No. 11) are sprayed together with a liquid diluent, wetted uniformly and dried at 40-50° C. to obtain granules.
    • Formulation Example 3 Emulsifiable Concentrate
    • [0683]
      30 Parts of the compound of the present invention (No. 12), 55 parts of xylene, 8 parts of polyoxyethylene alkyl phenyl ether and 7 parts of calcium alkylbenzenesulfonate are mixed and stirred to obtain an emulsifiable concentrate.
    • Formulation Example 4 Wettable Powder
    • [0684]
      15 Parts of the compound of the present invention (No. 15), 80 parts of a mixture of white carbon (hydrous amorphous silicon oxide fine powders) and powder clay (1:5), 2 parts of sodium alkylbenzenesulfonate and 3 parts of sodium alkylnaphthalenesulfonate-formalin-condensate are crushed and mixed to make a wettable powder.
    • Formulation Example 5 Water Dispersible Granule
    • [0685]
      20 Parts of the compound of the present invention (No. 16), 30 parts of sodium ligninsulfonate, 15 parts of bentonite and 35 parts of calcined diatomaceous earth powder are well mixed, added with water, extruded with 0.3 mm screen and dried to obtain water dispersible granules.
    Patent Citations
    Cited PatentFiling datePublication dateApplicantTitle
    US2785115 *4 Apr 195512 Mar 1957Smidth & Co As F LRotary kiln with integral cooler
    US3264177 *17 Feb 19642 Aug 1966Dow Chemical CoMethods for the control of arachnids
    US3309266 *1 Jul 196514 Mar 1967Chevron ResInsecticidal compositions containing oalkyl-s-alkyl phosphoroamidothioates and methods for killing insects therewith
    US4053608 *7 Aug 197511 Oct 1977Sankyo Company LimitedCompositions and methods for the treatment of coccidiosis
    US4181800 *6 Oct 19761 Jan 1980Fujisawa Pharmaceutical Co., Ltd.2-Azetidinone compounds and processes for preparation thereof
    US4808430 *11 Feb 198828 Feb 1989Yazaki CorporationMethod of applying gel coating to plant seeds
    US5416103 *16 Sep 199316 May 1995Basf AktiengesellschaftN-cyclohex(en)yl-pyridine carboxamides and compositions containing them for controlling fungal pests
    US5438070 *16 Sep 19931 Aug 1995Basf AktiengesellschaftCarboxanilides, their preparation and compositions containing them for controlling harmful fungi
    US5556988 *7 Jun 199517 Sep 1996Basf AktiengesellschaftAnilide derivatives and their use for combating botrytis
    US5876739 *23 Jun 19972 Mar 1999Novartis AgInsecticidal seed coating
    US6362369 *16 Feb 199926 Mar 2002Nihon Nohyaku Co., Ltd.Phthalic acid diamide derivatives fluorine-containing aniline compounds as starting material, agricultural and horticultural insecticides, and a method for application of the insecticides
    US6559341 *4 Jan 20026 May 2003Nihon Nohyaku Co., Ltd.Phthalic acid diamide derivatives, fluorine-containing aniline compounds as starting material, agricultural and horticultural insecticides, and a method for application of the insecticides
    US6603044 *29 Nov 19995 Aug 2003Nihon Nohyaku Co., Ltd.Phthalamide derivatives, or salt thereof agrohorticultural insecticide, and method for using the same
    US6639109 *27 Sep 200028 Oct 2003Nihon Nohyaku Co., Ltd.Process for production of thioalkylamine derivatives
    US6642379 *23 Jun 20004 Nov 2003Nihon Nohyaku Co., Ltd.Benzamide derivatives, insecticides for agricultural and horticultural use and usage thereof
    US6747041 *23 Jun 20008 Jun 2004Nihon Nohyaku Co., Ltd.Heterocyclic dicarboxylic acid diamide derivatives, agricultural/horticultural insecticides and method of using the same
    US6864289 *22 Sep 20008 Mar 2005Nihon Nohyaku Co., Ltd.Aromatic diamide derivatives or salts thereof, agricultural/horticultural chemicals and method of using the same
    US20010004181 *18 Dec 200021 Jun 2001Peter JaenkerPiezoelectric actuator system
    US20010041814 *16 Feb 199915 Nov 2001Masanori TohnishiPhthalic acid diamide derivatives fluorine-containing aniline compounds as starting material, agricultural and horticultural insecticides, and a method for application of the insecticides
    US20030119670 *1 Dec 200026 Jun 2003Tomohiro ArakiDifluoromethyltriazolone compounds, use of the same and intermediates for the production thereof
    US20030176428 *18 Nov 200218 Sep 2003Schneidersmann Ferdinand MartinPesticidal composition for seed treatment
    US20090023752 *5 Nov 200522 Jan 2009Bayer Cropscience AgN-Heterocyclylphthaldiamides as Insecticides
    US20090209769 *1 Mar 200620 Aug 2009Bayer Cropscience AgAlkyl-Analide Producing Method
    Referenced by
    Citing PatentFiling datePublication dateApplicantTitle
    US80535721 Mar 20068 Nov 2011Bayer Cropscience AgAlkyl-analide producing method
    US866934127 Aug 201211 Mar 2014Ticona LlcSolid-state polymerization of a liquid crystalline polymer
    US877822127 Aug 201215 Jul 2014Ticona LlcAromatic amide compound
    US885273027 Aug 20127 Oct 2014Ticona LlcMelt-extruded substrate for use in thermoformed articles
    US890625827 Aug 20129 Dec 2014Ticona LlcHeat-resistant liquid crystalline polymer composition having a low melting temperature
    US90054755 Jun 201414 Apr 2015Ticona LlcAromatic amide compound
    US904568527 Aug 20122 Jun 2015Ticona LlcCast molded parts formed from a liquid crystalline polymer
    US905151427 Aug 20129 Jun 2015Ticona LlcHigh flow liquid crystalline polymer composition
    US905701627 Aug 201216 Jun 2015Ticona LlcMelt polymerization of low melt viscosity liquid crystalline polymers
    US907413327 Aug 20127 Jul 2015Ticona LlcThermotropic liquid crystalline polymer with improved low shear viscosity
    US909679427 Aug 20124 Aug 2015Ticona LlcHigh flow liquid crystalline polymer composition
    US910279219 Feb 201411 Aug 2015Ticona LlcHigh performance polymer composition with improved flow properties
    US92063005 Jun 20148 Dec 2015Ticona LlcHigh strength thermotropic liquid crystalline polymer
    US20090209769 *1 Mar 200620 Aug 2009Bayer Cropscience AgAlkyl-Analide Producing Method
    WO2014149779A15 Mar 201425 Sep 2014Life Technologies CorporationChemical device with thin conductive element
    Classifications
    U.S. Classification544/335, 548/263.2, 548/373.1
    International ClassificationA01N43/78, A01N43/56, C07D239/26, A01N43/54, C07D233/54, C07D207/333, C07D239/30, C07D207/32, A01N43/653, C07D233/68, C07D231/08, C07D249/08, C07D231/20, C07D231/12, C07D231/18, C07D249/12, C07D231/16, A01N43/36
    Cooperative ClassificationA01N43/36, C07D231/12, C07D231/08, A01N43/653, C07D233/68, A01N43/54, C07D231/20, C07D231/18, C07D233/64, A01N43/56, C07D249/12, C07D239/30, C07D249/08, A01N43/78, C07D207/333
    European ClassificationC07D233/68, A01N43/78, C07D231/18, A01N43/653, A01N43/56, C07D231/20, A01N43/36, C07D231/08, A01N43/54, C07D207/333, C07D233/64, C07D249/12, C07D239/30, C07D231/12, C07D249/08